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ABSTRACT 
Exploring Lactobacillus paracasei probiosis and metabolic potential 
Probiotics have been used so far for the prevention and treatment of various medical conditions 
and to support general wellness: for this reason, they are currently the subject of significant 
microbiological and clinical research. In fact, a body of literature suggests that including 
probiotics in the diet can be a strategy to reduce host-related immune diseases and, in general, 
modulate the intestinal microbiota composition. Although the mechanisms of action of 
probiotics are still largely unknown, particularly at molecular level, it is well understood that 
they can act in different ways, through interaction with the other bacteria residing the same 
niche, as well as the host, at both local and systemic levels. The genus Lactobacillus, which has 
important industrial applications as fermented food starter and probiotic adjunct, is a 
taxonomically broad and heterogeneous group and includes the species Lactobacillus 
paracasei, which is generally associated with habitats rich in nutrients, such as dairy food and 
human ecosystems, like gut and vagina.  
The main purpose of my PhD activity, concerned the study of two L. paracasei strains, named 
DG and LPC-S01, isolated from two different ecological niches (human gut and vagina, 
respectively). They are already available on the market, included in two products as food 
supplements, but their characterization is still incomplete, particularly for LPC-S01. In order to 
deepen the knowledge about these strains, the first part of the work focused on exploring L. 
paracasei DG and LPC-S01 essential characteristics to define potential probiotics, by  using L. 
paracasei Shirota as reference strain. The comparative genomic analyses evidenced that strain 
LPC-S01, a bacterium isolated from human vagina, but plausibly having its origin in the gut, 
resulted having the genetic features of a niche-generalist member of its species. Similarly, strain 
DG exhibited the potential ability to adapt to a wide range of environmental conditions if 
compared with other strains of dairy origin. In vitro tests conventionally used to evidence 
probiotic properties revealed that strains LPC-S01 and DG possessed comparable ability to 
resist to gastro-intestinal transit, as evidenced by tolerance to bile, and to decrease NF-κB 
activation in Caco-2 cells, with respect to strain Shirota. Moreover, LPC-S01 displayed higher 
tolerance to gastric juice and higher capacity to adhere to Caco-2 epithelial cells (whereas 
Shirota showed inability to adhere on Caco-2-cells). The in vitro observations were confirmed 
by setting up a pilot intervention trial on healthy adult volunteers, that demonstrated that LPC-
S01 and DG can transiently colonize the gastrointestinal tract of the host, persisting for at least 
5 days after the end of a 7-days oral consumption (corresponding to an average of 7 
evacuations).  
Thanks to the comparative genomic analysis on L. paracasei strains DG and LPC-S01, we 
identified two gene clusters putatively coding for exopolysaccharides biosynthesis related 
enzymes. Exopolysaccharides (EPSs), apart  from  their  industrial  applications, are found to be  
associated  with  many  physiological functions, although their mechanism of action has not 
been fully clarified yet. In collaboration with Prof. Andy Laws, University of Huddersfield 
(United Kingdom), the second part of the work focused on the identification of the potential 
EPSs matrix from both strains DG and LPC-S01, and their structural characterization. 
Nonetheless, in the experimental conditions tested so far, only DG resulted able to synthetize 
EPSs. After performing its purification, we characterized DG derived EPS repeating unit by 
NMR spectroscopy based approaches. DG EPS structure resulted peculiar and unique compared 
to those identified in other lactic acid bacteria, prompting us to investigate its 
immunomodulatory potential, by using it as stimulus on phagocytes. Interestingly, THP-1 
macrophages were highly responsive to the EPS stimulus, particularly through the activation of 
COX-2 expression. Moreover, COX-2 expression was also subjected to an additive effect due to 
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the combination of EPS with the pro-inflammatory stimulus of lipopolysaccharides (LPS). This 
results strongly suggest a role of DG and its secreted polysaccharidic molecule in triggering 
stimulatory immune responses together with the activation of protective mechanisms of the 
intestinal mucosa.  
Starting by previous observations on other lactic acid bacteria, particularly on Lactococcus 
lactis, which demonstrated the ability to switch from fermentation to respiratory metabolism, 
and thanks to the identification of the operon cydABCD in L. paracasei, the third part of the 
work focused on evaluating if respiration was activated also in the strains under study. The 
respiratory metabolism, activated by the addition of heme and menaquinone, two essential co-
factors not synthetized by the cell, typically results in two main advantages for the cell: 
increased biomass and long-term survival. Our preliminary data, however, indicated that only 
one of the two phenotypes occurred in L. paracasei, namely a very strong robustness achieved 
only upon addition of both heme and menaquinone, that resulted in the maintenance of viability 
for long periods of storage at 4° C (>200 days). The robustness phenotype was present also 
when the two co-factors were added during the storage time, and not during growth. This fact, 
along with (i) the detection of the added heme only outside the cells, (ii) the under regulation of 
cydA evaluated by gene expression analyses, and (iii) the decrease of ATP reservoir, suggested 
that the phenotype observed was not a consequence of a respiratory metabolism.  Our data are 
instead more consistent with the presence of an external electron transfer, as already described 
for other intestinal bacteria. A deeper investigation is required to clarify the molecular basis of 
L. paracasei acquired resistance. However, our collected evidences, i.e. the robustness 
phenotype, can potentially be exploited in industrial applications to ameliorate the technological 
performances, but also in the niche colonized by the bacterium, where it can counteract 
environmental stresses and exert its probiotic potential by reducing and neutralizing damaging 
chemicals in the surrounding environment.       
 
In conclusion, this PhD work evidenced the multiple properties of two strains belonging to L. 
paracasei species to colonize the human gut (and potentially the vagina) upon oral 
administration, and to interact with the host immune system. Moreover, L. paracasei possesses 
very interesting metabolic abilities that may be exploited both in in vivo conditions and in the 
industrial processes. 
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RIASSUNTO 
Valutazione del potenziale probiotico e metabolico di Lactobacillus 
paracasei 
I probiotici sono utilizzati attualmente per la prevenzione e il trattamento di varie condizioni 
mediche e per mantenere uno stato di salute generale: per questa ragione, sono tutt’ora il 
soggetto di molte ricerche in ambito clinico e microbiologico. Infatti, numerose pubblicazioni 
suggeriscono che includere probiotici nella dieta può essere una strategia per ridurre patologie 
legate al sistema immunitario dell’ospite e, in generale, modulare la composizione del 
microbiota intestinale. Sebbene i meccanismi di azione dei probiotici siano ancora largamente 
sconosciuti, soprattutto a livello molecolare, è assodato che essi possano agire in diversi modi, 
attraverso l’interazione con gli altri batteri residenti nella stessa nicchia ecologica ma anche con 
l’ospite stesso, sia a livello locale sia sistemico. Il genere Lactobacillus, il quale possiede 
importanti applicazioni industriali come starter alimentare e integratore probiotico, è un ampio 
ed eterogeneo gruppo dal punto di vista tassonomico ed include la specie Lactobacillus 
paracasei, la quale è generalmente associata ad habitat ricchi in nutrienti, come alimenti caseari 
ed ecosistemi umani, come l’intestino e la vagina.  
Lo scopo principale della mia attività di dottorato ha riguardato lo studio di due ceppi di L. 
paracasei, denominati DG e LPC-S01, isolati da due nicchie ecologiche diverse (intestino e 
vagina umani, rispettivamente). Essi sono già disponibili sul mercato, inclusi in due prodotti 
come integratori alimentari, ma la loro caratterizzazione risulta ancora incompleta, 
particolarmente nel caso di LPC-S01. Al fine di approfondirne la conoscenza, la prima parte del 
lavoro si è focalizzata su esplorare le caratteristiche di L. paracasei DG e LPC-S01 essenziali 
per poterli definire come potenziali probiotici, utilizzando L. paracasei Shirota come ceppo di 
riferimento. Le analisi di comparazione genomica hanno evidenziato che il ceppo LPC-S01, un 
batterio isolato da vagina umana, ma plausibilmente avente origine intestinale, risulta avere le 
caratteristiche genetiche di un membro nicchia-generalista della sua specie. In modo simile, 
anche DG ha dimostrato la potenziale capacità di adattarsi ad un ampio range di condizioni 
ambientali se comparato ad altri ceppi di origine casearia. I test in vitro convenzionalmente 
usati per evidenziare proprietà probiotiche ha rivelato che i ceppi LPC-S01 e DG possiedono  
capacità di resistere al tratto gastrointestinale, come evidenziato dalla tolleranza alla bile, e di 
diminuire l’attivazione di NF-κB in cellule Caco-2, paragonabili al ceppo di riferimento Shirota. 
Inoltre, LPC-S01 mostrava più alta tolleranza al succo gastrico e più elevata capacità adesiva 
sul modello epiteliale intestinale Caco-2 (mentre Shirota ha dimostrato di non possedere 
quest’ultima capacità). Le osservazioni in vitro sono poi state confermate dalla messa a punto di 
uno studio di intervento pilota su volontari adulti sani, il quale ha dimostrato che LPC-S01 e 
DG sono in grado di colonizzare in modo transiente l’intestino dell’ospite, persistendo per 
almeno 5 giorni dopo la fine dell’assunzione orale del prodotto per 7 giorni (e corrispondente ad 
una media di evacuazioni pari a 7). 
Grazie alle analisi comparative sui genomi di L. paracasei DG e LPC-S01, abbiamo identificato 
due cluster genetici che putativamente codificano enzimi correlati alla biosintesi degli 
esopolisaccaridi. Gli esopolisaccaridi (EPS), oltre all’applicabilità industriale, sono stati 
associati a molte funzioni fisiologiche, anche se non è stato ancora chiarito il loro meccanismo 
di azione. In collaborazione con il Prof. Andy Laws, University of Huddersfield (Regno Unito), 
la seconda parte del lavoro è stata incentrata sull’identificazione della potenziale matrice 
esopolisaccaridica prodotta da DG e LPC-S01 e sulla loro caratterizzazione strutturale. 
Tuttavia, nelle condizioni sperimentali testate ad oggi, solo il ceppo DG è risultato capace di 
sintetizzare EPS. In seguito alla purificazione, abbiamo caratterizzato l’unità ripetuta dell’EPS 
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di DG mediante approcci di spettroscopia NMR. La struttura dell’EPS di DG è risultata 
peculiare e unica quando comparata con quelle identificate in altri batteri lattici, inducendoci ad 
investigare le sue proprietà immunomodulatorie, utilizzandolo come stimolo su modelli di 
fagociti. È stato interessante verificare che i macrofagi THP-1 erano molto responsivi allo 
stimolo di EPS, particolarmente attraverso l’attivazione dell’espressione di COX-2. Inoltre, 
l’espressione di COX-2 era anche soggetta ad un effetto additivo dovuto alla combinazione di 
EPS con lo stimolo pro-infiammatorio del lipopolisaccaride (LPS). Questi risultati suggeriscono 
fortemente un ruolo di DG e della sua molecola secreta nell’innescare risposte immunitarie di 
tipo stimolatorio oltre all’attivazione di meccanismi di protezione della mucosa intestinale.  
Partendo da osservazioni precedenti su altri batteri lattici, particolarmente su Lactococcus 
lactis,  che dimostravano la capacità di passare da un metabolismo fermentativo ad uno 
respiratorio, e grazie all’identificazione dell’operone cydABCD in L. paracasei, la terza parte 
del lavoro si è focalizzata su valutare se la respirazione venisse attivata anche nei ceppi allo 
studio. Il metabolismo di tipo respiratorio, attivato dall’aggiunta di eme e menachinone, due 
cofattori essenziali non sintetizzati dalla cellula, risulta tipicamente in due principali fenotipi: 
formazione di biomassa e sopravvivenza a lungo termine aumentati. Dati preliminari, tuttavia, 
hanno indicato che uno solo dei due fenotipi si verificava in L. paracasei, ossia una elevata 
resistenza ottenuta solamente in seguito ad aggiunta di entrambi eme e menachinone, la quale 
risultava nel mantenimento di vitalità per lunghi periodi di conservazione a 4° C (>200 giorni). 
Il fenotipo di resistenza era presente anche quando i due cofattori venivano aggiunti durante il 
periodo di conservazione, e non durante la crescita. Questo fatto, oltre a (i) la rilevazione del 
gruppo eme aggiunto solo all’esterno delle cellule, (ii) l’inibizione dell’espressione di cydA, (iii) 
la diminuzione del reservoir di ATP, suggerivano che il fenotipo osservato non era conseguenza 
di un metabolismo respiratorio. I nostri dati sono invece più coerenti con la presenza di un 
trasporto di elettroni esterno, come già descritto per altri batteri intestinali. È richiesta 
un’investigazione più approfondita per chiarire le basi molecolari dell’acquisita resistenza di L. 
paracasei. Tuttavia, le prove raccolte, i.e. il fenotipo di resistenza, può essere potenzialmente 
sfruttato in applicazioni industriali per migliorare le prestazioni tecnologiche, ma anche nella 
nicchia colonizzata dalla batterio, dove può essere in grado di controbilanciare gli stress 
ambientali e eseguire il suo potenziale probiotico mediante la riduzione e neutralizzazione di 
molecole dannose nell’ambiente circostante.  
In conclusione, questo lavoro di dottorato ha evidenziato le molteplici proprietà di due ceppi di 
L. paracasei di colonizzare l’intestino umano (e potenzialmente la vagina) in seguito a 
somministrazione orale, e ad interagire con il sistema immunitario dell’ospite. Inoltre, L. 
paracasei possiede abilità metaboliche molto interessanti che si posso sfruttare sia in condizioni 
in vivo sia in processi industriali.                    
Preface 
13 
 
PREFACE 
The activity of many microorganisms is necessarily connected to the survival of the 
multicellular eukaryotic organism in which they reside. During a common evolution, the host-
microbe relationship has, indeed, far exceeded the limits of simple commensalism, evolving 
into deep symbiosis (Rosenberg and Zilber-Rosenberg, 2011). For instance, a constantly 
increasing number of scientific reports is demonstrating that microbes associated to the human 
body carry out activities such as vitamin production, competitive exclusion of pathogens, 
regulation of intestinal motility, energy harvest from indigestible components of host diet, and 
modulation of host immune system (Frick and Autenrieth, 2013). Most of these activities are 
exerted by the trillions of microorganisms colonizing the intestinal tract, collectively known as 
the gut microbiota. Skin, oral, and vaginal microbiota are of key importance as well in 
maintaining the functionality of the corresponding host’s body site (Ma, 2012; Hanski, 2012; 
Guglielmetti, 2010; Borges, 2014). 
In particular, the  modulation  of  host  immune responses is  the  primary  means  by which 
commensal, food, or probiotic microorganisms are believed to exert their bioactivities (Adams,  
2010; Collier-Hyams and Neish, 2005).  In spite of this, the mechanisms determining the 
microbial ability to interact with the immune system of mammals are largely unexplored, 
particularly in the case of non-pathogen microorganisms such as commensal, food-associated 
and probiotic microbes. In this context, the study of host-microbe interactions can supply an 
essential fund of knowledge in order (i) to understand pathologies and dis-functional syndromes 
(for example ulcerative colitis, irritable bowel syndrome, atopic eczema, recurrent vaginal 
candidiasis) and (ii) to develop targeted treatment and prevention strategies, such as the 
probiotic intervention, which is intended - in its broadest sense - as the use of selected live 
microbial cells to benefit the host’s health. 
The interest on probiotic microorganisms has greatly increased during the past decade, because 
of the widespread belief in benefits of the probiotic approach towards disease prevention or 
management. Accordingly, sales of probiotic dietary supplements and foods are growing. The 
microorganisms most commonly employed as probiotics belong to the genus Lactobacillus. 
More specifically, species like L. acidophilus, L. rhamnosus and L. paracasei include the most 
important probiotics worldwide. For instance, the first probiotic product in history (the Yakult 
fermented milk) contains L. paracasei strain Shirota. The most studied probiotic nowadays is L. 
rhamnosus strain GG, whereas the most popular probiotic sold in Italy is L. paracasei DG, a 
strain included in the food supplement Enterolactis (Sofar S.p.A.). Nonetheless, at present, the 
Italian Ministry of Health accepts only one use indication concerning probiotics (“Favorisce 
l'equilibrio della flora intestinale” i.e. “Helps balance of the intestinal flora”), whereas the 
European Community, through the Food Safety Authority (EFSA) and the regulation (EC) N° 
1924/2006, has not yet approved any health claim related to probiotic products. It is 
unanimously accepted that the use of microorganisms as probiotics is drastically limited by the 
inadequate knowledge concerning the molecular mechanisms that support the potential effects 
of probiotic use (Rijkers, 2010). In this context, the immunologic characterization of single 
microbial cell components is a reductionistic approach based on scientific research, which can 
significantly contribute to unveil the molecular mechanisms governing the cross-talk between 
microorganisms and host. 
Another important factor to consider when characterizing a probiotic strain, it is how its 
metabolism can influence all the industrial processes to which the bacterium will be subjected, 
as well as the quality and shelf-life of the final product to be released on the market. Indeed, the 
food ingredient companies are constantly putting efforts in order to improve the quality and 
produce new innovative products, as well as increase the efficiency in their factories (Pedersen, 
2005; Gregoret, 2013). Many data are now available on Lactococcus lactis and its improvement 
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of growth efficiency and resistance due to the establishment of a second type of metabolism 
(apart from the classic fermentation) that is respiratory-like (Pedersen, 2012; Duwat, 2001). 
This capacity can be exploited at laboratory level, but the industrial scale production has 
already been confirmed for the above mentioned L. lactis, and this evidence leads to interesting 
perspectives also for other genera of bacteria used as probiotics, such as lactobacilli.  
 
Considered all the previous observations concerning probiotic bacteria and their components, 
the following topics have been investigated during the PhD research activity: 
1. Characterization of two L. paracasei strains, namely DG and LPC-S01 of gut and 
vaginal origin, respectively,  for their use as probiotics by means of a comparative 
approach using L. paracasei Shirota as reference strain.  In order to unravel their 
properties, the selected bacteria have been analysed through in silico, in vitro and in 
vivo techniques. Particularly, a draft genome of DG and LPC-S01 was generated and a 
comparative analysis was performed against other L. paracasei reference strains. In 
vitro methods conventionally employed for the assessment of the probiotic potential of 
microbial cells were included (resistance to acidity and bile salts, adhesion to Caco-2 
human epithelial cell line, inhibition of several microbial pathogens, production of 
bacteriocins, antibiotic resistances; Guglielmetti, 2008). Finally, a double-blind cross-
over pilot intervention trial was carried out in order to assess the ability of LPC-S01 
and DG to transiently persist in the gastrointestinal tract of healthy adults.  
 
2. Investigation of L. paracasei DG and LPC-S01 potential capacity to produce 
exopolysaccharides. The extraction and purification protocol allowed to obtain a clean 
exopolysaccharides fraction, which was further employed to identify the repeating unit 
composing the polymer by means of NMR spectrometry and other analytical 
chromatographic methods. The purified molecule was then used to assess its 
immunomodulatory potential on a transfected Caco-2 cell line for the measurement of 
NF-κB activation by means of bioluminescence quantification, and on two models of 
human macrophages (U937 and THP-1). 
 
3. Evaluation of the metabolic potential of L. paracasei as respiratory species, as 
hypothesized by Pedersen (2012) after identification of the cydABCD operon (coding 
for a terminal cytochrome oxidase), and on the basis of previous works conducted on 
L. lactis and Lactobacillus plantarum (Arioli, 2012; Brooijmans, 2009a; Brooijmans 
2009b; Pedersen, 2008). To assess the respiratory potential, classic microbiology 
methods (biomass formation, final pH, and long-term resistance evaluation) along with 
several molecular approaches were performed in presence of the essential co-factors, 
i.e. heme and menaquinone.  
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1.1 STATE OF THE ART 
1.1.1. The gastrointestinal tract and the gut microbiota 
 
The gastrointestinal tract (GIT) represents an ecosystem of the highest complexity. The mucosal 
surface provides a large area for the microbial adherence and colonization in the small intestine, 
which corresponds to 150–200 m2 area (Waldeck, 1990). A three-fold increase in the surface 
area is accomplished by circular folds, 7–10-fold by folding of the epithelium (intestinal villi) 
and 15–40-fold by the formation of microvilli in the enterocyte absorptive luminal membrane. 
Thereby, the necessary space for interactions between host and microorganisms during the 
digestive process and for microbial adhesion to the mucosal wall and concomitant colonisation 
is provided (Holzapfel, 2002). 
The GIT is a sterile environment at birth, and bacterial colonization begins during the delivery 
process (from the maternal faecal or vaginal flora and/or the environment). The bacteria that 
colonize the large gut initially are facultative anaerobic strains such as Escherichia coli and 
Streptococcus spp. These first colonizers metabolize any trace of oxygen in the gut, thereby 
reducing the environment into one with strong anaerobic conditions. The subsequent colonizing 
bacteria are largely determined by the feeding profile of the infant during the nursing and the 
weaning, when a complex microflora develops (Wallace, 2011). 
The human intestinal ecosystem acts as an “organ” synergistically with the host, which houses 
over 10
14 
microbial cells (which comprise bacteria, archaea, some protozoa, and anaerobic 
fungi) and different bacteriophages and viruses. The presence of a great number of microbial 
species (more than 1000) represents an immense metabolic potential and suggests strong 
regulatory effects on the human host. The diversity of the gut microbiota varies from segment to 
segment and, in addition, is determined by factors such as the diet, the genetic background and 
the physiological state of the host. A beneficial stable microbiota, found in the healthy host, is 
instead subject to dramatic changes as a consequence of pathological mechanisms: for example, 
patients with inflammatory bowel disease (IBD), either Crohn’s disease (CD) or ulcerative 
colitis (UC), exhibit reduced microbial diversity and disproportionate quantities of gram-
negative bacteria when compared to healthy subjects (Qin, 2010).  
The composition and function of human microbial populations associated with various body 
sites have been studied with the help of metagenomic tools as part of two recent initiatives – the 
NIH Human Microbiome Project (HMP) and the European Metagenomics of the Human 
Intestine (metaHIT) project (Peterson, 2009; Dusko Ehrlich and MetaHIT Consortium, 2011). 
These massive molecular approaches have already revealed the presence of three different 
clusters, or enterotypes, which correspond to one of three most abundant genera of human 
intestine: Bacteroides, Prevotella, and Ruminococcus (Arumugam, 2013; Varankovich, 2015). 
The following may be considered as the major physiological functions of the gut and its 
microbiota including the health-promoting effects. 
 
Barrier function and restoration. The gut mucosa provides the ﬁrst physical line of defense to 
prevent the passage of harmful intraluminal entities including foreign antigens, microorganisms 
and their toxins (Groschwitz and Hogan, 2009). The single cell layer that forms the physical 
epithelial barrier includes absorptive and secretory cells, goblet cells and Paneth cells. Goblet 
cells contribute to the formation of a protective mucus layer, whereas Paneth cells are located 
near the base of small intestinal crypts and secrete potent antimicrobial peptides, known as 
defensins, and antibodies (Figure 1.1; Cho, 2008). The regulation of barrier integrity and 
function is mediated by endogenous and exogenous factors, such as cytokines, chemicals and 
drugs. Pathogens and their toxins also have the ability to directly or indirectly modulate the 
intestinal barrier, as well as commensal bacteria. These latter have been proposed as key 
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modulators of intestinal barrier function (Natividad and Verdù, 2013). For instance, a recent 
study has indicated that the probiotic bacterium Lactobacillus rhamnosus GG promotes cell 
renewal and augments mucosal repair following dextran sodium sulfate (DSS) induced colitis 
via reactive oxygen species generation in epithelial cells (Swanson, 2011). 
 
Immune system stimulation. The immune system is immature at birth and develops, inducing 
the gut-associated lymphoid system (GALT) in the lamina propria and beyond, in the 
mesenteric lymph nodes, establishing immune tolerance, upon exposure to the intestinal lumen 
microbiota. Gut microbiota indeed stimulates the innate and the acquired immunity but, on the 
other hand, the key challenge of the host intestinal immune system is balancing the need to 
respond to pathogens (through humoral and cell-mediated immune mechanisms) while 
coexisting with commensal bacteria and food antigens (through a mechanism of immune 
tolerance/hypo-responsiveness) (Hardy, 2013). In normal conditions, the stimulation of the 
mucosal immune system by gut microbiota determines a state of “low-grade physiological 
inflammation”, a status of continuous activation in response to commensals and, if needed, to 
pathogens. Mucosal homeostasis (tolerance/suppression versus activation) requires a continuous 
balance between pro- and anti-inflammatory components (Rakoff-Nahoum, 2004; Scaldaferri, 
2013).  
Being considered as the largest “immune organ” in the human body, the gut architecture 
comprises three different types of antigen-presenting cells (APCs): epithelial cells, specialized 
epithelial cells (microfold M cells) and dendritic cells (DCs) (Fig.1.1). Epithelial cells or 
enterocytes, at the apical surface, linked by tight junctions, prevent the penetration of microbial 
pathogens but can also facilitate vesicular bacterial/antigenic transfer across the barrier by 
receptor-mediated pinocytosis. The antigenic material is then processed and presented in form 
of a major histocompatibility complex molecule (MHC) expressed on the basolateral 
membrane, with both chemokines and cytokines that modulate underlying dendritic cells and 
macrophage responses (Collier-Hyams and Neish, 2005). 
Microfold (M) cells are inserted in the epithelial monolayer above areas of follicular lymphoid 
tissue, namely Peyer’s patches, where they form a gateway, trans-cytosing microorganisms and 
allowing controlled access to a range of immune cell types. They can induce the expansion and 
activation of follicular lymphocytes but, unlike enterocytes, they do not secrete anti-microbial 
components or present antigens but, instead, shuttle macromolecules and microorganisms to 
other effector cells such as DCs and macrophages present in the M cell pocket (Jang, 2004).  
Pathogenic bacteria or disruptions of the epithelial barrier activate DCs through interaction with 
their arm-like extensions (dendrites) present between the tight junctions that allow the 
independent sampling of the luminal contents (Chieppa, 2006; Rescigno, 2001). Upon 
sampling, DCs are primed to activate T cells towards a Th1/Th2 polarization. In particular, the 
cytokine milieu skews the differentiation of naive CD4+ T cells into T helper Th1‑, Th2‑, Th17- 
or regulatory T‑cell subsets (Cho, 2008).  
 
Production of nutrients and improvement of their bioavailability. Several members of the 
intestinal microbiota produce vitamins and minerals and provide them to the host. For instance, 
it has been observed that germ-free animals require 30% more energy in their diet, and 
supplementation with vitamins K and B is mandatory to maintain their body weight (Lee and 
Hase, 2014). Moreover, the gut microbiota possesses glycosidases able to hydrolyse the 
linkages of oligo- and polysaccharides non-digested or incompletely digested by the intestinal 
enzymes. In this way, the resulting monosaccharides are available to be metabolized (Perez 
Chaia and Oliver, 2003).    
 
1.1 State of the art 
19 
 
Impact on both weight and mood. Gut microbiota regulates several host metabolic functions, 
and microbial dysbiosis is associated with altered energy homeostasis, as observed in humans 
and animal models of obesity. Particularly, a reduction in bacterial diversity, coupled with 
overall compositional shifts, such as reduced abundance of Bacteroidetes and a proportional 
increase in Firmicutes phylum, have been verified. Moreover, the microbiome of the obesity 
model was significantly better equipped with genes involved in the transport and metabolism of 
undigested carbohydrates (Turnbaugh, 2006; Duca, 2014). 
Depression is a multi-factorial disease being caused by biological, psychological, and social 
factors. There has been recent major interest in the gut–brain axis in relation to depression. 
Three general mechanisms have been suggested to describe how the gut microbiota influences 
depression, namely through inflammation, the Hypothalamic–Pituitary–Adrenal axis (HPA), or 
interference with neurotransmitter signaling. (Dantzer, 2008; Naseribafrouei, 2014).  
 
Production of signalling molecules. Carbohydrate fermentation leads to short-chain fatty acids 
(SCFAs) production, such as butyrate, which has been known to inhibit DNA synthesis and 
stimulate apoptosis, and to significantly improve the absorption of calcium, magnesium, and 
phosphorus (Perez Chaia and Oliver, 2003). Moreover, several studies demonstrated that 
butyrate and butyrate-producer bacteria levels were strongly decreased in colon affected by 
ulcerative colitis and cancer (Machiels, 2014; Singh, 2014). 
 
It can be concluded that the establishment and maintenance of a stable gut microbiota, through 
the appropriate exposure to commensal organisms and their prebiotic substrates, has a 
paramount impact on the colonization dynamics and the well-being of the host.  
 
 
 
Fig. 1.1. Key features of the intestinal immune system (Cho, 2008). 
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1.1.2. The vaginal tract and its microbiota 
 
The vaginal mucosa of reproductive aged women is comprised of a multilayered stratified 
squamous epithelium that rests on a lamina propria and reaches a large surface area up to 360 
cm
2. It is kept moist by a ﬂuid that is partly secreted as a plasma transudate through the vaginal 
wall with contributions from the cervical and vestibular glands. Like the epidermis, the human 
vaginal epithelium contains basal and suprabasal layers and undergoes terminal differentiation 
to form a cornified envelope comprised of a flattened layer of specialized cells. However, 
vaginal stratum corneum does not have intercellular tight junctions, and does not usually 
keratinize or form a complete lipid envelope, so it is penetrable by microorganisms and cellular 
and molecular mediators of the immune system (Anderson, 2014; Merk, 2015). Immune cells 
residing in the reproductive tract have two roles: maintain immunity against vaginal pathogens 
in the lower tract and establish immune tolerance for sperm and the embryo/fetus in the upper 
tract. The  leukocytes  are distributed in either an aggregated or a dispersed  form  in  the  
epithelial  layer,  lamina  propria,  and stroma. Antimicrobial molecules are  another important 
factor  in  mucosal immunity and are produced in the mucosa of the female reproductive tract. 
Their production is significantly influenced by  estrogen,  which  acts  differently  in  the  upper 
and lower reproductive tracts. High levels of estrogen, a characteristic of the preovulatory 
period, increase the production of  some  antimicrobial  peptides,  such  as  secretory  leukocyte 
peptidase inhibitor (SLPI), β-defensin 1-2 (HBD 1-2), and elafin from the endometrial 
epithelium (Lee, 2015). On the other hand, estrogen suppresses the LPS- and poly (I:C)-induced 
secretion of proinflammatory cytokines, including TNF-α, macrophage  inflammatory  protein  
3α  (MIP3α,  CCL20),  IL-1β, IL-6,  and  IL-8  from  uterine  epithelial  cells.  IgG  levels  in  
the  uterine  cavity  peak  in  the  periovulatory period. In contrast, the lower reproductive tract, 
including the cervix and the vagina, maintains a low level of IgA, IgG, and lactoferrin  and  
decreased secretions of  β-defensin 2, elafin, SLPI,  and  α-defensin1-3  (HNP1-3) (Lee, 2015; 
Pudney, 2005; Wira, 2014). 
Despite the proximity of the vagina to the anus, the variety of microorganisms present in this 
district is much lower than in the gut. The reduced receptivity of the vagina, different nutrient 
availability and competition with indigenous microorganisms can be the reasons for this lower 
diversity in the vaginal tract. Some microbes found in the gut can also be found in the vagina, 
demonstrating that the proper receptors, nutrients, and oxygen tension are present for these 
organisms to grow (Cribby, 2012). The microbial species that inhabit the vaginal tract play an 
important role in preventing illnesses of the host, including bacterial vaginosis (BV), urinary 
tract infections (UTI), yeast vaginitis, and sexually transmitted diseases including human 
immunodeﬁciency virus (HIV) (Reid and Bocking, 2003). Historically, it was demonstrated 
that the vaginal microbiota was composed only from “gram positive bacilli” (Döderlein, 1892) 
but, nowadays, knowledge has significantly broadened and we know that it is characterized by a 
high number of lactobacilli (10
7–108 cfu/g of vaginal fluid in healthy premenopausal women). 
Among them, those belonging to the Lactobacillus acidophilus group and Lactobacillus 
fermentum are most frequently isolated, although others, such as L. plantarum, L. brevis, L. 
jonsonii, L. casei, L. delbrueckii, and L. salivarius, are isolated as well (Redondo-Lopez, 1990). 
However, other lactic acid bacteria genera have been found in the vaginal tract, such as 
Pediococcus spp., Weisella spp., Streptococcus spp. and Leuconostoc spp. The vaginal vault is 
colonized within 24 h of a female child’s birth and remains colonized until death. Lactobacilli 
become the predominant inhabitants of the vagina at the time of puberty, while menopause is 
marked by a dramatic reduction in estrogen production, resulting in drying and atrophy of the 
vaginal epithelium. When estrogen levels drop, glycogen content in the vaginal epithelium 
decreases, leading to depletion of lactobacilli (Farage, 2010). The balance between a healthy 
and diseased state can change depending on a number of factors such as environmental 
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exposures, microbial interspecies competition or commensalism, hormone levels and host 
defenses. In general, the presence of high numbers of lactic acid bacteria (LAB) in the vagina is 
equated with “healthy”, whereas low numbers or absence as being “abnormal”.  
The mechanisms by which LABs stabilize the vaginal microbiota are the production of 
antimicrobial compounds, i.e. hydrogen peroxide, lactic acid, and bacteriocin-like substances. 
Vaginal pH varies from 6.6 (±0.3) to 4.2 (±0.2) between day 2 and day 14 of the menstrual 
cycle and the maintenance of these values is achieved by means of the production of lactic acid 
by LABs as well as the secretion of organic acids by the vaginal epithelial cells (Charlier, 
2009). Another mechanism exploited by endogenous LABs in the healthy urogenital tract, is the 
capability to adhere and compete for adhesion sites in the vagina thus excluding the 
colonization of pathogenic bacteria by occupying or masking (by steric hindrance) their 
potential binding sites to the mucosa (Borges, 2014). 
When LABs, and particularly lactobacilli, are disrupted, they are subsequently replaced by 
predominatly anaerobic bacteria including Gardnerella vaginalis, Mycoplasma hominis, 
Prevotella and Peptostreptococcus, causing bacterial vaginosis (BV). This urogenital disease is 
the most common in women, affecting about 19-24% of them in reproductive age (Allsworth 
and Peipert, 2007; Bastani, 2012). It is associated with high pH, a decrease in antimicrobial 
activity of the vaginal ﬂuid compared to healthy women, and local impairment of the innate 
immune pathways, but it does not exhibits inﬂammation, except for a slight increase in IL-1 and 
IL-8, which prevent the attraction of inﬂammatory cells (macrophages and neutrophils) (Donati, 
2010). A second major abnormality of the vaginal microbiota is instead caused by the 
replacement of the normally present Lactobacillus spp. with aerobic microorganisms, and for 
this reason it is denominated aerobic vaginitis (AV). These bacteria are predominantly enteric 
commensals or pathogens: group B streptococci (GBS), Escherichia coli, and Staphylococcus 
aureus are the organisms most frequently associated with AV (Rampersaud, 2012). 
 
In this context, probiotics are currently the subject of significant clinical research. A growing 
body of work now exists describing the role of various probiotic strains in ameliorating chronic 
intestinal inflammation, diarrhea, constipation, vaginitis, irritable bowel syndrome, atopic 
dermatitis, sepsis, food allergies, and liver disease (Saez-Lara, 2015; Parma, 2014; Didari, 
2015; Baquerizo Nole, 2014; Marchesi, 2015). 
 
 
1.1.3. History and use of probiotics 
 
Throughout the history of microbiology, most human studies have focused on the disease-
causing organisms found on or in people; in the last 100 years (and mainly in the last 20 years), 
however, many reports have centred on the beneﬁts of the resident bacteria and, as a 
consequence, on probiotics (Gregoret, 2013). The term “probiotic” was initially used in the 
1960s and comes from a Greek word meaning "for life". Although a relatively new word, the 
use of probiotics stretches back in the 1800s, when a beneficial association of “lactic acid 
producing” microorganisms with the human host has been suggested by Döderlein (1892) for 
vaginal bacteria and, more particularly, for lactic acid bacteria (LAB) in gut ecology studies 
conducted by Moro (1900), Beijerinck (1901), and Cahn (1901). However, scientific literature 
about this topic did not appear until 1905, when Elie Metchnikoff, who had worked with 
Pasteur in the 1860s, was credited with making the association of longevity among Caucasians, 
not to the yogurt they consumed, but rather to the lactobacilli used to ferment the yogurt and the 
presence of these lactobacilli in the colon (Metchnikoff, 1908). It was probably Vergio (1954) 
who first introduced the term “probiotic” and compared the detrimental effects of antibiotics 
and other antimicrobial substances on the gut microbial population with factors (“Probiotika”) 
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favourable to the gut microflora in his manuscript “Anti- und Probiotika” (Holzapfel, 2002). In 
the 1950s–1980s, research focused on screening potential probiotic strains from isolates in 
nature or from human hosts, and on defining their mechanisms of action, in order to understand 
the complex interactions of normal microbiota and the ability to resist pathogenic invasions 
(McFarland, 2015; Williams, 2010). So far, probiotics have been used for the prevention and 
treatment of various medical conditions and to support general wellness; among them, 
Lactobacillus and Biﬁdobacterium constitute the most frequently used genera. Some of their 
beneficial health effects have been validated, whereas other uses are supported by limited 
evidences. Illnesses associated with the gastrointestinal tract have been a common target of 
probiotics, mainly due to their ability to restore gut microbiota. The strongest evidence for the 
use of probiotics lies in the treatment of certain diarrheal diseases, especially rotaviral diarrhea 
in children (Pham, 2008; Vanderhoof and Young, 2008). Although clinical trial results are still 
conflicting, probiotic therapy may also be beneficial in the treatment of Crohn's disease, 
ulcerative colitis (UC), irritable bowel syndrome (IBS), and Helicobacter pylori infections 
(Santosa, 2006; Pham, 2008; Scarpellini, 2008). Other illnesses not associated with the 
gastrointestinal tract, including various urogenital problems, upper respiratory infections, 
allergic diseases, atopy, may also respond to probiotics (Pham, 2008; Scarpellini, 2008; Senok, 
2005; Reid, 2003; Goldin and Gorbach, 2008; Williams, 2010).  
 
 
1.1.4. Regulation and definition of probiotics 
 
The Food and Agriculture Organization of the United Nations (FAO) and the World Health 
Organization (WHO) define probiotics as “Live microorganisms which when administered in 
adequate amounts confer a health benefit on the host” (FAO/WHO, 2002). This definition, 
formulated during the FAO/WHO Expert Consultation in 2002, origins from the need to clarify 
the role of probiotics. Indeed, recognizing the inequality of many products on the market and 
the lack of any regulatory guidelines, the Experts panel had the task to examine whether or not 
probiotics had proven benefits and if so, to establish a set of guidelines that would ensure 
product safety and reliability. The resultant report  not only established that there were indeed 
excellent data on probiotics, but also developed a set of Guidelines or Operating Standards. 
These guidelines, which have been received favourably by Codex Alimentarius, constitute a set 
of parameters required in order to term a product or strain as “probiotic” (Reid, 2005). In 
Europe, the European Food Safety Authority (EFSA) has proposed a frame-work for the safety 
evaluation of micro-organisms in the food chain, similar in purpose to the generally recognized 
as safe (GRAS) approach, and taking into account the experience of use (Qualiﬁed Presumption 
of Safety, QPS, concept) (EFSA, 2012; Vankerckhoven, 2008). 
According to the Guidelines proposed by FAO/WHO and EFSA mentioned above, the criteria 
of selection can be summarized in evaluation steps. The first step in the selection of an 
organism or product being referred to as a “probiotic” is to identify and characterize the 
organism to genus and species level using internationally accepted methodologies 
(Vankerckhoven, 2008). Moreover, each organism must be designated with its strain name. This 
is important in order to differentiate reliable and proven strains and products from those of 
dubious quality and safety. This clear identification will ensure that consumers know exactly 
what strains are in the food products (Reid, 2005).  
Secondly, an extensive characterization performed under in vitro conditions is necessary in 
order to gain knowledge about the selected strains and their mechanisms of action (FAO/WHO, 
2002). A list of the main in vitro tests for the study of probiosis is shown in Table 1.1.   
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Tab. 1.1. Main currently used in vitro tests for the study of probiotic strains (“Guideline for the Evaluation 
of Probiotics in Food”, FAO/WHO, 2002). 
  
Resistance to gastric acidity 
Bile acid resistance 
Adherence to mucus and/or human epithelial cells and cell lines 
Antimicrobial activity against potentially pathogenic bacteria 
Ability to reduce pathogen adhesion to surfaces 
Bile salt hydrolase activity 
Ability to modulate immune responses 
  
 
All of these data are valuable and can provide scientific insight in the characteristics of 
probiotic organisms, but validation with in vivo trials (at least using an animal model) are 
strongly suggested by the FAO/WHO, to prove that the probiotic confers a signiﬁcant 
improvement in health. These assays generally include evaluations of the capacity to stimulate 
the host immune system, as well as to prevent enteric infections or other gut-associated 
pathologies (Gregoret, 2013). 
Given their long history of consumption in traditional fermented foods and their residency in 
the gastrointestinal and genitourinary tracts of vertebrates, the most common microorganisms 
used as probiotic (i.e. lactobacilli and bifidobacteria) have been awarded the status of GRAS by 
the American Food and Drug Agency. However, a probiotic strain can only be utilized if it 
fulﬁlls certain criteria related to safety aspects (Adams and Marteau, 1995; Ammor, 2007) and, 
specifically, it should be tested using laboratory and human studies to confirm that the product 
under study is not responsible for a number of side-effects: (i) systemic infections, (ii) antibiotic  
resistances, (iii) deleterious metabolic activities (biogenic amines or toxins production, 
haemolytic activity, bile salt deconjugation), (iv) excessive immune stimulation in susceptible 
individuals, and (v) genetic transfer (Marteau, 2002).  
Among technological criteria, strain viability and maintenance of desirable characteristics 
during product manufacture and storage is a requirement for probiotic strains to assure a 
beneﬁcial effect on the consumer (Champagne, 2011).  
European Union (EU) consumers have used probiotic foods for decades, but with the 
implementation of EU legislation on health claims starting in 2009, no specific health claims for 
probiotic foods have been approved by EFSA, which is responsible for reviewing health claim 
substantiation in the EU. As a result, probiotic food labels cannot communicate any health 
benefits to consumers in the EU (Glanville, 2015).  
 
 
1.1.5. Mechanism of action of probiotics 
 
Many rigorous studies have suggested that emerging nutritional strategies including probiotics 
diets may be able to reduce these host-related immune diseases and modulate the intestinal 
microbiota. Although the mechanisms of action of probiotics are largely unknown at molecular 
level, a probiotic can act in a number of ways, that can be summarized as follows (Fig. 1.2).  
A first level of interaction is direct and takes place within the gut lumen between the probiotic 
strain and the microbiota. The mucosal epithelia provide an enormous surface area for invading 
pathogens, but its integrity can be enhanced by probiotics through competition for adhesive 
access to epithelial cells. Moreover, this transient intimate association allows exchanging 
mediators between the bacterium and the host immune system. It has been considered that 
multiple factors (either unspecific or specific) of the bacterial cell surface are responsible for the 
adhesion capacity:  electrostatic forces (such as divalent cations, probably Ca
2+
), biosurfactants 
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(such as glycolipids, lipopeptides, protein-like substances, phospholipids, substituted fatty 
acids, and lipopolysaccharides),  glycoproteins, carbohydrates (Boris, 1998; Ren, 2014; Merk, 
2005).  
There are also many other mechanisms underlying effects of probiotics and they are likely to be 
multifactorial:  reduction of luminal pH, competition for nutritional sources, and the production 
of organic acids, hydrogen peroxide, bacteriocin or bacteriocin-like substances (de LeBlanc 
Ade, 2010; Chenoll, 2011; Collado, 2007; Hardy, 2013). Bacteriocins are antimicrobial 
peptides, with a variety of killing mechanisms, including cytoplasmic membrane pore 
formation, interference with cellular enzymatic reactions (such as cell wall synthesis) and 
nuclease activity. Nisin (a lantibiotic produced by certain strains of Lactococcus lactis) is the 
only bacteriocin that has been approved by the World Health Organization for use as a food 
preservative (Gillor, 2005; Borges, 2014). A few bacteriocins from vaginal isolates of 
Lactobacillus spp. have also been identiﬁed, such as salivaricin produced by the vaginal 
bacterium L. salivarius CRL 1328, that exhibited activity against E. faecalis by dissipating 
membrane potential and transmembrane proton gradient (Vera Pingitore, 2009). Acid 
production has long been known to be detrimental to some microorganisms in the gut as well as 
the vagina, not only inhibiting viruses such as HIV, rotavirus and even inﬂuenza virus, but also 
displacing some pathogens from surfaces (Reid, 2006).  
 
A second level concerns the interaction with the gut mucus and the epithelium, and includes 
barrier effects, digestive processes, mucosal immune system, and enteric nervous system.  
The mucus, composed of mucins secreted by goblet cells and polymerized, grants protection 
from pathogens, enzymes, toxins, dehydration and abrasion: it has been demonstrated that 
Lactobacillus plantarum 299v and Lactobacillus rhamnosus GG are able to up-regulate the 
production of intestinal mucins (MUC2 and MUC3) which overturn the adherence of the 
enteropathogenic  bacterium  Escherichia  coli  O157:H7  to  intestinal  epithelial  cells (Mack, 
1999; Caballero-Franco, 2007). Other studies have shown that S. thermophilus and L. 
acidophilus enhance barrier integrity by phosphorylation of actinin and occludin in the tight 
junctions region of epithelial cells, thereby inhibiting the invasion of pathogens into human 
intestinal epithelial cell lines (Resta-Lenert, 2003). Similarly, probiotic bacterial cell wall 
products such as peptidoglycan and lipoteichoic acids have been shown to augment apical 
tightening and sealing of tight junctions and the Th2-type cytokine release by activation of the 
pattern recognition receptor TLR-2 (Cario, 2004). Other TLRs involved in recognition of 
bacterial components are TLR-4 and TLR-9, which are activated by  lipopolysaccharides of 
Gram-negative bacteria and CpG DNA sequences, respectively (Gomez-Llorente, 2010; Zhong, 
2012).  TLR-4 activation by LPS activates Th1-type cytokine secretion (Cario, 2007), which, in 
IBD, is upregulated and contributes to sensitizing the mucosa to the proinﬂammatory effects of 
bacterial endotoxins. Through TLRs and via the release of soluble mediators, probiotics can 
also modulate the nuclear factor-kappa B (NF-κB) signal transduction pathway in epithelial 
cells, resulting in inhibition of NF-κB translocation to the nucleus and reduction in the 
degradation of IκB kinase through modulation of proteasome function (Petrof, 2004).  
Since TLRs contribute to establish the level of mucosal responsiveness to intestinal microbiota-
derived products and to regulate the amplitudes of the inﬂammatory responses, it is likely that 
probiotic immunomodulatory effects depend, at least partially, on TLR modulation. This has 
been evidenced by D’Incà (2011), who observed reduced TLR-4 levels in patients with 
ulcerative colitis (UC) after rectal administration of L. paracasei DG. Simultaneously, in the 
pro-inﬂammatory cytokines TNF-α and IL-1β were reduced and the anti-inﬂammatory cytokine 
IL-10 was increased. This action, orchestrated by a probiotic strain, may make the mucosa more 
sensitive to commensal non-pathogenic Gram-positive bacteria, recognized by TLR-2 receptors, 
which are then able to induce protective responses.  
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Substantial evidence has shown that probiotics can modulate mucosal immune function, in a 
strain-dependent fashion, also by the control of antibodies pool, as seen for the probiotic strains 
L. rhamnosus  GG, Bifidobacterium animalis subsp. lactis Bb12 and Saccharomyces boulardii, 
which can enhance production and secretion of protease-resistant IgA through alteration of the 
cytokine milieu in the gut mucosa, after induction of B-cells maturation (Shang, 2008). Other 
mechanisms include the increase of phagocyte and natural killer cell activity, and the induction 
of regulatory dendritic cells and CD4+Foxp3+T cells responses (Paineau, 2008; de LeBlanc 
Ade, 2010; Kwon, 2010).  
 
Signalling to the host beyond the gut to the liver, systemic immune system, and other potential 
organs such as the brain, is considered the third level of interaction. Physiological studies on the 
role of the intestinal microbiota in maintaining normal GI function, are now supported by 
molecular work, indicating that indeed, colonization with common commensals can modify the 
expression of a variety of genes involved not only in immunity and barrier function, but in also 
in motility and neurotransmission. Verdù et al. (2009) observed that, in gnotobiotic models and 
in animal models of post-infective gut dysfunction, oral probiotic therapy may influence the 
neuromotor apparatus. To investigate the effect of different probiotic strains on this type of 
dysfunction, mice were treated post-Trichinella spiralis infection with different probiotic 
strains. Among these, Lactobacillus paracasei NCC2461 significantly attenuated post-infective 
muscle hypercontractility, and this was accompanied by decreased expression of inflammatory 
mediators in the muscle layer, such as COX-2 (Verdù, 2004).  
 
 
 
Fig. 1.2. The three levels of action of probiotics (Rijkers, 2010). 
 
 
 
 
It is important to underline, however, that it is not possible to generalize these individual effects 
for every probiotic, and each individual strain must be tested for each property. The key to the 
effective use of probiotics in treating human disease is to match the correct probiotic strain with 
the desired clinical outcome (Wallace, 2011).  
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1.1.6. Lactic Acid Bacteria (LAB) 
 
Lactic Acid Bacteria (LAB) consist of several genera but we can consider a core group 
consisting of four: Lactobacillus, Leuconostoc, Pediococcus and Streptococcus. Recent 
taxonomic revisions have proposed several new genera and the remaining group now comprises 
the following: Aerococcus, Alloiococcus, Carnobacterium, Dolosigranulum, Enterococcus, 
Globicatella, Lactococcus, Oenococcus, Tetragenococcus, Vagococcus, and Weissella. 
Lactobacilli, Carnobacteria and some Weissella are rods while the remaining genera are cocci.  
LAB are gram-positive, usually non-motile, non-spore-forming, and catalase-negative. The 
bacteria within this group produce lactic acid as their major end product through fermentation 
of carbohydrates. Lacking the ability to synthesize cytochromes and porphyrins (components of 
respiratory chains), they are not able to generate ATP by creation of a proton gradient. 
Therefore, LAB can only obtain ATP by fermentation (Khalid, 2011). 
 
 
1.1.6.1. The genus Lactobacillus 
 
The genus Lactobacillus is a taxonomically broad and heterogeneous group, which has 
important industrial applications as fermented food starter and probiotic adjunct. It comprises 
more than 130 species, and is generally associated with habitats rich in nutrients. It has been 
reported as the main autochthonous microbiota in cheeses made from different milk types 
(Martín-Platero, 2009; Abriouel, 2008), with Lactobacillus plantarum and Lactobacillus 
paracasei species being dominant. Moreover, lactobacilli are found in the gastrointestinal tract 
soon after birth. In healthy humans, they are normally present in the oral cavity (10
3
-10
4 
cfu/g), 
the ileum (10
3
-10
7 
cfu/g), and the colon (10
4
-10
8 
cfu/g), and they are the dominant 
microorganisms in the vagina (Laville-Larma, 2012).  
Owing to their non-pathogenic profile lactobacilli (together with bifidobacteria) are the most 
commonly used species and significantly influence human health through a range of effects 
which include: detoxification of xenobiotics, biosynthesis of vitamin K, metabolic effects of 
fermentation of indigestible dietary fibre, positive influence on transit of luminal contents by 
peristalsis, competition with pathogenic microbes for nutrients and binding sites on mucosal 
epithelial cells and modulation of the host’s immune response (Hardy, 2013; Maurice, 2013; 
Nilsson, 2008). Regarding the latter mentioned function, lactobacilli have shown a role in 
modulating the immune response, both innate and adaptive, through induction of dendritic cell 
maturation and further stimulation of lymphocytes to release pro-inflammatory cytokines, such 
as tumour necrosis factor alpha (TNF-α), interferon-gamma (IFN- γ) and interleukin-12 (IL-12) 
(Chiang, 2012).  
Inside the Lactobacillus genus, the L. casei group of species (i.e., L. casei, L. paracasei, and L. 
rhamnosus) includes some of the most conventional and well-characterized probiotic strains, 
such as L. paracasei Shirota (considered the ﬁrst probiotic ever; Nanno, 2011), and L. 
rhamnosus GG (Szajewska and Chmielewska, 2013). Our research group developed a method 
according to a technique known as high resolution melting analysis (HRMa), which was applied 
to a 150 bp groEL gene fragment. The HRMa clustered L. casei group strains in three groups 
that exactly corresponded to the three species, providing a simple, labor-saving, and rapid 
strategy to obtain the genotyping of a bacterial isolate and simultaneously potentially confirm 
its affiliation to the L. casei group of species (Koirala, 2015).  
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1.1.6.2. Lactobacillus paracasei 
 
Strains of the L. paracasei species have been isolated from several diverse ecological niches 
such as raw milk, plants, fermented artisanal products (fermented milk, cheese, sourdough 
bread starter, and fermented vegetables), and the intestinal tracts and reproductive systems of 
humans and animals. The remarkable ecological adaptability of L. paracasei to diverse habitats 
can be plausibly explained by very frequent accumulation of indels and genome 
rearrangements, which originated a high level of genotypic and phenotypic diversity in the 
species (Cai, 2007; Smokvina, 2013).  
L. paracasei Shirota is one of the most intensively studied probiotics that has been used in the 
production of the fermented milk Yakult since 1935. Its benefits include improvement in the 
balance of intestinal microbes and volatile fatty acids in the gastrointestinal environment, 
antitumor activity, activation of the immune system, antimicrobial activity and improvement in 
the frequency of defecation and stool quality (van den Nieuwboer, 2015; Wang, 2015; 
Matsumoto, 2010). Sgouras (2004) studied the potential inhibitory effect of strain Shirota on 
Helicobacter pylori and found out that it possessed activity, but it was not dependent on a 
secreted molecule. On the contrary, the entire bacterium showed inhibition suggesting that the 
lactic acid produced was involved in inhibition of H. pylori urease system  and its reduced 
ability to survive at a low pH in the absence of urea.  
Chiang (2012) reviewed the role of L. paracasei strain NTU 101 in modulation of numerous 
immune responses and prevention of several diseases. This strain (and its fermented products), 
isolated from a newborn infant faeces, proved to be effective for the management of blood 
cholesterol and pressure, prevention of gastric mucosal lesion development, immunomodulation 
and alleviation of allergies, anti-osteoporosis and inhibition of fat tissue accumulation. 
Regarding immunomodulation, Tsai (2008) studied the effect of a daily consumption of L. 
paracasei NTU 101 (10
8
 cfu/day) for 3, 6 and 9 weeks on BALB/c mice. The antigen-
presenting ability of DCs and the expression of natural killer group-2 D molecules, capable of 
triggering natural killer cell-mediated cytotoxicity, were found to be upregulated. Lymphocyte 
proliferation and antibody production were also significantly increased in mice after the 
feeding. Interestingly, innate and adaptive immunity remained constant even after the most 
protracted feeding time, thus indicating the time dependence of the bacterial-mediated enhanced 
immunity (Tsai, 2008). Furthermore, feeding mice with strain NTU 101, significantly increased 
the percentages of CD4+ T cells in both Peyer’s patches and the spleen. The data also showed 
that Peyer’s patch-derived immunomodulation induced intestinal IgA+-producing cells in the 
lamina propria and increased CD4+ T cell - dendritic cell interactions, and higher mRNA 
expression levels of IL-1β, IL-10, IL-12, IFN-γ and TNF-α (Tsai, 2010).  
 
Given that most effects of probiotics are strain-speciﬁc (Azaïs-Braesco, 2010), the intrinsic high 
heterogeneity existing among L. paracasei strains makes this species an optimal source for the 
selection of novel candidate probiotic strains possessing unique technological and health-
promoting traits.  
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1.2 AIMS OF THE STUDY 
The regular intake of beneficial microorganisms, or probiotics, is an extensively-studied 
approach for tapping into the health benefits bestowed by commensal microorganisms 
colonizing the gastrointestinal tract (GIT) of the healthy human host. During my PhD activities, 
I was involved in the study of two Lactobacillus paracasei strains, named DG and LPC-S01, 
isolated from two different ecological niches (human gut and vagina, respectively). These 
strains are already available on the market, since they are included in two products as food 
supplements. However, a deep characterization is still missing, particularly for LPC-S01. On 
the contrary, L. paracasei DG, which is included in a commercial product named Enterolactis
®
, 
has recently demonstrated probiotic properties thanks to in vivo studies that showed its ability to 
interact with the host (D’Incà, 2011; Tursi, 2013; Ferrario, 2014). Moreover, it is one of the 
most popular probiotic supplements in Italy.  
Firstly, we focused our attention on the evaluation of their probiotic potential by means of 
several techniques using a comparative approach. Indeed, we added a third strain to utilize as 
reference, that is L. paracasei Shirota, the first probiotic product sold in the fermented milk 
drink “Yakult”. In order to unravel their properties, the selected bacteria had been analysed 
through in silico, in vitro and in vivo analyses. Particularly, we generated a draft genome of DG 
and LPC-S01 and performed a comparative genomic analysis against other L. paracasei 
reference strains. In addition, they were included in several in vitro tests conventionally 
employed to establish the intestinal probiotic potential of microbial strains. Finally, we carried 
out a double-blind cross-over pilot intervention trial in order to assess the ability of LPC-S01 
and DG to transiently persist in the gastrointestinal tract of healthy adults.  
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1.3 MATERIALS AND METHODS 
 
1.3.1 Bacterial strains and culture conditions 
 
Unless differently speciﬁed, lactobacilli were grown at 37° C in De Man-Rogosa-Sharpe (MRS) 
broth (Difco Laboratories Inc., Detroit, MI) for 24 h. L. paracasei LPC-S01 and DG were 
isolated from the commercial products PreGyn
®
 and Enterolactis
®
 Plus (Sofar S.p.A.), 
respectively; L. paracasei strain Shirota was isolated from Yakult fermented milk; strain 
FMBr3 was isolated from Raschera artisanal Italian cheese. 
 
 
1.3.2. Genome sequencing, sequence annotation, and comparative analysis 
 
The draft genome sequences of L. paracasei LPC-S01, DG, and FMBr3 were obtained through 
Ion Torrent PGM (Life Technologies, Germany) according to a previously described protocol 
(Milani, 2013) by GenProbio Ltd. The raw sequence data were assembled using MIRA v.3.9 
(http://www.chevreux.org/projects_mira.html), applying default parameters recommended for 
Ion Torrent data processing. Initial automated annotation of the L. paracasei genomes was 
performed using RAST, combined with BLASTX. Results of the gene-ﬁnder program were 
combined manually with data from BLASTP analysis against a non-redundant protein database 
provided by the National Center for Biotechnology Information (NCBI). LPC-S01 draft genome 
sequence was compared with other L. paracasei genome sequences by means of BLAST Ring 
Image Generator (BRIG; Alikhan, 2011).  
 
 
1.3.3. Bacterial resistance to simulated gastric juices and bile 
 
One hundred microliters of L. paracasei culture containing 10
8–109 CFU/ml were transferred to 
6 ml of simulated gastric juice at pH 2 (1 g l
-1
 DIFCO peptone, 100 mM KCl, 500 U ml
-1
 
pepsin) or simulated gastric juice at pH 3 (125 mM NaCl, 45 mM NaHCO3, 7 mM KCl, 500 U 
ml
-1
 pepsin). Cells in 0.1 M phosphate buffer pH 7 were used as control. After 90 min of 
incubation at 37° C, viability was monitored by plating on MRS agar. Afterwards, cell 
suspension was neutralized by adding 1 M phosphate buffer pH 8 and centrifuged at 10,000 × g 
for 12 min. Bacterial cell pellet was then suspended in 5 ml bile solution (1 g l
-1
 peptone, 0.3% 
Difco Oxgall in 0.1 M phosphate buffer at pH 6.5). Cells in 0.1 M phosphate buffer pH 6.5 in 
the presence of 1 g l
-1
 peptone were used as control. The number of viable cells was determined 
after 3 h of incubation at 37°C by plating on MRS agar. Plates were incubated under anaerobic 
conditions and colonies were counted after 48 h. The ability to grow in presence of bile was 
also investigated by inoculating bacteria in MRS broth supplemented with increasing 
concentrations of Oxgall (from 0.0625 to 9.6%). Growth was assessed by measuring the optical 
density at 600 nm. 
 
 
1.3.4. Bacterial adhesion to Caco-2 cell line 
 
The adhesion of L. paracasei strains to Caco-2 (ATCC HTB-37) cell layer was assessed as 
previously described (Guglielmetti, 2008). In brief, Caco-2 cells were grown in Dulbecco’s 
Modiﬁed Eagle’s Medium (MEM) supplemented with 10% (v/v) heat-inactivated fetal calf 
serum, 100 U ml
-1
 penicillin, 100 mg ml
-1
 streptomycin, 0.1 mM non-essential amino acids, 2 
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mM L-glutamine and incubated at 37° C in an atmosphere of 95% air and 5% carbon dioxide. 
For adhesion experiments, fully differentiated Caco-2 were used (i.e., 15 days after conﬂuence). 
Approximately 2×10
8 
cells for each bacterial strain (determined microscopically with Neubauer 
Improved counting chamber; Marienfeld GmbH, Lauda-Königshofen, Germany) were 
incubated with a monolayer of Caco-2 cells for 1 h at 37° C. Monolayers were washed three 
times with phosphate-buffered saline pH 7.3 (PBS) to release unbound bacteria and incubated 
with 3 ml of methanol for 8 min at room temperature to ﬁx cells. Afterwards, cells were stained 
with 3 ml of Giemsa stain solution (1:20; Carlo Erba, Milano, Italy) and left 30 min at room 
temperature in the dark. Finally, monolayers were washed three times with PBS, dried in an 
incubator for 1 h, and examined microscopically (magniﬁcation, 400×) under oil immersion. All 
experiments were performed in duplicate. 
 
 
1.3.5. Antagonistic activity against pathogens 
 
We investigated the ability of L. paracasei strains to secret inhibitor molecules against 
pathogens by disc diffusion assay. Lactobacillus plantarum strain WHE 92 was used as a 
positive control for bacteriocin production (Ennahar, 1996). We used seven indicator 
microorganisms: Salmonella enterica MIMms, Listeria monocytogenes FMB4b, Escherichia 
coli VE7108, Streptococcus pyogenes emm TYPE 77, Pseudomonas aeruginosa FMBpa18, 
Staphylococcus aureus FMBDR, and Candida albicans ATCC MYA2876. Indicator bacteria 
were cultivated in Brain Heart Infusion (BHI) agar medium (Oxoid S.p.A., Milan, Italy), 
supplemented with 0.3% yeast extract and 1% glucose (ygBHI), whereas C. albicans was 
cultivated on Sabouraud dextrose agar (Oxoid S.p.A., Basingstoke, UK). Three different 
fractions for each Lactobacillus strain (tester bacteria) were used: (i) broth culture at stationary 
growth phase, (ii) cell-free broth (obtained by centrifugation at 10,000 × g for 10 min and 
sterilization with a 0.22 µm syringe ﬁlter), and (iii) cell-free broth neutralized with NaOH to pH 
7.4. Sterile MRS was used as negative control. The assay was carried out as follows: 0.1 ml 
from an over-night culture of the indicator strains were plated on ygBHI (or Sabouraud) agar in 
order to obtain a conﬂuent growth after incubation. Sterile paper discs (Whatman ™ Grade AA 
9 mm disc, Maidstone, UK) were dipped into three different preparations from tester bacteria 
and subsequently positioned on the Petri dishes inoculated with the indicator strain. Plates were 
kept at 4° C for 2 h and then incubated at 37° C. The presence of an inhibition halo was checked 
after 24 or 48 h. 
 
 
1.3.6. Fermentation proﬁle 
 
Carbon source fermentation was determined in a 96-well microtiter plate in a ﬁnal volume of 
200 µl with a basal CHL medium at pH 6.3 (Bio-Merieux, Montelieu-Vercieu, France) 
containing bromocresol purple as pH indicator, and the desired ﬁlter-sterilized carbohydrate at a 
ﬁnal concentration of 0.5% (w/v). The 45 different substrates tested (Tab. 1.2) were from 
Sigma-Aldrich (St. Louis, MO, USA), with the exception of fructooligosaccharides (FOS) 
which were from Actilight
®
 (Giulio Gross S.p.A., Trezzano sul Naviglio, Italy), and blastose, 
which was purified in our laboratory. Cells from an over-night culture of L. paracasei were 
collected by centrifugation, washed with PBS, and used to inoculate the liquid medium in 
microtiter wells (1/100 inoculation). Plates were examined for colour change (from purple to 
yellow) after 24 and 48 h incubation at 37° C. 
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1.3.7. NF-κB activation assay 
 
The activation nuclear factor κB (NF-κB) was studied by means of a recombinant Caco-2 cell 
line stably transfected with vector pNiFty2-Luc (InvivoGen, Labogen, Rho, Italy) as in 
Taverniti (2013). In brief, recombinant Caco-2 monolayers (approximately 3 × 10
5 
cells/well), 
cultivated in the presence of 50 µg ml
-1
 zeocin, were washed with 0.1 M Tris-HCl buffer (pH 
8.0) and then incubated with 3.5 × 10
8
 cells of L. paracasei suspended in fresh DMEM 
containing 100 mM HEPES (pH 7.4), resulting in a MOI of approximately 1000. In a different 
set of experiments, Caco-2 monolayers were incubated with 0.1 ml of cell-free broth obtained 
by centrifugation and ﬁlter-sterilization from a stationary-phase culture of L. paracasei. 
Stimulation was conducted by adding 2 ng ml
-1
 of IL-1β. After incubation at 37° C for 4 h, the 
samples were treated and the bioluminescence was measured as described by Stuknyte (2011). 
Two independent experiments were conducted in triplicate for each condition. 
 
 
1.3.8. Susceptibility to antibiotics and production of biogenic amines  
 
The minimal inhibitory concentrations (MICs) of L. paracasei have been determined using a 
micro-dilution method in LSM broth (ISO-Sensitest broth, Oxoid supplemented with 10% v/v 
MRS Difco) as described in the ISO10932 IDF 223 document and recommended by EFSA 
(2012). The data are reported as average of two independent assays. The ability to produce 
cadaverine, tyramine, histamine and putrescine respectively from L-lysine, tyrosine disodium 
salt, L-histidine monohydrochloride and L-ornithine monohydrochloride was investigated by a 
qualitative test, according to the method proposed by Bover-Cid and Holzapfel (1999). All 
amino acids were purchased from Sigma. Strains were inoculated (1%) in MRS broth 
containing 0.1% of each amino acid precursor and incubated at 37° C for 18 h. The qualitative 
test to evaluate decarboxylase activity was performed in an agar medium specially formulated 
(0.5% tryptone, 0.5% yeast extract, 0.5% meat extract, 0.25% NaCl, 0.05% glucose, 0.1% 
Tween 80, 0.02% MgSO4, 0.005% MnSO4, 0.004% FeSO4, 0.2% ammonium citrate, 0.001% 
thiamine, 0.2% K2HPO4, 0.01% CaCO3, 0.005% pyridoxal phosphate, 1% amino acid 
precursor, 0.006% bromocresol purple, 2% agar; pH 5.3). 10 µl of each culture were placed on 
the medium containing the same amino acid precursor. The plates were incubated at 37°C for 4 
days. Positive test is indicated by the colour change and by amino acid precipitation around the 
corresponding spot (for tyramine only). 
 
 
1.3.9. Human intervention trial 
 
The study protocol was approved by the Research Ethics Committee of the Università degli 
Studi di Milano (opinion no. 37/12, December 2012). Written informed consent was obtained 
from all subjects before recruitment. The intervention study consisted of a randomized, double 
blind, cross-over pilot trial with two parallel groups (Fig. 1.3). Each volunteer was asked to 
participate to 6 visits: before run-in period (visit V0); before the ﬁrst treatment (V1); after the 
ﬁrst treatment (V2); before the second treatment (V3); after the second treatment (V4), and at 
the end of the trial (V5) (Fig. 1.3). After a 4-week pre-recruitment phase, volunteers have been 
randomized to receive 1 capsule daily of L. paracasei LPC-S01 (product A, 5 subjects) or L. 
paracasei DG (product B, 6 subjects) every day for 1 week, in addition to their habitual diet. 
After a 2 week wash-out period, the volunteers received a daily capsule of the other product for 
1 week. Volunteers received directions to keep the products at room temperature and to avoid 
exposure to heat sources. Volunteers received also oral and written instructions to consume the 
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capsule during the morning, while drinking natural water, at least 15 min before breakfast; 
alternatively, volunteers were allowed to consume capsule in the evening at least 3 h after the 
last meal of the day. The two probiotic preparations (provided by Sofar S.p.A., Trezzano Rosa, 
Italy) consisted of a gelatine capsule containing about 24 billion viable cells of the bacterial 
strain L. paracasei DG (CNCM I-1572) and LPC-S01 (DSM 26760), respectively; silicon 
dioxide and magnesium stearate were also added inside capsules as antiagglomerants. Capsules 
were delivered to participants in metal boxes sealed with a plastic cap containing desiccant 
salts. From the last day of consumption of the probiotic capsules, for the following 7 days, the 
volunteers provided one stool sample per day. Furthermore, participants provided a faecal 
sample at visits V1, V3, and V5 (Fig. 1.3). The sample was collected in a sterile plastic pot no 
more than 24 h before visit. Volunteers were asked to preserve the faecal sample at room 
temperature until delivery to the laboratory, according to the recommendations on storage 
conditions of intestinal microbiota matter in metagenomic analysis provided by Cardona (2012). 
During the trial period, the participants compiled a weekly diary (including a Bristol stool chart) 
of their bowel habits.  
 
Fig. 1.3. Schematic  of  study  design  and  flow.  V0–V5,  visits  before  the  run-in period,  before  the  
first  treatment,  after  the  first  treatment,  before  the  second  treatment,  after  the second treatment, and 
after final follow-up, respectively.   
 
 
 
 
 
1.3.10. Faecal DNA extraction and qPCR 
 
Stools were stored at −80° C until DNA extraction, performed by means of QIAamp DNA 
Stool Mini Kit (Qiagen, Valencia, CA). Before the extraction, the sample was homogenized in a 
Bead Beater Precellys 24 (Bertin Technologies, Montigny le Bretonneux, France) after addition 
of 0.45 g 0.5 mm glass beads. Subsequently, the extraction proceeded consistently with 
manufacturer’s recommendations. Real-Time quantitative (qPCR) protocols were adopted for 
the quantiﬁcation of L. paracasei DG in faecal metagenomic DNA (targeting the 
glycosyltransferase gene welF, with primers rtWELFf, 5′-TACTAAAGAAATTAGCTTTTGT-
3′ and rtWELFr, 5′- AGTAATGTCTGCATCCTCCA -3′ ; Ferrario, 2014) and LPC-S01 
(targeting an hypothetical protein coding sequence with primers qS01a-F, 5 ′ -
TGGAAGAGACCCTGCGAA-3 ′ and qS01a-R, 5′-GAGGTTGATTCACAAACCGTGC-3′). 
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These two genes were selected because they resulted unique to the respective strain as revealed 
by a search in the GenBank nucleotide database. A gradient PCR was initially performed to 
standardize the qPCR conditions. qPCR ampliﬁcations were carried out in a ﬁnal volume of 15 
µl containing 7.5 µl of EvaGreen® Supermix and 0.5 µM of each primer. We used 100 ng of 
faecal DNA template in each reaction. Samples were ampliﬁed with the following programs: for 
rtWELF primers, initial hold at 95° C for 3 min, and 44 cycles at 95° C for 30 s, 58° C for 30 s 
and 72° C for 30 s; for qS01a primers, initial hold at 95° C for 3 min, and 40 cycles at 95° C for 
30 s, 62° C for 30 s and 72° C for 30 s. Melting curves were analysed to conﬁrm the speciﬁcity 
of the ampliﬁcation products. To generate the standard curves with spiked faeces for DG and 
LPC-S01 detection, a 200 mg matrix of faecal sample was added with 1 × 10
9 
bacterial cells and 
DNA was extracted as reported above. Six-fold dilution series of isolated DNA were prepared 
and used in qPCR reactions. The equation of the derived standard curves was used to calculate 
the correlation between Ct values and the concentration of bacterial cells per g of faeces. 
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1.4 RESULTS AND DISCUSSION 
 
1.4.1. Comparative genomics to reveal indels of chromosomal regions in L. paracasei LPC-
S01 and DG 
 
We generated a draft genome sequence of Lactobacillus paracasei LPC-S01 and DG, 
consisting of 17 and 20 contigs, respectively. Comparative genomic analysis was performed 
using strain LPC-S01 or DG as reference against the other following five L. paracasei strains: 
the type strain of the species (L. paracasei JCM 8130T), the probiotic strain Shirota, a strain 
isolated from Raschera Italian artisanal cheese (FMBr3), and two other L. paracasei strains 
whose complete genome is available in GenBank (strains 8700:2 and N1115) (Fig. 1.4). The 
draft genome sequences of strains L. paracasei LPC-S01, DG and FMBr3 were generated by 
our group. When we used L. paracasei LPC-S01 as reference genome in the comparative 
analysis, we identified 14 genomic islands with putatively known biological functions, which 
have not been found in the genomes of type strain JCM 8130T or other L. paracasei strains. 
These chromosomal islands, which discriminate LPC-S01 genome from the others, include 7 
mobile genetic elements (e.g. prophages, phage remnants, and integrated plasmids; Fig. 1.4), a 
transposon containing a phospho-β-galactosidase operon (region a in Fig. 1.4; Fig. 1.5A), a 
putative taurine transport and metabolization operon (b; Fig. 1.5B), a large sugars 
transport/metabolization island (c; Fig. 1.5C), an ABC-type Fe
3+
 transport system (d; Fig. 
1.5D), and a putative nucleotide transport and metabolism operon (e; Fig. 1.5E). We also found 
in the genome of strain LPC-S01 two regions putatively involved in exopolysaccharide (EPS) 
synthesis. Specifically, one of these EPS regions (namely, EPS2; Fig. 2.4A in Chapter 2) was 
found exclusively in the genome of L. paracasei LPC-S01 and is constituted of 14 putative 
genes, including 6 genes potentially coding for glycosyl transferases. Notably, BLASTN search 
revealed inside EPS2 a region of about 8 kb encompassing 8 putative genes, which did not find 
any significant match in the GenBank database (genes from A to H in Fig. 2.4A). 
In addition, strain DG possessed three genetic regions that are absent in LPC-S01: a 
maltose/maltodextrin utilization gene cluster (referred as a in Fig. 1.6; in Fig. 1.7A) an arsenical 
resistance operon (b, in Fig. 1.7B), and a fumarate reductase gene (c, in Fig. 1.7C). As in LPC-
S01, we could identify other genomic islands including 6 mobile genetic elements, two of them 
corresponding to prophages and phage remnants. Interestingly, we could identify an EPS region 
also in DG genome, which resulted intriguing because, as for the one belonging to LPC-S01, 
did not find any match on NCBI database for a long extent of its length (Fig. 2.4B). For this 
reason we focused further attention on this kind of macromolecule production, as described in 
Chapter 2.  
In subsequent comparative analyses, we used the genome of the other L. paracasei strains as 
reference to identify missing chromosomal islands in the genome of strains LPC-S01 and DG. 
Largely most of the genomic regions that are absent in our strains genome refer to mobile 
genetic elements and DNA restriction-modification systems. Furthermore, the genome of strain 
L. paracasei 8700:2 had a tetracycline efflux region, a galactitol/sorbitol phosphotransferase 
transport and utilization system, and a α-mannosidase operon. Finally, the genetic regions 
putatively coding for β-glucosidase and chitinase operons were found in the genome of strain 
FMBr3 but not in DG and LPC-S01 (data not shown). 
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Fig. 1.4 Comparative genomic analysis of Lactobacillus paracasei LPC-S01(reference genome) with the 
genome sequences of other six L. paracasei strains. Grey rectangles indicate mobile genetic elements. pφ, 
prophage-related regions. mge, mobile genetic element; mge1, putative integrated plasmid; mge2, putative 
mobile genetic element containing a restriction-modification system. EPS, putative exopolysaccharide 
coding operon. Letters flanking red rectangles refers to panels of Figure 1.5.  
 
 
 
 
 
 
 
 
Fig.1.5 (next pages). In silico predicted functional organization of the chromosomal regions of 
Lactobacillus paracasei LPC-S01 that discriminates it from the other strains included in the comparative 
genomic analysis depicted in Figure 1.4. Letters in the panels of this figure refer to the letters flanking red 
rectangles in Figure 1.4. (A) Putative phospho-β-galactosidase operon. In black are indicated transposase-
associated putative genes. In white are indicated putative genes that are also present in the genome of the 
other L. paracasei strains considered for comparative genomic analysis. (B) Putative taurine ABC-type 
transport and metabolization operon. (C) Multi-transport region for the uptake of sugars and other small 
molecules. The membrane transport mechanism is indicated above the picture, whereas the transported 
molecule is indicated below. ABC, ATP binding cassette transport system, PTS, phosphotransferase 
transport system. Gal-NAc, N-acetylgalactosamine; Glu-NAc, N-acetylglucosamine; Co+, cobalt ions. (D) 
Putative ABC-type Fe3+ transport system. Gene “a”, putative acetyltransferase (COG0456) coding gene; 
gene “b”, putative gene coding for an uncharacterized protein (DegV family, COG1307). (E) Putative 
nucleotide transport and metabolism operon. MFS, major facilitator superfamily. In white are indicated 
putative genes that are also present in the genome of all the other L. paracasei strains considered. 
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Fig.1.6. Comparative genomic analysis of Lactobacillus paracasei DG (reference genome) with the 
genome sequences of other six L. paracasei strains. Grey rectangles indicate mobile genetic elements. pφ, 
prophage-related regions. mge, mobile genetic element. EPS, putative exopolysaccharide coding operon. 
Letters flanking red rectangles refers to panels of Figure 1.7. 
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Fig.1.7. In silico predicted functional organization of the chromosomal regions of Lactobacillus paracasei 
DG that discriminates it from the other strains included in the comparative genomic analysis depicted in 
Figure 1.6. Letters in the panels of this figure refer to the letters flanking red rectangles in Figure 1.6. (A) 
Putative maltose/maltodextrin utilization gene cluster. (B) Putative arsenic resistance operon. (C) FMN 
and fumarate reductase coding sequences. In black are indicated transposase-associated putative genes. In 
white are indicated putative genes that are also present in the genome of all the other L. paracasei strains 
considered. 
 
 
 
 
 
 
Summarizing, we found the presence of numerous accessory genes (i.e., unique to a particular 
strain) that suggests the niche-generalist nature of DG and, more evident, of LPC-S01; such 
potential ability to adapt to a wide range of environmental conditions is evidenced, for instance, 
by the presence of large chromosomal regions including genes for the utilization of numerous 
sugars (Fig. 1.5C). Similar regions are also present in the genome of DG and Shirota, which are 
of human intestinal origin. On the contrary, it was proposed that the adaptation of L. paracasei 
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to the nutrient-rich milk environment had been gone along with extensive decay of genes 
involved in carbohydrate utilization (Broadbent, 2012). Accordingly, we found the lack of 
genes for sugar transport and metabolism in the chromosome of the dairy strains L. paracasei 
FMBr3 and N1115 compared to LPC-S01, DG, and Shirota (Fig. 1.4 and Fig. 1.6). 
 
 
1.4.2. In vitro assays to evaluate acid tolerance, adhesion ability and pathogen inhibition 
capacity  
 
To  meet  the main  criteria  for  the  selection  of  potential probiotic  strains  and  crucial  
factors  for  beneficial  health effects, probiotic bacteria have to withstand the harsh 
environment of digestive enzymes and gastric juice in the stomach as well as bile secreted in the 
duodenum (Lim and Ahn, 2012). The probiotic potential of strains L. paracasei LPC-S01 and 
DG was assessed through in vitro experiments including L. paracasei Shirota as reference 
probiotic strain. The potential ability to survive the gastro-intestinal transit was assessed in 
simulated gastric juices at pH 3 or 2 (90 min incubation), followed by 3 h incubation in bile 
(Oxgall) solution. All strains showed high tolerance to pH 3; cell viability, in fact, was not 
signiﬁcantly reduced after 4.5 h (Fig. 1.8A). Conversely, pH 2 determined a drastic reduction of 
the viability of all tested strains. However, L. paracasei LPC-S01 displayed the highest 
tolerance, which was signiﬁcantly higher than that of the reference strain L. paracasei Shirota. 
This latter is an acid-tolerant bacterial strain with demonstrated survivability to human 
gastrointestinal transit (Tuohy, 2007; Wang, 2015). 
Growing concentrations of Oxgall were added to the MRS broth to assess the ability to grow in 
presence of bile. The adaptation to bile salts is strain-specific and is related to changes in 
carbohydrate fermentation,  glycosidase activity (Burns, 2010), exopolysaccharide production 
(Ruas-Madiedo, 2009; Ruiz, 2007), composition of membrane proteins and fatty acids 
(Gueimonde, 2007), increased adhesion to human mucus and inhibition of pathogen adhesion 
(Muñoz-Quezada, 2013). In the present study, all of the tested strains exhibited similar bile 
tolerance at concentrations between 0.3% and 0.5% (corresponding to the physiological 
concentrations of human bile (Ren, 2014)) with a dose-dependent inhibition of the bacterial 
growth. On the contrary, growth was completely arrested at Oxgall concentrations higher than 
1%. In speciﬁc, Shirota displayed the best tolerance to bile, even though not statistically 
signiﬁcant (Fig. 1.8B). 
 
The Caco-2 cell line is commonly used as a model for assessing the ability of probiotics to 
adhere to human intestinal epithelial cells. Bacterial adhesion properties mainly depend on the 
molecules exposed at the external cell surface (Guglielmetti, 2008; Polak-Berecka, 2014) and 
there exists a great variability among strains; however, many probiotics are known to inhibit 
adhesion and displace pathogens such as Salmonella enterica, Escherichia coli, Listeria 
monocytogenes, Staphylococcus aureus, and Clostridium difficile (Collado, 2007). Furthermore, 
the adhesion capacity is a very important parameter for a probiotic candidate because it avoids 
the bacterial elimination by peristaltic movements and allows the interaction with the immune 
system (Muñoz-Quezada, 2013). When the ability of the bacterial strains under study to adhere 
to the Caco-2 epithelial cell layer was tested, we found that only LPC-S01 displayed a marked 
adhesive phenotype, corresponding to an adhesion index (i.e., bacterial cells per 100 Caco-2 
cells) of more than 2000 (Fig. 1.9). Also strain DG displayed adhesion ability, whereas strain 
Shirota was unable to adhere on Caco-2 cells, as observed in previous studies (Botes, 2008; 
Guglielmetti, 2008). As mentioned above, genome analysis revealed the presence in LPC-S01 
of putative exopolysaccharide coding region (EPS2) containing a cluster of five genes which 
are not present in the other known L. paracasei genomes. Therefore, EPS2 could potentially 
1.4 Results and Discussion 
40 
 
support the synthesis of a peculiar exopolysaccharide molecule, which could plausibly 
contribute to the adhesion ability of  LPC-S01. Exopolysaccharides have been proposed to 
promote Lactobacillus adhesion (Ren, 2014), although, more frequently, the presence of a 
polysaccharide capsule has been shown to reduce adhesion by masking cell surface 
Lactobacillus adhesive determinants (Lebeer, 2012; Horn, 2013; Dertli, 2015), which are most 
commonly proteins (Lebeer, 2012; Polak-Berecka, 2014), (lipo)teichoicacids (Granato, 1999), 
and/or fatty acids (Polak-Berecka, 2014). 
 
 
Fig. 1.8. (A) Tolerance of Lactobacillus paracasei strains to simulated gastric juice at pH 2 (90 min 
incubation) and bile (180 min incubation). Dashed lines refer to controls (i.e., bacterial cells incubated in 
phosphate buffer, pH 6.5). Data are reported as the number of viable bacterial cells (CFU) plotted on a 
semi-logarithmic diagram. Vertical bars at each point refer to standard deviation calculated on three 
independent experiments conducted in duplicate. Asterisk between strain LPC-S01 and Shirota at the end 
of the experiment indicates statistically signiﬁcant difference according to two-tailed unpaired Student’s t 
test (*P < 0.05). (B) Growth of Lactobacillus paracasei strains in MRS broth supplemented with 
increasing concentrations of bile (Oxgall). 
 
 
 
 
 
 
 
 
 
 
A 
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Fig. 1.9. Adhesion of Lactobacillus paracasei strains to the Caco-2 epithelial cell layer as observed with 
Giemsa staining under a light microscope. Bars, 25 µm. One Caco-2 nucleus for each layer is indicated 
with the letter N. LPC-S01 adhesion was speciﬁc to Caco-2 cells: no adhesion was detected on the cover 
glass underlying Caco-2 cells (G; top part of the panel on the left). 
 
 
 
 
 
We also tested the ability of the bacteria under investigation to produce inhibitor molecules 
against pathogens by disc diffusion assay carried out by using cell-free MRS broths cultures. 
With the only exception of L. plantarum WHE 92 against L. monocytogenes, used as positive 
control, none of the neutralized broths was able to prevent pathogens growth, suggesting that, 
plausibly, the only inhibitory molecules produced by tested L. paracasei strains were organic 
acids. Regarding the lack of activity against C. albicans, it is known that many yeasts can 
tolerate acids and resist hydrogen peroxide action, probably because of their cell wall structure 
and the ability to form bioﬁlm, so it is very difficult to identify probiotic strains that are 
effective against this pathogenic microorganism  in the vagina (Reid, 2006).  
 
 
1.4.3. Activation of NF-κB in transfected pNiFty2-Luc Caco-2 cells 
 
We employed a reporter cell line obtained by transfecting Caco-2 cells with a luciferase reporter 
vector induced by active NF-κB (Guglielmetti, 2010a). The NF-κB reporter system was chosen 
to study the immunomodulatory properties of the strains under study, as this transcription factor 
regulates many physiological processes, including the innate and adaptive immune responses, 
cell death and inflammation (Gilmore, 2006; Perkins, 2007). NF-κB indeed owns a critical 
function since it can enhance the transcription of many cytokines (including tumour necrosis 
factor (TNF)-α, IL-1, IL-6, and IL-8, which are thought to be important in the generation of 
acute inflammatory responses), growth factors, adhesion molecules, immunoreceptors, and 
acute-phase proteins. Thus, activated NF-κB initiates both extracellular and intracellular 
regulatory events that result in priming the inflammatory cascade (Stuknyte, 2011). In our 
experiments, we tested the effect of the microorganisms on NF-κB activation under the 
presence of the pro-inﬂammatory cytokine IL-1β. For all three L. paracasei strains, both 
bacterial cells and cell-free neutralized broths were able to signiﬁcantly decrease the NF-κB-
dependent production of bioluminescence. Particularly, we found that the highest ability to 
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reduce NF-κB activation was exerted by DG and LPC-S01 cells, and by broth from Shirota 
culture (Fig. 1.10).  
 
 
Fig.1.10. Effect of L. paracasei strains on Caco-2 cells stably transfected with an NF-κB/luciferase 
reporter vector, in the presence of 5 ng ml-1 of IL-1β. Data in the histograms are the means (± standard 
deviations) from two independent experiments conducted in triplicate. RLU, relative luminescence units. 
Asterisks indicate statistically signiﬁcant differences according to two-tailed unpaired Student’s t-test: 
***P < 0.001; **P < 0.01; *P < 0.05. 
 
 
1.4.4. Utilization of sugars as carbon sources 
 
Afterwards, the in vitro probiotic properties of LPC-S01 and DG were assessed by testing their 
ability to produce acid from 45 different carbohydrate sources. Gut microorganisms are readily 
able to degrade available substrates, derived from either the diet or endogenous secretions. 
Major substrates available are starches and soluble dietary fibres, but also oligosaccharides and 
portions of non-absorbable sugars and sugar alcohols (in lower concentrations) (Wallace, 2011). 
Among them, the fructans (inulin, fructo-oligosacharides (FOS)) and galacto-oligosaccharides 
(GOS) are the most extensively studied prebiotics which, owing to their chemical structure, are 
indigestible in the small intestine and are anaerobically fermented by bacteria in the colon 
(Hardy, 2013). These carbohydrates fermentation results in the production of short chain fatty 
acids (SCFAs), especially acetate, propionate and butyrate, that have significant positive 
impacts on intestinal epithelial cell function, including maintenance of metabolism, 
proliferation, differentiation and promotion of low pH levels in the gut environment, favouring 
beneficial microbes with a concomitant reduction in pathogens viability (Ohigashi, 2013). In 
addition, histamine, carbon dioxide, and other neutral, acidic, and basic end products derive 
from these reactions.  
The fermentation patterns of L. paracasei strains were very similar. In detail, the three tested 
strains fermented cellobiose, FOS, fructose, galactose, glucose, inulin, maltulose, mannitol, 
mannose, ribose, salicine, sorbose, sucrose, trehalose, and turanose. In addition, LPC-S01 was 
the only strain that fermented (although weakly) esculin and L-arabinose, and the only not 
fermenting sorbitol. Moreover, only strain DG was able to rapidly ferment maltose and 
maltodextrins, plausibly due to the presence of the putative genetic cluster described above 
(Fig. 1.7A), and unable to use lactose and lactulose. Finally, Shirota was the only strain unable 
to ferment tagatose (Tab. 1.2). Interestingly, all the three L. paracasei strains were able to 
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utilize the non-conventional disaccharide blastose (6-O-β-D-fructofuranosyl-α, β-D-
glucopyranoside) produced in a FOS mixture by Cladosporium cladosporioides MUT 5506 and 
recently identified and fully characterized (Zambelli, 2014; Zambelli, 2016). 
 
Tab. 1.2. Phenotypic characterization of Lactobacillus paracasei strains based on acid production from 45 
carbon sources. +++, positive; –, negative; +, weak activity.  
 
  LPC-S01 DG Shirota 
 D-Glucose +++ +++ +++ 
 Lactose +++ - +++ 
 D-Fructose +++ +++ +++ 
 D(+)-Xylose - - - 
 D-Galactose +++ +++ +++ 
 Sucrose +++ +++ +++ 
 Maltose + +++ - 
 L(+)-Arabinose + - - 
 D(-)-Arabinose - - - 
 D(+)-Trehalose +++ +++ +++ 
 D(+)-Mannose +++ +++ +++ 
 L-Rhamnose - - - 
 Cellobiose +++ +++ +++ 
 L(+)-Sorbose +++ +++ +++ 
 D-Sorbitol - +++ +++ 
 Inulina +++ +++ +++ 
 Lactulose +++ - +++ 
 D-Mannitol +++ +++ +++ 
 FOS (Actilight) +++ +++ +++ 
 Salicine +++ +++ +++ 
 Maltodextrin - +++ - 
 α-ciclodextrin - - - 
 β-ciclodextrin - - - 
 Arabinogalactan - - - 
 Maltulose +++ +++ +++ 
 D(+)-Turanose +++ +++ +++ 
 Isomaltulose (palatinose hydrate) - - - 
 GOS +++ + +++ 
 D(-)-Ribose +++ +++ +++ 
 Xylan from beechwood - - - 
 Red Arabinian from sugar-beet - - - 
 Arbutin - - - 
 D(-)-Tagatose +++ +++ - 
 D(+)-Fucose - - - 
 D(+)-Raffinose - - - 
 Glycerol - - - 
 D-Gluconic acid + + - 
 Meso-Erythritol - - - 
 Melibiose - - - 
 Myo-Inositol - - - 
 Inositol - - - 
 D-Glucoron-gamma-Lactone - - - 
 Glycogen - - - 
 Esculin + - - 
 Blastose +++ +++ ++ 
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1.4.5. Safety evaluation of L. paracasei DG and LPC-S01 
 
In order for probiotics to be considered as safe, they should be free of transmissible antibiotic-
resistance genes (FAO/WHO, 2002; EFSA, 2008), since antibiotic-resistant foodborne species 
can  act as “reservoirs” of resistance genes and persist in the human host environment in the 
absence of selective pressure (Ammor, 2007; Comunian, 2010). On the basis of this 
precautionary principle and to prevent potential risks to human health, the European Food 
Safety Authority (EFSA) has proposed a framework for the safety evaluation of 
microorganisms in the food chain, similar in purpose to the Generally Recognised As Safe 
(GRAS) approach, taking into account experience of use (Qualiﬁed Presumption of Safety, 
QPS) (Gregoret, 2013). 
We studied the antibiotic resistance of L. paracasei DG and LPC-S01 by the microdilution 
assay recommended by International Organization for Standardization (ISO, 2010) with 
reference to the EFSA breakpoints for L. casei/paracasei (EFSA, 2012). The minimal inhibitory 
concentrations for L. paracasei LPC-S01 and Shirota were below the breakpoints for all 
antibiotics (Tab. 1.3). Only strain DG displayed resistances to gentamycin, kanamycin and 
chloramphenicol slightly higher than EFSA breakpoints. In general, MICs were higher for L. 
paracasei DG than the other strains for most antibiotics. However, we did not find any acquired 
antibiotic resistance gene in the genome (chromosome and plasmids) of L. paracasei DG; 
moreover, subsequent experiments (described in Chapter 2)  demonstrated that the modestly 
increased ability of strain DG to tolerate antibiotics is probably due to the presence of an 
abundant and peculiar exopolysaccharide, which partially hinders antibiotic penetration into the 
cell. In addition, it was reported that often lactobacilli have a high natural resistance to 
aminoglycosides, such as gentamicin and kanamycin (Bernardeau, 2008; Guglielmetti, 2010b). 
Therefore, the observed increased resistance of strain DG to certain antibiotics may be plausibly 
considered intrinsic and not associated to horizontally transmissible genetic elements. 
 
  
Tab. 1.3. Antibiotic sensitivities of Lactobacillus paracasei strains determined according to the 
microdilution assay recommended by EFSA (2012). Data are reported in mg l-1. MIC, minimal inhibitory 
concentration (MIC). *, MIC higher than EFSA breakpoint. 
 
 
 
EFSA breakpoint DG LPC-S01 Shirota 
Ampicillin 2 2 2 0.25 
Vancomycin not required >256 >256 >256 
Gentamicin 32 64* 32 8 
Kanamycin 64 <256* 32 64 
Streptomycin not required 32 32 32 
Erythromycin 1 1 0.5 1 
Clindamycin 1 0.25 0.062 0.062 
Tetracycline 4 1 2 1 
Chloramphenicol 4 8* 4 4 
Amoxicillin not indicated 8 1 0.5 
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Finally, the safety of L. paracasei strains was also estimated by assessing the bacterial 
decarboxylation of amino acids, which generates biogenic amines in food (Deepika 
Priyadarshani and Rakshit, 2014). According to our experiments, none of the tested L. 
paracasei strains produced histamine, tyramine, putrescine and cadaverine (data not shown), 
which are among the most common biogenic amines found in food products (Naila, 2010). 
 
 
1.4.6. L. paracasei LPC-S01 and DG persistence in the gut of healthy adults 
 
Ingested bacteria are exposed to the harsh environmental conditions in the human stomach 
(gastric acid) and small intestine (especially the proximal sections, which contain hydrolytic 
enzymes and bile salts), along with the highly diverse and competitive environment presented 
by the human gut microflora, which limit the ability of probiotic strains to persist in the GIT. As 
a consequence, distinction should be made between microorganisms capable of colonizing the 
human gut and those able to persist or remain metabolically active during passage through the 
gut (Tuohy, 2007). The acid tolerance and adhesion properties of LPC-S01 suggested that this 
bacterium might tolerate and adapt to the gastrointestinal environment. Effectively, probiotics 
can be administered vaginally or orally because lactobacilli can migrate passively from the 
rectum to the vagina via perineum (Vásquez, 2005). Consistently, bacteria colonizing the 
vaginal mucosa (both commensals and vaginosis-associated microbes) have been isolated from 
the rectum and the mouth, suggesting that gut and oral cavity act as extra-vaginal reservoirs of 
vaginal microbiota bacteria (van de Wijgert, 2014). Therefore, it appears plausible that the oral 
administration of probiotic bacteria may potentially inﬂuence the vaginal microbiota through 
two possible mechanisms: (i) modiﬁcation of the intestinal microbiota (e.g., by reducing 
potentially harmful bacteria and increasing endogenous lactobacilli); (ii) direct migration to the 
vaginal mucosa via the gastrointestinal route. The time for this intervention to affect the vaginal 
tract is evidently longer than direct vaginal instillation, however an advantage of the oral 
approach is the possibility to deliver probiotics in foods and dietary supplements thus favouring 
the accomplishment of long-term treatments. 
To test this hypothesis, we performed a pilot intervention trial, in which we compared the gut 
persistence of L. paracasei LPC-S01 with that of strain DG. We enrolled 11 healthy adult 
volunteers, who were asked to consume for 1 week a capsule per day containing LPC-S01 or 
DG cells. Out of 11 enrolled volunteers, 8 concluded the study. Three volunteers dropped out of 
the study due to non-conformity (n = 1) and protocol violation (missed probiotic consumption; 
n = 2) (Fig. 1.3). Capsules, which contained about 24 billion CFU of L. paracasei, were well 
tolerated by all participants and no adverse events were reported. In order to quantify L. 
paracasei cells in the faecal samples all over the trial, we used qPCR with primers targeting 
gene welF (speciﬁc for strain DG; Ferrario, 2014) and a gene coding for a hypothetical protein 
(speciﬁc for strain LPC-S01). We estimated that strain LPC-S01 reached a concentration of 
about 10
8
 cells per g of faeces, persisting above the detection limit (10
5
 cells per g of faeces) for 
about 5 days, which was not significantly dissimilar to the persistence of the reference L. 
paracasei DG, a strain already demonstrated to colonize the human gut of healthy adults and 
induce specific modifications in the microbiota composition (DeVecchi, 2008; Ferrario, 2014). 
In effect, according to repeated measure ANOVA, we did not ﬁnd signiﬁcant differences in the 
persistence of the two L. paracasei strains (Fig. 1.11). Our data are in agreement with other 
studies, which observed that the persistence of L. paracasei Shirota in the gastrointestinal tract 
of healthy adults is lower than 1 week after cessation of the probiotic ingestion (Tuohy, 2007; 
Wang, 2015).  
The persistence of a certain probiotic strain in the gut plausibly depends on the evacuation 
frequency. In our study, we found persistence of strains LPC-S01 and DG as average for 7 
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evacuations (Fig. 1.11A). No data correlating the day of persistence with the number of 
evacuations were found in literature. 
 
 
Fig. 1.11. (A) Bacterial concentration of L. paracasei DG and LPC-S01 in the faecal samples collected 
during the study per single participant. (B) Average change in the faecal concentration of L. paracasei 
cells after the probiotic-intake period. Vertical bars denote 0.95 conﬁdence intervals. Current effect 
according to repeated measures ANOVA performed to determine the statistical signiﬁcance of the 
treatment × time interaction: F (5,65) = 0.794; p = 0.558. 
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1.5 CONCLUSIONS 
We explored the essential characteristics of L. paracasei DG and LPC-S01 (two strains already 
present on the market as food supplements), which can help to define them as potential 
probiotics. According to comparative genomic analyses, L. paracasei LPC-S01, a bacterium 
isolated from human vagina but plausibly having origin from the gut, possesses the genetic 
features of a niche-generalist member of its species. Similarly, also strain DG exhibits the 
potential ability to adapt to a wide range of environmental conditions if compared with strains 
of dairy origin.  In vitro tests evidenced that the probiotic properties of strain LPC-S01 and DG, 
with respect to the reference probiotic strain L. paracasei Shirota, are equal for the bile 
tolerance and the reduction of NF-κB activation in Caco-2 cells. Strain LPC-S01, however, 
displayed a higher tolerance to gastric juice and higher capacity to adhere to Caco-2 epithelial 
cells (Shirota is unable to adhere on Caco-2-cells). We could confirm that both strains under 
study are safe for human consumption, since they do not contain any acquired antibiotic 
resistance and do not produce biogenic amines, and they can be administered in high number 
(24 billion CFU) to healthy people without adverse events. The pilot intervention trial results 
demonstrated that LPC-S01 and DG transiently colonize the gastrointestinal tract of the host, 
persisting for at least 5 days after the end of a 7-days oral consumption (corresponding in 
average to 7 evacuations).  
Finally, we consider of particular interest the remarkable ecological adaptability demonstrated 
by the vaginal isolate L. paracasei LPC-S01: indeed, its safety and functional properties may 
support its use as probiotic to be administered per os for potential intestinal as well as vaginal 
applications. In this perspective, our future perspectives include the design of a clinical trial 
consisting on the oral administration of LPC-S01 to healthy adult women, in order to verify the 
potential ability of this probiotic bacterium to (i) modulate the intestinal and vaginal microbiota, 
and (ii) colonize the human vagina via gastrointestinal route.  
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2.1 STATE OF THE ART 
2.1.1. Overview on exopolysaccharides 
 
Exopolysaccharides are long-chain carbohydrate polymers released by a wide range of 
microorganisms, including yeasts, moulds, microalgae and bacteria (Donot, 2012). In general, the 
exocellular polymers comprise the capsular polysaccharides, which form a cohesive layer or 
capsule covalently linked to the cell surface, and the exopolysaccharides (EPS), which form a 
slime layer loosely attached to the cell surface or secreted into the environment. Some bacteria 
produce only one type of polysaccharide, whereas, in some cases, they can produce both forms 
(Nwodo, 2012; Degeest, 2001; Ruas-Madiedo and de los Reyes-Gavilán, 2005). The history of 
bacterial exopolysaccharides began during the mid-20
th
 century with the discovery of an 
exopolysaccharide in wine, which would later be known as dextran and the prokaryote 
responsible for the production was identified as Leuconostoc mesenteroides (Linker and Jones, 
1966). Over the course of time, other exopolysaccharides have been discovered, including 
cellulose, alginate and xanthan. Most of the LAB producing EPS belong to the genera 
Streptococcus, Lactobacillus, Lactococcus, Leuconostoc, and Pediococcus. Production of EPS is 
also reported for bifidobacteria (Patel and Prajapati, 2013; Hidalgo-Cantabrana, 2014).  
 
 
2.1.2. Classification of exopolysaccharides on the basis of the chemical structure 
 
The overwhelming diversity of bacterial polysaccharides allows categorizing them based on 
chemical structure, functionality, molecular weight and linkage bonds. Following the chemical 
composition, exopolysaccharides can be further classified as homopolysaccharides (HoPS) and 
heteropolysaccharides (HePS). HoPS are the polymeric form of one type of monosaccharide unit, 
and can be clustered into three groups according to the linkage bonds and the monomeric unit: α-
D-glucans, β-D-glucans, and fructans. They exhibit molecular weights ranging from 4×104 to 
2×10
7 
Da, and the most common glycosidic bonds are 1-6, 1-3 and 2-6 linkages. Glucans vary in 
their degrees of branching and, consequently, result in the formation of different polymer types: 
for instance, dextran, mutan, and alternan are α-glucans, whereas levan and inulin-type HoPS are 
fructans (Ruas-Madiedo and de los Reyes-Gavilán, 2005). 
On the other hand, HePS are composed of repeating units, varying in size from disaccharides to 
octasaccharides, and demonstrate little structural similarity to one another (Tab. 2.1). The 
monomers forming the repeating unit include D-glucose, D-galactose, L-rhamnose and, in some 
cases, N-acetylglucosamine (GlcNAc), N-acetylgalactosamine (GalNAc), or glucuronic acid 
(GlcA). Non-carbohydrate substituent such as phosphate, acetyl and glycerol are sometimes 
present (Ruas-Madiedo, 2002; Hidalgo-Cantabrana, 2012). Bonds between monomeric units at 
the backbone of the polymers are 1,4-β- or 1,3-β- linkages and 1,2-α- or 1,6-α- linkages. The 
former are characterized by strong rigidity whereas the latter are more flexible. In spite of their 
heterogenic composition, HePS exhibit a smaller variability in size, ranging from 1×10
4
 to 6×10
6
  
Da (Badel, 2011).  
It is easily deducible that the great variety in bacterial EPSs is conferred by the presence of 
different isomers, linkage types, and organic or inorganic monosaccharide substituents that could 
be combined in repeating units which have, as well, different degrees of polymerization and 
branching patterns. Moreover, depending on the substituents present in the repeating units of 
HePSs, we can distinguish among non-charged, charged or neutral polymers. Within the latter, a 
special mention goes to the “zwitterionic” EPSs, characterized by having both positively (e.g. 
free amine) and negatively (e.g. phosphate or carboxylate) charged moieties within their 
repeating units. These molecules have been reported to be able to modulate the immune system, 
2.1 State of the art 
61 
 
both innate and adaptive response, although they are very rare among bacteria (Hidalgo-
Cantabrana, 2012; McLoughlin and Kasper, 2009).  
 
 
Tab. 2.1. Monomer composition of heteropolysaccharides produced by a number of representative 
Lactobacillus strains (Patten and Laws, 2015). 
 
Strain     Monosaccharide composition   
L. acidophilus 5e2   glucose, galactose, N-acetyl-D-glucosamine (3:3:1) 
L. acidophilus LMG9433   glucose, galactose (4:1) 
L. brevis glucose, galactose (3:3)   
L. casei CG11   glucose, rhamnose (variable) 
L. delbrueckii subsp. bulgaricus 291     glucose, galactose (3:3) 
L.  delbrueckii subsp. bulgaricus EU23   rhamnose, glucose (3:3)   
L.  delbrueckii subsp. bulgaricus LY03, 
24, 25   
galactose, glucose, rhamnose (5:1:1)   
L.  delbrueckii subsp. bulgaricus 
NCFB2074 
glucose, galactose (3:3)   
L.  delbrueckii subsp. bulgaricus NCDC 
285   
rhamnose, galactose (1:7)   
L. fermentum V10 glucose, rhamnose, galactose (1:13: 2)    
L. helveticus MB2-1   EPS 1: galactose, glucose and mannose (1:3:1)  
EPS 2: galactose, glucose and mannose (1:1:9)  
EPS 3: galactose, glucose and mannose (1:1:3)  
L. helveticus subsp. Rosyjski      glucose, galactose, N-acetyl-D-mannosamine (2:2:1) 
L. johnsonii 151 galactose,  glucose (3:2)   
L. johnsonii FI9785 EPS-2: glucose, galactose (4:2)    
L. kefiranofaciens WT-2B   glucose, galactose (3:3)   
L. mucosae DPC 6426   mannose, glucose, galactose (3:2:2)   
L. plantarum EP56   glucose, galactose and rhamnose (3:1:1)  
L. plantarum MTCC 9510         glucose, mannose (2:1) 
L. rhamnosus C83 glucose, galactose (2:3) 
L. rhamnosus GG   galactose, rhamnose, N-acetyl-D-glucosamine (4:1:1)   
L. rhamnosus KF5 S1 S1: glucose, arabinose, glucosamine, galactosamine,   
galactose (2:1:1:1:1)  
S2: rhamnose, glucose, galactose (2:1:1)  
L. rhamnosus R   glucose, galactose, rhamnose (2:1:4)   
L. rhamnosus RW-9595M   rhamnose, glucose, galactose, pyruvate (4:2:1:1)   
L. sakei O-1   glucose, rhamnose (3:2) 
 
 
2.1.3. Biosynthetic pathways leading to the production of EPSs in lactic acid bacteria 
 
The differences between homopolysaccharides and heteropolysaccharides do not reside 
exclusively in the chemical structure but also in enzymes and site of their synthesis. 
Concerning HoPS, their synthesis requires the presence of sucrose as substrate, which donates 
the corresponding glycosyl moiety in a reaction catalysed by the glycansucrases, members of the 
glycoside hydrolase (GH) family and referred to as glucansucrases and fructansucrases (family 
GH68 and GH70, according to CAZy classification), involved in the polymerization of α-glucans 
and β-fructans, respectively. This reaction occurs extracellularly, where the sucrase catalyses the 
transfer of the released monosaccharides to an acceptor molecule in creating a glycosidic bond. 
The energy liberated by degradation of sucrose present in the culture medium is employed to 
catalyse the transfer of a glycosyl residue on forming the polysaccharide (van Hijum, 2006; 
Badel, 2011). On the other hand, β-glucans are less frequent in LAB, and to date, the few that 
have been described have the same structure: 1,3-β-D-glucans with side ramifications of a single 
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1,2-linked β-D-glucose (Zeković, 2005; Kearney, 2011). These β-glucans are synthetized through 
a different mechanism in which another single enzyme type, a glucosyltransferase, which does 
not use sucrose as substrate, is involved (Dols-Lafarge, 2008). This enzyme belongs to the 
COG1215 membrane-bound glycosyltransferase family; topology predictions show that a 
conserved cytosolic domain is flanked by two and four transmembrane segments (Werning, 
2006; Hidalgo-Cantabrana, 2014). The formation of HoPS can occur separately from the 
bacterial cell or within its cell wall (Donot, 2012).  
 
In contrast, HePS biosynthesis occurs mainly within the bacterial cell and is altogether a more 
complex process (summarized in Fig. 2.1), which can be separated into four distinct stages:  
1) Active transport of the sugar into the bacterial cytoplasm through protein complexes, such as 
the phosphoenolpyruvate (PEP)–sugar phosphotransferase system (PTS) (Postma, 1993). During 
the transmembrane PEP-PTS transport, free-state sugar molecules are phosphorylated to their 
sugar-6-phosphate form.  
2) Synthesis of sugar-1-phosphates via phosphomutase enzymes. Phosphoglucomutase (PGM), 
the enzyme involved in the conversion of glucose-6-phosphate to glucose-1-phosphate, 
potentially has an important role in the bifurcation of the flux towards the catabolic (e.g. 
formation of fructose-6-phosphate and, consequently, glycolysis with biomass and ATP 
formation) or the anabolic pathways (biosynthesis of sugar nucleotides, the precursors of EPSs). 
Alternatively, sugar molecules may also enter the bacterial cell in a pre-phosphorylated state 
(Welman and Maddox, 2003; Torino, 2005). 
3) Activation and coupling of sugars with nucleotides. As an example, UDP–glucose and dTDP–
glucose are formed via the action of UDP–glucose pyrophosphorylase and dTDP–glucose 
pyrophosphorylase, respectively. These sugar nucleotides are probably bound to a 
phosphorylated lipid carrier on the cytoplasmic face of the bacterial cell wall via the enzymatic 
action of a membrane-associated priming glycosyltransferase (GTF). Following the attachment, a 
series of additional EPS-specific GTF enzymes catalyses the synthesis of the repeated unit 
(Lebeer, 2009).  
4) Exportation of the repeated unit from the cytoplasmic face to the periplasmic face of the 
membrane after the attachment on a C55-isoprenoid–lipid carrier linked to the cytoplasmic 
membrane and the intervention of a flippase enzyme. The subsequent polymerization occurs 
extracellularly (Lebeer, 2009; Welman and  Maddox, 2003).  
As the biosynthesis of homopolysaccharides only requires one enzyme, a single gene encoding 
the appropriate enzyme is present (Korakli and Vogel, 2006; van Hijum, 2006). Conversely, 
those strains which synthesize heteropolysaccharides require the combined action of a series of 
gene products, in order to reach the complexity of the chemical and structural composition of the 
repeating units. This complexity is also reflected in the organization of the genes encoding the 
proteins involved in their synthesis, which are present in eps clusters, located within the 
chromosomal DNA or on plasmids (Suresh Kumar, 2007). Specifically, heteropolysaccharides 
eps gene clusters are typically arranged in operons with all the genes orientated in the same 
direction, having a high coding density and a highly conserved structural–functional 
organization. (Jolly and Stingele, 2001; Lebeer, 2008). This pattern is, in some cases, 
characterized by the subsequent categories: (i) regulation, (ii) chain length determination, (iii) 
biosynthesis of the repeating unit, and (iv) polymerization and export (Lebeer, 2008).  
Mobile elements are often located bordering the eps clusters, which could explain the instability 
of HePS production phenotype in some LAB (De Vuyst, 2011; Ruas-Madiedo, 2009).  
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Fig. 2.1. Hypothetical heteropolysaccharide biosynthesis pathway. GTF, glycosyltransferase; PMG, 
phosphoglucomutase (Hidalgo-Cantabrana, 2014). 
 
 
 
 
 
 
2.1.4. Importance of the exopolysaccharides produced by LAB 
 
The polysaccharides derived from different LAB show large variation in composition, charge, 
spatial arrangement, rigidity and ability to interact with proteins: for this reason, several 
functions have been attributed to these macromolecules.  
 
 
2.1.4.1. Functions of EPSs in bacteria 
 
EPSs play a major role in bacterial biofilm structure allowing the stabilization of the 3D 
structure, helping to withstand shear forces to minimize the intercellular repulsions among the 
bacteria by shielding the electrostatic charges on their surfaces (Watnick and Kolter, 1999; 
Sutherland, 2001). In addition to a structural role in biofilms, EPSs are thought to be responsible 
for the enhancement of nutrient and water entrapping and have also been shown to protect 
bacteria towards environmental threats, such as bacteriophages, antibiotics, lysozyme, metal ions 
and acidic conditions (Patten and Laws, 2015; Badel, 2011). Another indirect function of EPSs is 
that they facilitate the communication between cells because they aggregate bacteria and 
decrease cell-to-cell distances. Moreover, in various pathogens, EPS molecules (specifically, the 
capsular fraction) act as shield of other cell surface effector molecules recognized by the host 
pattern recognition receptors (PRRs), thus impeding macrophage and neutrophil-mediated 
phagocytosis (Lebeer, 2010).  
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2.1.4.2. Technological applications 
 
Polysaccharides  may  function  in  foods  as  viscosifying  agents, stabilizers,  emulsifiers,  
gelling  agents,  or  water-binding  agents. Concerning EPSs from LAB, they have found their 
most valuable application in the improvement of the rheology, texture and “mouthfeel” of 
fermented milk products, such as yoghurts, as well as the reduction of syneresis. Indeed, although 
having no taste on their own, EPSs increase the time the milk product spends in the mouth, and 
hence impart an enhanced perception of taste (Duboc and Mollet, 2001). Moreover, there is a 
high consumer demand for smooth and creamy yoghurt products, which is typically met by 
increasing the content of fat, sugars, proteins or stabilizers (e.g. pectin, starch, alginate or 
gelatine). Afterwards, the consumer demand for products with low fat or sugar content and low 
levels of additives, as well as cost factors, makes EPSs a valuable alternative (Jolly, 2002). 
Among others, they have long been used in traditional fermented drinks, such as Kefir, or in the 
Scandinavian fermented milk drinks Viili (Vinderola, 2006; Ruas-Madiedo, 2006).  
Even if there are no defined chemical characteristics that allow to predict the viscosity of an EPS 
molecule, some generalized trends have, however, become apparent: high concentrations, high 
specific volumes, chemical composition, chain length, structure of the subunits, molar mass and 
radius of gyration of the EPS molecule determine the physical characteristics and thereby their 
viscosity-intensifying properties (Ruas-Madiedo and de los Reyes-Gavilán, 2005; Tuinier, 1999). 
Low yields of EPS (corresponding normally to about 0.8-2.5 g/l) can be optimized by modulating 
the fermentation conditions, such as the carbon source and its quantities, pH, temperature, and 
salt concentrations (Patten and Laws, 2015; Årsköld, 2007; Mende, 2012). In general, long 
chains of subunits (high molecular mass) and/or stiff chains are required to improve viscosity. As 
mentioned above, backbone linkages of the 1,4-β type, as found in Lactococcus lactis subsp. 
cremoris B40, for example, result in stiffer chains than 1,4-α or 1,3-β linkages (Laws and 
Marshall, 2001).  
 
 
2.1.4.3. Physiological benefits in the host 
 
2.1.4.3.1. Prebiotic effects 
 
EPSs are not hydrolysed by host digestive enzymes, and therefore allow probiotic bacteria to 
overcome the environmental challenges and to persist for longer periods in the gut, thus 
enhancing their colonization (Fanning, 2012). An early study by Ruijssenaars (2000) 
demonstrated the resistance to biodegradation of EPSs from strains L. sakei O-1 and L. helveticus 
Lh59, thus suggesting that EPSs could survive the enzymatic stresses of the colonic milieu. 
Additionally, Hongpattarakere (2012) documented the ability of EPSs isolated from L. plantarum 
A3 to highly resist in vitro gastric and intestinal digestion. However, once the EPSs arrive in the 
colon lumen, they should then be able to selectively stimulate the growth of those bacterial 
species capable of eliciting a beneficial effect on the host. Bifidogenic activities have been 
observed for EPSs isolated from L. rhamnosus E/N and L. plantarum DM5 (Polak-Berecka, 
2013; Das, 2014). It is clear that Lactobacillus-produced EPSs show some promises as prebiotic 
biopolymers in vitro, nevertheless, these effects have yet to be observed in vivo. 
 
 
2.1.4.3.2. Immunomodulatory activity 
 
An increasing number of studies on the biological effects of LAB EPSs is demonstrating the 
ability of these polymers to interact with the host immune system. Figure 2.2 summarizes the 
pathways and immune cells involved in the effects EPSs might exert at intestinal level. 
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Most investigations of EPSs immunoregulatory effects have focused on macrophages: initial 
studies in this field described their mitogenic activities, as observed for EPSs isolated from L. 
rhamnosus RW-9595M and L. delbrueckii subsp. bulgaricus 1073R-1, which significantly 
promoted the proliferation of human and murine macrophages (Chabot, 2001; Kitazawa, 1998). 
The capacity of L. delbrueckii subsp. bulgaricus 1073R-1 to trigger immune responses and 
mitogenic effects has been attributed to the acidic portion of its HePS, specifically to the 
phosphate group attached to one monomer of the repeated unit, as confirmed by the reduction of 
the stimulatory effect determined by chemical dephosphorylation of the EPS molecule 
(Nishimura-Uemura, 2003; Kitazawa, 1998).  
Regarding the high-molecular weight (HMW) EPS isolated from L. rhamnosus RW-9595M, it 
has also been demonstrated the inhibition of TNF-α, IL-6 and IL-12 expression and the 
stimulation of IL-10 secretion in murine peritoneal macrophages, thus suggesting an anti-
inflammatory role for this molecule (Bleau, 2010). In addition, L. paracasei Shirota harbours an 
eps cluster of 10 genes which is involved in the synthesis of a HMW cell-wall polysaccharide 
capable of suppressing inflammatory responses; Yasuda (2008) showed that knockout-mutants of 
eps genes were able to induce the production of TNFα, IL-12, IL-10 and IL-6 in mouse 
macrophages (RAW-264.7) and mouse spleen cells, to a higher extent than the wild-type 
bacterium. It has been proposed that this kind of inhibitory activity towards the activation of pro-
inflammatory responses can be attributed to the HMW nature of the EPS (Hidalgo-Cantabrana, 
2012). On the contrary, EPSs isolated from L. paracasei subsp. paracasei NTU101 and L. 
plantarum NTU102 exhibited only pro-inflammatory effects on macrophages, stimulating the 
expression of IL-6 and TNF-α (Liu, 2011). Finally, Vinderola (2006) demonstrated that the oral 
administration of kefiran, the EPS isolated from Lactobacillus kefiranofaciens, increased the 
secretion of luminal IgA in the small and large intestine in BALB/C mice, thus suggesting a 
potential role in the stimulation of the adaptive immunity and, specifically, of B-cell-dependent 
humoral (antibody-mediated) immunity.  
  
 
Fig. 2.2. Beneficial activities potentially attributed to exopolysaccharides. CK, cytokines; DC, dendritic 
cell; Teff cells, lymphocyte T effector cells; Treg cell, lymphocyte T regulatory cell; B cell, lymphocyte B 
cell; ROS, reactive oxygen species (Hidalgo-Cantabrana, 2014). 
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2.2 AIMS OF THE STUDY 
In light of (i) the importance of exopolysaccharides in technological applications and, more 
interestingly, in the cross-talk between bacteria and host, and (ii) the presence of putative eps 
operons in the genome, we investigated the potential EPS producing properties of L. paracasei 
DG and LPC-S01. To this aim, we performed an extraction and purification protocol in order to 
obtain a clean exopolysaccharides fraction, which was further employed to identify the repeating 
unit composing the polymer by means of NMR spectrometry and other analytical 
chromatographic methods. The purified molecule was then used to assess its immunomodulatory 
potential on the transfected pNiFty2-Luc Caco-2 cell line and on two models of human 
macrophages, namely U937 and THP-1. 
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2.3 MATERIALS AND METHODS 
 
2.3.1. Bacterial strains and culture conditions 
 
Lactobacillus paracasei strains DG and LPC-S01 were grown at 37° C in de Man-Rogosa-
Sharpe (MRS) broth (Difco Laboratories Inc., Detroit, MI) for 24 h. This culture was used to 
inoculate 500 ml-1.5 l of chemically defined medium (CDM, Tab. 2.2).   
 
Tab. 2.2 Chemically defined medium (CDM) used to cultivate L. paracasei. 
 
 Medium (g l-1) 
Sol. 1  
 
(NH4)2SO4 2 
MgSO4 x 7 H2O 0.15 
MnSO4 x 4 H2O 0.02 
Sol. 2  
 
Adenine 0.005 
Pyridoxal 0.002 
Nicotinic acid 0.001 
Ca2+-D-pantothenate 0.001 
Riboflavin 0.001 
Thiamine 0.001 
Vitamin B12 0.000001 
Biotin 0.00001 
p-aminobenzoic acid 0.000005 
Folic acid 0.00001 
Sol. 4 * 
 
Guanine 0.005 
Xanthine 0.005 
Uracil 0.005 
Sol. 5  
 
K2HPO4 4.56 
Sol. 6  
 
Sodium acetate 0.05 
Sodium citrate 0.02 
KH2PO4 0.01 
NaCl 0.002 
CaCl2 0.002 
Sol. 7  
 
Tween 80 1 
Tween 20 1 
Glycerol 1 
Glucose   
 20 
Casaminoacids   
 1 
* Dissolved in 1M NaOH. An equal volume of 1M HCl was added to the medium to neutralize the pH. 
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2.3.2. EPS isolation and purification 
 
The multistep extraction and puriﬁcation of EPS was performed from 0.5-1.5 l CDM 
supplemented with 2% glucose. After growth at 37° C for 48 h, cells were collected by 
centrifugation at 12,000 x g for 15 min at 4°C (Avant J-26 XPI, Beckman Coulter Ltd, High 
Wycombe, UK) and separated from the exhausted medium. The two fractions were then treated 
separately. The exhausted medium was added with an equal volume of absolute ethanol and 
stored at 4°C for 48 h. After storage, it was centrifuged at 25,000 x g for 35 min at 4°C. The 
pellet obtained (fraction S1, Fig. 2.3) was dissolved in deionized water (about 20-50 ml), whereas 
the supernatant was added with a second volume of ethanol and stored again at 4°C for 48 h. 
Subsequently, the centrifugation step was repeated and the pellet (fraction S2, Fig. 2.3) was 
dissolved in deionized water as above. Concerning cell fractions, the pellet was dissolved in 100 
ml 1 M NaOH and stirred overnight at 4°C. Afterwards, it was centrifuged again at 12,000 x g 
4°C for 15 min in order to remove sodium hydroxide. After resuspension of the pellet in PBS 
buffer, cells were sonicated at a power of 45% for 10 min, in order to detach the EPS from the 
cell wall. The resulting slurry was centrifuged at 10,000 x g 4°C for 10 min and the pellet 
(containing bacterial cells) was discarded. Crude EPS was precipitated by the addition of an 
equal volume of chilled absolute ethanol; this was stored 48 h at 4°C and then centrifuged at 
25,000 x g 4°C for 35 min. The recovered pellet (fraction C1, Fig. 2.3) was re-dissolved in 
deionized water (about 20 ml). The resulting supernatant was instead added with a second 
volume of absolute ethanol and again incubated 48 h at 4°C. Another centrifugation, as described 
above, let us recover the second precipitated fraction (C2, Fig. 2.3), which was dissolved in 
deionized water.  
Small neutral sugars and proteins were then removed by dialysis (with 100 kDa cut-off cellulose 
acetate membranes) of the extracted fractions for 72 h at 4°C, against three changes of deionized 
water per day. After three days, the contents of the dialysis membrane were collected and 
lyophilized in a freeze-dryer (Northern Scientific, York, UK). The extraction protocol is outlined 
in Fig. 2.3. The dry mass of EPS was then determined.  
 
Fig. 2.3 Outline of the extraction protocol used to purify EPS from L. paracasei. 
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2.3.3. Monomer composition and linkages of the EPS 
 
For sugar composition determinations, 1 mg ml
-1 
EPS was hydrolysed prior to analysis by 
treatment with 2 ml of 2 M TFA (120°C for 2 h); the solution was then let evaporate under a 
constant stream of nitrogen atmosphere at 60°C to give monomers, whose identity was 
determined using high performance anion exchange chromatography (HPAEC) on a Dionex ICS-
5000 system (Dionex Corporation, Sunnyvale, USA) equipped with a CarboPac PA20 anion 
exchange analytical column (150 mm x 3 mm). Monomers were eluted using a 10 mM sodium 
hydroxide mobile phase at a flow rate of 0.5 ml min
-1
 and detected using a pulsed amperometric 
detector (PAD) ED40 (Dionex) operating with a gold working electrode and an Ag/AgCl 
reference electrode. The identity was determined by comparison of the detector response to pure 
standards of the individual monomers (100 ppm).  
The hydrolysed monomers were also analysed by gas-chromatography mass-spectrometry 
(GC/MS). To derivatize the sample, the monomers mix resuspended in 1 ml Milli-Q water was 
added with 10 mg NaBH4 and the reduction step ran at 40°C for 2 h. After evaporation of the 
solution as described above, 1 ml glacial acetic acid was added to the residue, and again 
evaporated to dryness. Subsequently, 3 ml methanol were added and then evaporated in order to 
remove the borate complex and to give the methylated sugar alditols. They were then added with 
2 ml pyridine and 2 ml acetic anhydride; acetylation reaction ran at 100°C for 2 h. At the end of 
the reaction the solution was evaporated and the acetylated monomers resuspended in water. 
Extraction with chloroform was performed to collect the organic phase, containing the alditol 
acetate sugars. Any trace of water was removed by adding anhydrous sodium sulphate and 
storing the sample 30 min at 4°C. Sodium sulphate was removed by filtration on filter paper and 
chloroform by evaporation. The resulting residue was resuspended in 2 ml acetone for the 
GC/MS analysis, performed on an Agilent 7890A GC system (Santa Clara, CA, USA) coupled to 
an Agilent 5675c quadrupole MS. The samples were eluted from a SGE column (BPX5, 25 m  
0.32 mm-id, 0.5 lm ﬁlm; HP5, 15 m 0.32 mm-id) with helium (9 psi, ﬂow rate 1 ml min-1) and 
using a temperature program (start temperature 150°C, hold time 4 min and a ﬁnal column 
temperature of 250 °C reached via a rising gradient of 4°C/min).  
For linkage analysis, 3 mg EPS were permethylated using 0.7 ml anhydrous dimethylsulphoxide 
(DMSO)  and stirring at room temperature for 20 min (until formation of a slurry). Afterwards, 
70 mg sodium hydroxide along with 60 µl methyl iodide were added and, after 20 min, the 
resulting solution (methylated polysaccharide) was separated and isolated. Specifically, after 
addition of 3 ml of Milli-Q water, extraction with dichloromethane was performed and the 
organic phase was collected. After evaporation, the protocol followed was the same described 
above for the monomer analysis (e.g. hydrolysis, reduction and acetylation steps). The identity of 
the various methylated alditol acetates was determined by GC/MS and by analysis of the 
individual fragmentation patterns observed in the MS. The samples were eluted from a HP-5 
column (30 m 0.25 mm-id, 0.25 lm ﬁlm) using helium as carrier (9 psi, ﬂow rate 1 ml min-1) and 
using the following temperature programme: start temperature of 155 °C, hold time of 1 min and 
a ﬁnal column temperature of 195 °C reached via a rising gradient of 0.75 °C min-1.  
 
 
2.3.4. NMR analyses of exopolysaccharides 
 
For NMR analyses, EPS freeze-dried samples were dissolved (10 mg ml
-1
) directly in D2O (Goss 
Scientific Instruments Ltd, Essex, UK). NMR spectra were recorded at an elevated probe 
temperature of 70°C. The elevated temperature was initially chosen as it shifted the HOD signal 
to a higher field, into a clear region of the spectrum. The higher temperature also increased 
spectral resolution by reducing the sample viscosity. All of the NMR spectra were recorded on a 
Bruker Avance 500.13 MHz 
1
H (125.75 MHz 
13
C) spectrometer (Bruker-Biospin, Coventry, UK) 
operating with Z-field gradients where appropriate, and using Bruker’s pulse programs. Chemical 
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shifts are expressed in ppm relative to either internal or external acetone; δ 2.225 for 1H and δ 
31.55 for 
13
C. 
The 2D gs-DQF-COSY spectrum was recorded in magnitude mode at 70°C. TOCSY 
experiments were recorded with variable mixing times (60, 90 and 120 ms). The 2D-
heteronuclear 
1
H–13C HSQC, and phase sensitive HSQC-TOCSY spectra were recorded using 
Bruker pulse sequences and 256 experiments of 1024 data points. The NOESY spectrum was 
recorded using a Bruker pulse sequence and 256 experiments of 1024 data points using a mixing 
time of 200 ms. For the majority of spectra, time-domain data were multiplied by phase-shifted 
(squared-) sine-bell functions. After applying zero-filling and Fourier transformation, data sets of 
1024–1024 points were obtained. 
 
 
2.3.5. NF-κB activation by exopolysaccharides 
 
The experiment was conducted on the transfected Caco-2 cell line described in Chapter 1, 
Paragraph 1.3.7. In this set of experiments, Caco-2 pNiFty2-Luc monolayers were incubated with 
0.1 ml of L. paracasei DG EPS corresponding to a final concentration of 100 µg ml
-1
. The 
stimulation was conducted by adding 10 ng ml
-1
 of IL-1β. After incubation at 37° C for 4 h, the 
samples were treated and the bioluminescence was measured as described by Stuknyte (2011). 
Two independent experiments were conducted in triplicate for each condition. 
 
 
2.3.6. Activation of U937 and THP-1 human macrophage cell lines: cell culture, growth 
conditions, and stimulation protocol 
 
The cell line U937 (ATCC CRL-1593.2™) was derived from a human histiocytic lymphoma 
(Sundstrom and Nilsson, 1976). These cells are maintained as replicative, non-adherent cells and 
have many of the biochemical and morphological characteristics of blood monocytes (Harris and 
Ralph, 1985). When treated with phorbol myristate acetate (PMA), U937 cells differentiate to 
become adherent, non-replicative cells with characteristics similar to tissue macrophages, 
including similar isoenzyme patterns (Radzun, 1983) and other phenotypic markers (Harris and 
Ralph, 1985).  The monocytic THP-1 cell line was purchased from American Type Culture 
Collection (Manassas, VA, USA). THP-1 cells were originally cultured from the peripheral blood 
of 1 year child with acute monocytic leukemia (Tsuchiya, 1980). They are  non-adherent  cells, 
which can be differentiated into macrophage-like cells using PMA through a protein kinase C-
mediated ROS-dependent signaling  pathway (Traore, 2005).  Treatment  of  THP-1  with  PMA 
(10 ng ml
-1
 overnight) leads to a decrease in the expression of LDL receptor and an increase in 
the expression of scavenger receptors (Johnson, 2003). These alterations allow the cells to take 
up modified lipoproteins and to become foam cells with excessive accumulation of lipid, 
primarily cholesterol ester, that make THP-1 a reasonable model to mimic monocyte–
macrophage behavior during the atherogenesis process (Del Bò, 2015). 
The normal growth medium for U937 and THP-1 cells consisted of RPMI 1640 medium (Lonza, 
Basel, Switzerland) supplemented with 10 % (v/v) fetal bovine serum (FBS) (Gibco-BRL, Life 
Technologies, Milan. Italy), 2 mM L-glutamine, 100 units ml
-1
 penicillin and 100 μg ml-1 
streptomycin (Sigma-Aldrich). Cells were seeded at a density of 5×10
5
 cells well
-1
 in 12-well 
plates and incubated at 37°C in a humidified atmosphere of 95% air and 5% CO2. Differentiation 
was induced by the addition of PMA (Sigma-Aldrich) into the cellular medium at a final 
concentration of 100 nM and was allowed to proceed for 24 and 48 h, for THP-1 and U937, 
respectively. Afterwards, cells were washed once with sterile PBS buffer to remove all non-
adherent cells. One hour before the bacteria were added to the cells, the culture media was 
replaced with RPMI 1640 medium supplemented with 1% (v/v) FBS to allow the cells to adapt. 
Bacteria were used at MOIs of 100 and 1000, and lipopolysaccharide (LPS, final concentration of 
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1 μg ml-1) from Salmonella enterica (Sigma-Aldrich) was used as positive control for pro-
inflammatory stimulus in U937 cells. An untreated sample, i.e., only RPMI 1640 medium with 1 
% (v/v) FBS, was used as control. 
 
 
2.3.7. Preparation of RNA and qRT-PCR 
 
After incubating U937 or THP-1 cells at 37 °C four 4 h, the supernatant was carefully removed 
from each well and the total cellular RNA was isolated from the adhered cells with the Total 
RNA Blood and Cultured cells Kit (GeneAid, New Taipei City, Taiwan) . Afterwards, DNA 
traces were removed by treatment with DNAse enzyme (Sigma-Aldrich), following the 
manufacturer’s instructions. RNA concentration and purity was determined with a Take3 
Multivolume Plate Reader (Biotek, Luzern, Switzerland) and reverse transcription to cDNA was 
performed with the iScript Select cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, CA), 
using the following thermal cycle: 5 min at 25° C for, 30 min at 42° C, and 5 min at 85° C. Real-
time Quantitative PCR (qRT-PCR) was carried out in order to measure the mRNA expression 
levels of cytokines by means of the SYBR Green technology using the SsoFast EvaGreen 
Supermix (Bio-Rad) on a Bio-Rad CFX96 system according to the manufacturer's instructions. 
The primers used are as follows (5’3’): GAPDH forward GGGAAGGTGAAGGTCGGAGT; 
GAPDH reverse TCAGCCTTGACGGTGCCATG; IL10 forward 
AGCAGAGTGAAGACTTTCTTTC; IL10 reverse CATCTCAGACAAGGCTTGG; TNF-α 
forward TCAGCTCCACGCCATT; TNF-α reverse CCCAGGCAGTCAGATCAT; COX2 
forward CCCTTGGGTGTCAAAGGTAA; COX2 reverse TGAAAAGGCGCAGTTTACG. All 
primers were designed previously and their specificity was assessed with melting curves during 
amplification and by 1 % agarose gels (Taverniti, 2012). Quantitative PCR was carried out 
according to the following cycle: initial hold at 95° C for 30 s and then 39 cycles at 95° C for 2 s 
and 60° C for 5 s. Gene expression was normalized to the reference gene gapdh. The amount of 
template cDNA used for each sample was 15 ng. All results regarding cytokine mRNA 
expression levels are reported as the fold of induction (FOI) respective to the control (namely 
unstimulated U937 or THP-1), to which we attributed a FOI of 1. 
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2.4 RESULTS AND DISCUSSION 
 
2.4.1. Identification of putative genetic clusters for exopolysaccharide biosynthesis 
 
As mentioned in Chapter 1, we generated a draft genome sequence of L. paracasei DG and LPC-
S01 and, by comparative analysis with other genomes of the same species, we identified several 
genomic islands with putatively known biological functions. Among them, we found two 
different unique genomic regions in DG and LPC-S01 genomes containing a cluster putatively 
encoding genes involved in the biosynthesis of exopolysaccharide (EPS) molecules. 
Interestingly, these two regions were different between each other and, more importantly, did not 
find any match with other sequences in GenBank database, as observed by performing a  
BLASTN  search. Specifically, search on strain LPC-S01 revealed a region of about 8 kb 
encompassing eight putative genes (genes from A to H in Fig. 2.4A). Similarly, we identified in 
DG genome a 13 kb region coding for several putative glycosyltransferases involved in EPS 
synthesis and, even in this case, a region of about 7 kb in the centre of the cluster found no match 
in the database (genes from D to L in Fig. 2.4B).  
 
 
2.4.2. Purification of EPS from L. paracasei DG and LPC-S01 
 
The quantity of exopolysaccharides produced varies with bacterial species and, in laboratory 
conditions, several physicochemical factors play a crucial role in EPS production yield, including 
pH, temperature, incubation time and, above all, medium composition (carbon, nitrogen and 
cation sources) (Nwodo, 2012). During my experience at the University of Huddersfield (United 
Kingdom), under the guide of Prof. Andy Laws, I attempted to extract the EPS from the strains 
under study by using different media, specifically MRS, Huddersfield Bifidobacteria Medium 
(HBM) and, finally, the chemically defined medium (CDM) indicated in Tab. 2.2. HBM has been 
developed by Alhudhud (2014) and its composition is based on Reinforced Clostridial Medium 
(RCM). Specifically, RCM has been modified in order to remove all those molecules that are 
EPS equivalents (EPS-E), in particular casein and yeast extracts components, which both 
interfere with the quantiﬁcation and characterization of the EPS. In our experiments, HBM did 
not prove to be effective since L. paracasei strains showed a very slow growth rate and a low 
biomass formation, probably due to the absence of various salts and amino acids in the modified 
medium. On the other hand, MRS allowed a very fast and abundant biomass formation but, 
nonetheless, the EPS fraction was partially contaminated by the EPS-E molecules present in the 
extracts included in the medium. For this reason, the best results were obtained by developing the 
chemically defined medium (CDM, Tab. 2.2), which contains all the micro- and macro-elements 
needed by L. paracasei without adding complex components such as beef and yeast extracts. 
Under the conditions tested, and by following the extraction protocol indicated in Fig. 2.3, we 
obtained a final product ascribable to a crude EPS isolate only from L. paracasei strain DG 
batch. We concluded that strain L. paracasei LPC-S01 did not produce EPS under the tested 
conditions; however, there are several factors, as mentioned above, which can influence the EPS 
synthesis. For this reason, further investigation is needed in order to test the hypothesis that strain 
LPC-S01 express the putative eps operon we identified in its genome. For instance, a screening 
of different carbon sources, such as disaccharides (e.g. lactose instead of glucose) or 
oligosaccharides, could be useful to investigate more extensively LPC-S01 capacity to secrete 
EPSs (Laws, 2008; Polak-Berecka, 2013). In addition, bacterial growth phase may be also crucial 
since, reportedly, EPS production may be limited to the exponential rather than stationary growth 
phase (Pham, 2000; Yang, 2010; Arsköld, 2007).  
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Fig. 2.4. BLASTN search results for the regions from Lactobacillus paracasei LPC-S01 (A) and DG (B), 
which putatively code for the enzymes involved in the synthesis of an exopolysaccharide (EPS). The ﬁgure 
has been obtained adding a picture of the putative EPS operon over the graphic representation of the 
BLASTN output. Genes outside the putative EPS operon are indicated in white, genes belonging to the EPS 
cluster are indicated in grey or black if they did find or not a match on BLASTN, respectively.  
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2.4.3. Identification of monomers composing L. paracasei DG EPS 
 
The analysis of the hydrolysed macromolecule extracted by strain DG was performed by means 
of HPAEC and GC/MS, in order to discover the identity of the monomers composing the 
polymer. In Fig. 2.5A, the chromatogram indicates three main signals, with retention times 
corresponding to the standards of rhamnose, galactosamine and galactose, respectively. Thanks 
to the gas-chromatography mass spectrometry analysis, we could confirm these data: in Fig. 2.5B 
the chromatogram corresponding to DG EPS indicates two peaks with retention times of 6.009 
and 13.150 min. By analysing their fragmentation profile we could identify that they 
corresponded to those of rhamnose and of an hexose, respectively. The galactosamine signal was 
missing, probably due to the loss of the amino group during the derivation steps.  
 
 
Fig. 2.5. HPAEC (A) and GC/MS spectrum (B) indicating the monomer composition of DG EPS.   
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2.4.4. Structural identification of L. paracasei DG EPS repeating unit 
 
The previous analyses helped us to identify the components of DG’s EPS repeating unit. In order 
to gain information about the quantity and the sequence of monomers, a detailed analysis of a 
number of 1D and 2D-NMR spectra was then necessary. The analysis of the anomeric region of 
the 
1
H NMR (Fig. 2.6, δ= 4.4–6 ppm) identiﬁed six proton resonances: four corresponded to 
anomeric α sugars signals since they displayed a single peak (labelled A to D with decreasing 
chemical shift), whereas the two remaining signals belonged to β sugars (E and F), because 
having doublet peaks. The presence of six major anomeric protons thus suggested that the 
repeating unit is a exasaccharide. The 
1
H NMR also gave us additional information: the presence 
of methylated sugars, as deduced by the appearance of two signals in the low region of the 
spectrum (between 1.2 and 1.4 ppm), ascribable to the rhamnose identified by the 
chromatographic analyses, and the presence of one signal with chemical shift δ= 2.08, typical of 
the proton bounded to the acetyl group of N-acetylated sugars, such as GlcNAc and GalNAc. 
 
 
Fig. 2.6. 1H NMR spectrum for L. paracasei DG EPS recorded at 70 °C in D2O. Magnified region showing 
anomeric H1’s is inserted in the bottom left, magnified region showing the low ppm are of the spectrum is 
in the bottom right. 
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The 
13
C 135 DEPT spectrum, shown in Fig. 2.7, contains six signals in the anomeric region 
confirming that the EPS has a exasaccharidic repeated unit. A high field ring carbon at 53.86 
ppm and an acetyl–methyl group at 21 ppm confirmed the presence of an N-acetyl amino sugar. 
We could also detect a negative peak in the DEPT 135 spectrum corresponding to C6, thus 
suggesting that at least one of the six sugars is a hexose. 
 
Fig. 2.7. DEPT 135 13C NMR spectrum of L. paracasei DG EPS recorded at 70 °C in D2O; magnified 
region showing anomeric C1’s is inserted in the bottom left.  
  
 
 
 
The position of the remaining ring protons was established through analysis of the scalar 
coupling observed in the corresponding 
1
H–1H COSY and 1H–1H TOCSY spectrum, as shown in 
Fig. 2.8. The COSY spectrum (blue in Fig. 2.8) allowed us to assign the protons on the spectrum 
based on the vicinal coupling, that is to identify the protons belonging to ring carbons linked 
together. On the other hand, TOCSY spectrum (performed with mixing times 30–250 ms, red in 
Fig. 2.8), gave us information about the correlations among all the protons in the sugar ring. By 
assigning all the cross peaks in the 2D spectra, we could identify four residues in the repeating 
unit, corresponding to rhamnose (sugars from A to D), as observed in the panel on the right of 
Fig. 2.8 which highlights the low ppm area of the spectrum. The 
1
H-
13
C HSQC spectrum helped 
us to confirm the identity of the remaining two residues: N-acetyl galactosamine (GalNAc, sugar 
E), and galactose (Gal, sugar F) (data not shown). Finally, in order to uncover how these residues 
are linked together in the repeating unit, we performed a NOESY NMR (red, Fig. 2.9) , which 
reveals the spatially proximal proton pairs and helps to determine a sequence of molecules. As 
shown in Fig. 2.9, we could identify six cross peaks in the 2D spectrum corresponding to the 
interaction between the protons close in the space and belonging to the carbons involved in the 
glycosidic bond. The linkages of the different monomers in the oligosaccharide repeat unit were 
confirmed using a combination of these latter chemical shift data with the linkage analysis of the 
methylated alditol acetates performed with GC/MS. The GC/MS profiles shown in Fig. 2.10 
indicate the presence of a terminal hexose (galactose, 6.993 min), two 1,2-linked rhamnoses 
(4.046 min), a 1,3-linked rhamnose (4.218 min), a 1,2,3-linked rhamnose (5.207 min), and a 1,3-
linked N-acetylated residue (GalNAc, 6.277).  
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Fig. 2.8. COSY (blue) and TOCSY (red) 2D NMR spectrum of EPS from Lactobacillus paracasei DG 
recorded at 70 °C in D2O. On the right a panel shows a selected region of the spectrum, corresponding to the 
low ppm area (1-2.5 ppm). The identity of cross peaks is noted by the sugar residue, as A–F, and by 
identifying the location of hydrogens within the ring as 1–6.  
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Fig. 2.9. COSY (green) and NOESY (red) 2D NMR spectrum of EPS from Lactobacillus paracasei DG 
recorded at 70 °C in D2O. The identity of cross peaks is noted by the sugar residue, as A–F, and by 
identifying the location of hydrogens within the ring as 1–6.  
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Fig. 2.10. GC/MS profiles indicate the different type methylated alditol acetates obtained by derivation of 
DG EPS for the linkage analysis.   
 
 
 
 
 
In conclusion, the combined results of the chemical and spectroscopic analyses let us build the 
repeating unit of L. paracasei DG EPS, which results being a branched exasaccharide with the 
novel following structure: 
 
 
     
 
 
 
2.4.5. Activation of NF-κB in recombinant Caco-2 cells by L. paracasei DG EPS 
After the structure characterization, the EPS isolated from L. paracasei DG, we studied its 
possible involvement in mediating the bacterial effects on the host immune system. Indeed, there 
are many evidences about the ability of EPSs isolated from lactobacilli to interact with the host 
immune cells and trigger immunomodulatory responses (Liu, 2011; Vinderola, 2006; Gao, 2015; 
Ciszek-Lenda, 2011a; Ciszek-Lenda, 2011b; Patten, 2014); however, the molecular mechanisms 
by which they promote these effects, and their overall role in immune homeostasis, are yet to be 
elucidated. NF-κB is an important intracellular signalling molecule that mediates the activation 
of various cytokine genes in response to microbial products. In the cytosol, the nuclear 
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localization sequence of NF-κB is hidden by IκB but, upon stimulation, IκB is degraded, 
allowing NF-κB to translocate into the nucleus where it may bind the promoters of cytokine 
genes (Hayden and Ghosh, 2004). This transcription factor was proved to be activated in mouse 
peritoneal macrophages upon stimulation with the EPS producing strain L. paracasei KB28, 
causing induction of TNF-α, IL-6, and IL-12 via its modulation (Kang, 2011). Similar effects 
have been reported for the EPS produced by Lactobacillus acidophilus NCFM on Caco-2 cells 
(Li, 2014).   
We utilized the isolated DG’s EPS macromolecule as stimulus in the experiments on the 
recombinant pNiFty2-Luc Caco-2 cell line. We found that, differently from the whole bacterial 
cells and their exhausted broth (Fig. 1.10), the purified EPS molecule was unable to either 
decrease or increase the activation of NF-κB, with or without addition of the pro-inflammatory 
stimulus of IL-1β (Fig. 2.11).  
 
Fig. 2.11. Effect of the purified Lactobacillus paracasei DG EPS on the human transfected pNiFty2-Luc 
Caco-2 cell line, at baseline or stimulated with 10 ng ml-1 of IL-1β. EPS was tested at a concentration of 100 
μg ml-1. Data in histograms are the means (+ standard deviations) from at least three independent 
experiments conducted in triplicate. Data are reported as relative luminescence units (RLU). 
 
 
 
 
2.4.6. Immunomodulatory activity of L. paracasei DG and its isolated exopolysaccharide 
 
After the preliminary immunological investigation performed on epithelial cells, we employed 
cells belonging to the innate immune system to study the host’s immune responses triggered by 
L. paracasei DG and its isolated EPS. We utilized two models of macrophages, U937 and THP-
1, both professional phagocytes that undergo activation upon environmental signals such as 
microbial products and cytokines (Benoit, 2008; Italiani and Boraschi, 2014). We quantified 
through qRT-PCR the gene expression of TNF-α (a cytokine involved in inflammatory 
responses; Belardelli, 1995), IL-10 (a potent anti-inflammatory interleukin inhibiting the 
production of proinflammatory cytokines in several cell types; Taverniti, 2012) and COX-2. 
Cyclooxygenase (COX), or prostaglandin synthase H (PGH), is a homodimer enzyme involved in 
the synthesis of prostaglandins (PGs) starting from arachidonic acid (Funk, 2001). PGs are 
involved in several physiological processes and contribute to the protection of the gastrointestinal 
mucosa (Williams, 1999; Morteau, 2000). Two isoforms of the COX enzyme have been 
identified and described (Kujubu, 1991). COX-1 is constitutively expressed in a wide range of 
tissues, whereas COX-2 is constitutively expressed in very few tissues but is induced by several 
stimuli, including bacterial components (Herschman, 1996; Taverniti, 2012). At first, we 
investigated the effect of strains DG, Shirota  (both at a MOI= 50), and the isolated EPS molecule (30 
µg ml
-1
) on the genes activation in the U937 cell model upon presence or absence of an inflammatory 
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stimulus, that is LPS from S. enterica. After 4 h of stimulation, U937 cells proved not to be 
responsive to LPS; consequently we limited our evaluation on the bacterial stimuli at a basal 
level. DG EPS induced a pronounced pro-inflammatory profile, as evidenced by an enhanced 
induction of COX-2 and TNF-α, as compared to IL-10 (Fig. 2.12A). We also found that the cells 
of strain DG triggered COX-2 expression more than strain Shirota (Fig. 2.12A).  
Afterwards, we utilized another macrophages cell line model, named THP-1. The involvement of 
the EPS in the immunostimulating effects of DG was confirmed by adding DG bacterial cells 
without the EPS (naked DG = nDG, i.e., strain DG after detachment of its EPS by washes with 
PBS and mild sonication) as stimulus. In this set of experiments, we could observe that all the 
whole cells showed very weak effects on the modulation of the cytokines expression. However, 
interestingly, we observed that the removal of the EPS resulted in a decrease in COX-2 and TNF-
α induction levels (Fig. 2.12B). The use of the isolated EPS molecule to immunostimulate the 
THP-1 macrophages led to an increase of TNF-α and, to even higher values, of COX-2, with a 
similar trend observed in U937 macrophages experiments (Fig. 2.12C). Finally, when co-
stimulating the THP-1 with LPS from S. enterica, we could observe that an additive effect had 
occurred between LPS and EPS on COX-2 expression, which nearly doubled (from 80 and 85 
FOI with the single stimuli LPS or EPS, respectively, to about 140 FOI when combined together; 
Fig. 2.12D). The same effect occurred when THP-1 cells were co-stimulated with LPS and strain 
DG but not with nDG. Taken together, these data suggest that EPS could play a dominant role in 
the ability of strain DG to trigger COX-2 expression in macrophages.  
Although other studies have suggested that lactic acid bacteria could affect COX-2 secretion, 
there is no clear consensus in the literature. For instance, several probiotic preparations were 
found to reduce the amount of prostaglandins and levels of COX-2 gene expression at the 
intestinal level in murine models and in vitro (Lee, 2008; Urbanska, 2010; Amdekar, 2011). In 
contrast, other papers reported a significant up-regulation of COX-2 expression levels by 
probiotic bacteria in vitro and in vivo (Khailova, 2010; Otte, 2009; Kwon, 2010). Differences in 
tested strains and model systems likely explain the lack of consensus found in the literature. 
The ability of the strain DG and its EPS to induce COX-2 expression suggests that this bacterium 
could directly affect inflammatory processes not only by modulating cytokine secretion but also 
by inducing prostaglandin production. The observed effect on the activity of the COX-2 gene 
could thus be of immediate benefit for the host’s mucosa; furthermore, rapid COX-2 upregulation 
in response to injury or inflammation has been reported to restore mucosal integrity (Tan, 2000). 
Our results appear also in accordance with the study conducted by D’Incà (2011), who reported a 
beneficial role of L. paracasei DG in patients with ulcerative colitis after rectal administration of 
the probiotic. Accordingly, the authors propose that DG’s possible mechanisms of action are 
related to the alterations in the microbiota (as observed also in healthy volunteers by Ferrario, 
2014) and the contribution to the modulation of the mucosal immune response through signalling 
molecules, ultimately modifying the overall cytokine balance.  
A number of Lactobacillus-derived EPSs have demonstrated beneficial effects on the innate and 
adaptive immunity of the intestine (Amdekar, 2011; Bleau, 2010); therefore, these biopolymers, 
and particularly DG’s EPS, could be potentially exploited to reduce intestinal inflammation 
associated with chronic diseases. Further efforts need to be undertaken to identify the EPS 
receptor and, consequently, elucidate  the immunomodulatory mechanism of action of DG’s EPS. 
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Fig. 2.12. Quantitative analysis of cytokine gene expression in human macrophages U937 (A) and THP-1 
(B,C and D) after 4 h stimulation with L. paracasei DG, L. paracasei Shirota, L. paracasei nDG and the 
isolated DG EPS molecule. Expression levels of TNF-α, IL-10 and COX-2 are shown as the fold change of 
induction (FOI) relative to the control (unstimulated macrophages), which was set at a value of 1. LPS was 
used as a co-stimulator at a concentration of 1 μg ml-1. EPS was tested at concentrations of 30 μg ml-1. 
Bacterial cells were used at a MOI of 50. Presented data are the means of measurements (+ standard 
deviations) for a result representative of three independent experiments. 
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2.5 CONCLUSIONS 
Among the modes of action by which probiotics are thought to contribute to human health, the 
modulation of the immune responses, resulting in both local and systemic effects, is probably the 
most important but, at the moment, also the more obscure (Goldin and Gorbach, 2008). For this 
reason, a better understanding of how probiotic bacteria interact with host cells is needed for their 
optimal application. 
Bacterial cell wall and secreted molecules are key probiotic ligands that can interact with the host 
receptors and activate various signalling pathways, thus triggering the final probiotic effect. 
Among the most studied probiotics, lactic-acid bacteria possess a cell wall that is typically 
composed of a thick peptidoglycan layer decorated with proteins, teichoic acids and 
polysaccharides (Lebeer, 2010).  Exopolysaccharides, apart  from  their  industrial  applications,  
are found to be  associated  with  many  physiological functions, but their mechanism of action 
has not been clearly established, and is probably diverse and complex (Patel and Prajapati, 2013).  
Thanks to the comparative genomic analysis on L. paracasei strains DG and LPC-S01, we could 
identify two gene clusters putatively coding for exopolysaccharides biosynthesis. Interestingly, 
GenBank search revealed that such regions are unprecedented. For this reason, during my period 
as visiting scholar at the University of Huddersfield, United Kingdom, I attempted to extract the 
EPSs molecules produced by both strains under study: however, only strain DG synthetized this 
kind of macromolecules in the tested conditions. After purification, we were able to characterize 
DG EPS repeating unit by means of chromatographic and NMR spectroscopy, and we could 
uncover that it possessed a novel structure, never identified before in any other lactic acid 
bacterium. Afterwards, the purified molecule was utilized as stimulus to assess its 
immunomodulatory potential on Caco-2 cells and two macrophages cell lines, namely U937 and 
THP-1. These latter macrophages were highly responsive to the EPS stimulus. Particularly, the 
purified molecule showed a great ability to enhance the expression of TNF-α and COX-2, leading 
to the activation of an innate immune response with a pro-inflammatory direction. Nonetheless, 
the activation of COX-2, also subjected to an additive effect due to the combination of EPS with 
the pro-inflammatory stimulus of LPS, strongly suggests a role of DG and its secreted 
polysaccharidic molecule in the protection of intestinal mucosa, as observed in previous studies 
(Tan, 2000; D’Incà, 2011). In conclusion, these results provide us additional information about 
strain DG probiotic potential and its mechanisms of action in the cross-talk with the host.  
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3.1 STATE OF THE ART 
 
3.1.1. Overview on lactic acid bacteria metabolism 
 
Lactic acid bacteria (LAB) have been traditionally used for the production of a diverse range of 
fermented foods with improved shelf-life, taste and nutritional properties. For this reason, their 
metabolic and genetic properties have been studied by means of several approaches oriented to 
metabolic and genetic manipulation (Brooijmans, 2009a). LAB have been classified as non-
respiring, obligate anaerobes, producing lactic acid as a major end product from glucose. 
Specifically, they can be divided in obligate homofermentative, facultative heterofermentative, 
and obligate heterofermentative (Axelsson, 2003). The homofermentative species metabolize 
hexoses via glycolysis generating pyruvate, which is reduced to lactic acid as the sole end 
product. They are not able to metabolize pentoses. Obligate heterofermentative LAB do not 
utilize hexoses through glycolysis since they do not harbour the enzyme fructose 1,6-biphosphate 
aldolase, which catalyses fructose 1,6-biphosphate scission in glyceraldehyde 3-phosphate and 
dihydroxyacetone phosphate. For this reason, they ferment glucose through the pentose 
phosphate pathway, generating three final products in equimolar ratio: lactic acid, ethanol and 
CO2 (and small quantities of acetic acid). They can utilize also pentoses, but without production 
of CO2. Facultative heterofermentative bacteria, which comprise Lactobacillus paracasei,  can 
utilize both hexoses and pentoses. Hexoses are fermented via glycolysis with production of lactic 
acid as sole final product (as in homofermentative LAB);  pentoses are oxidized through the 
pentose phosphate pathway, without production of CO2 (Kandler, 1983; Gänzle, 2015). 
 
3.1.2. Respiratory metabolism in LAB: state of the art 
 
Several LAB species have been reported to have a double metabolic life: they can switch from 
fermentation to aerobic respiration metabolism when provided with heme, and for some bacteria, 
heme and menaquinone (Pedersen, 2012). This observation dates back to the early seventies, 
when some studies demonstrated that exogenous heme could induce a behavior that resembled 
respiration in various LAB, including Lactococcus lactis, Enterococcus faecalis, Streptococcus 
dysgalactiae species and Leuconostoc mesenteroides. The first evidences related to the 
respiratory behavior concerned two main phenotypes: growth improvement and/or induction of 
cytochrome formation (Sijpesteijn , 1970). 
The first requisite for a lactic acid bacterium to have a respiratory metabolism is the presence of 
three main membrane components:  
(i) an NADH dehydrogenase which acts as electron donor;  
(ii) a quinone (in Gram-positive bacteria menaquinones), which is a lipophilic non-protein 
molecule that delivers electrons from the dehydrogenase to a final acceptor enzyme 
complex and concomitantly contributes to maintaining an electrochemical gradient 
(proton-motive force). Numerous LAB lack menaquinones biosynthesis genes, but can 
assimilate them from the environment (for instance ad vitamin K2).  
(iii) an acceptor protein complex, namely a cytochrome oxidase, that reduces oxygen to 
water in the presence of H
+
. This enzyme is encoded by the operon cydABCD , where 
cydA and cydB encode for the structural subunits, whereas cydC  and cydD are required 
for the assembly (Puri-Taneja, 2007). Its activity depends on heme cofactor, which has 
to be administered exogenously. Various LAB encode genes for heme biosynthesis 
pathway; for instance, Lactobacillus reuteri harbors genes which may lead to vitamin 
B12 synthesis; others, like L. lactis, encode genes that allow iron insertion in the 
protoporphyrin. Nonetheless, to date no LAB encode the full complement of genes 
(Lechardeur, 2010). 
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Subsequently, protons extruded by the respiratory chain can be utilized by the FoF1 ATP 
synthase to generate ATP (Fig. 3.1). Unlike fermentation, energy from the respiration chain is 
generated by the activity of the ATP synthase, which recovers H
+ 
and generates ATP. In LAB, 
and particularly in L. lactis, the ATP synthase enzyme complex was initially identiﬁed for having 
the reverse role in fermentation, i.e. the elimination of intracellular H
+ 
that accumulates with 
lactic acid production. However, more recent studies suggest that H
+ ﬂux may be bidirectional 
(Blank, 2001; Koebmann, 2008).  
 
 
Fig. 3.1 Schematic figure of electron transport chain components in respiration-competent LAB. Benefits of 
respiration as compared to fermentation growth are indicated. ROS, reactive oxygen species. (Lechardeur, 
2010).  
 
 
 
 
 
In his review Pedersen (2012) classified LAB in the context of respiratory potential according to 
genetic characteristics, particularly for the presence of cyd genes (coding for the terminal 
cytochrome oxidase), and genes involved in the synthesis of menaquinones. Such classification is 
shown in Tab. 3.1.  
The most extensively investigated LAB for the respiratory metabolism is L. lactis, an important 
species in the dairy industry, that conventionally converts 1 mole of glucose to 2 moles of lactate 
with the generation of 2 moles of ATP during glycolysis. Nonetheless, L. lactis is very tolerant to 
oxygen and satisfies the above cited requisites for respiration. In fact, its putative respiratory 
chain contains a heme-dependent bd-type cytochrome, encoded by the cydABCD operon that is 
capable of generating a proton motive force (Brooijmans, 2007). 
Furthermore, L. lactis chromosome harbors genes encoding menaquinone biosynthesis enzymes; 
menaquinone production was in fact demonstrated for this bacterium (Tab. 3.1; Morishita, 1999; 
Wegmann, 2007). For these reasons, a well-documented literature provides data about L. lactis 
respiratory metabolism upon addition of heme in aerobic conditions, which leads to intense 
alteration of its phenotype, consisting in  improved growth efficiency, increased bacterial 
biomass, resistance to oxygen, and robustness (long-term survival)(Duwat, 2001; Gaudu, 2002; 
Arioli, 2012). 
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Tab 3.1. Lactic acid bacteria classification of predicted or demonstrated respiration proficiency (Pedersen, 
2012). 
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These phenotypes are attributed to 4 main features intrinsic to the respiration process:  
i) it is energetically more efﬁcient than fermentation;  
ii) it generates less acid stress: NADH is regenerated to NAD+ by respiration chain NADH 
activity, to the detriment of lactate dehydrogenase, which uses NADH as cofactor for 
the reduction of pyruvate to lactate;  
iii) it generates less oxidative stress: respiration reduces oxygen to water, decreasing 
intracellular oxygen;  
iv) it acts as a “sink” for free electrons generated by the membrane NADH dehydrogenase 
(Lechardeur, 2010). 
The extensive characterization of respiration in L. lactis has led to the examination of other LAB; 
studies on some Leuconostoc mesenteroides isolates revealed similar effects of respiration on 
growth and long-term survival. Among lactobacilli, which are deﬁcient for both heme and 
menaquinone synthesis, Lactobacillus plantarum is probably the most studied, especially strain 
WCFS1 (Kleerebezem, 2003). Results indicate that conventional (static) fermentation conditions 
give better growth yields than aerobiosis; nevertheless, in aerobiosis, at the presence of heme and 
menaquinone, yields and long term survival are greatly improved (Brooijmans, 2009a). 
Interestingly, the same authors suggested that heme is also able to activate an anaerobic electron 
transport chain in L. plantarum WCFS1, in which nitrate is the terminal electron acceptor 
(Brooijmans, 2009b). 
Regarding L. casei group species, a recent work by Zotta (2014) investigated the capability of 
more than a hundred strains belonging to L. casei, L. paracasei and L. rhamnosus species to cope 
with the presence of oxygen, ROS (reactive oxygen species) generating compounds, heme and 
menaquinone. They found that L. casei and L. rhamnosus exhibited the best adaptation to the 
aerobic conditions and most strains were also capable to consume oxygen. On the other hand, in 
the tested L. paracasei strains, heme supplementation impaired the growth of aerobic cultures, 
suggesting a reduced ability to use this compound and/or toxic accumulation into the cells. 
 
 
3.1.3. External electron acceptors 
 
Besides the extensive work on respiration, a smaller number of papers have demonstrated that the 
metabolic shift described above for L. lactis can occur also in the absence of heme, with the final 
electron transfer step being carried out mostly by quinones to the external environment. In fact, 
quinones in their reduced form (hydroquinones or quinols) can also directly reduce O2 to some 
extent and thus enable the bacterium to endure microaerophilic conditions (Newman and Kolter, 
2000). The same phenomenon can also occur in anaerobic environments, such as the human 
colon or the soil sediments, where redox potentials are substantially lower (-500 to -200mV), and 
where microbial growth and metabolism can rely (apart from fermentation) on the presence of 
alternative electron acceptors through an extracellular electron transfer (EET) to recycle electron 
carriers (such as NADH to NAD
+
).  These acceptors can be exogenous or endogenous, as for L. 
lactis, in which the production of a variety of soluble and insoluble quinones leads to the 
establishment of this transfer (Freguia, 2009). Specifically, L. lactis along with L. plantarum can 
exploit an exogenous soluble quinone, namely 2-amino-3-dicarboxy-1,4-naphthoquinone 
(ACNQ), the amino-functionalised precursor of menaquinone biosynthesis, for the reduction of 
hexacyanoferrate. This reduction was concomitant with a metabolic shift that generate pyruvate 
and acetate (in L. plantarum) and also acetoin (in L. lactis) (Yamazaki, 2002).  
In other notable works, Khan (2012a and 2012b) studied the intestinal bacterium 
Faecalibacterium prausnitzii, a well-recognized butyrate-producing health-producing species 
inhabiting the human gut. They employed a microbial fuel cell system to investigate how the 
microorganism exploits the vitamin riboflavin, a soluble redox-active component commonly 
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present in the gut lumen, as an electronophore for extracellular electron transfer (EET). They 
showed that F. prausnitzii can electrochemically reduce riboflavin with the concomitant 
oxidation of NADH to NAD
+
.  The utilization of riboflavin as electron acceptor was observed 
also in L. lactis by Masuda (2010). 
The fact that exogenous extracellular molecules can participate in the electron transfer to 
inorganic or organic compounds indicates that they may give a significant contribution to the 
dissipation of oxidative stress and redox-active substances in many environments, such as soil 
and human gut (Watanabe, 2009; Newman and Kolter, 2000). In fact, the human gut bears many 
redox-active substances derived from host, diet, and gut microbiota (van Niel, 2012; Khan, 
2012a; Khan, 2012b). For this reason, the possibility that endogenous or exogenous extracellular 
molecules can be exploited in such environments remains an important open question. 
. 
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3.2 AIMS OF THE STUDY 
Lactobacillus paracasei is an obligate anaerobic lactic acid bacterium, with a facultative 
heterofermentative metabolism. From the genomic analysis conducted by Pedersen (2012), it has 
been classified as a potential respiratory species since it harbors the cydABCD operon, coding for 
a terminal cytochrome oxidase. Starting by this genetic prediction, and basing on previous 
several works conducted on Lactococcus lactis and Lactobacillus plantarum (Arioli, 2012, 
Brooijmans, 2009a; Brooijmans 2009b; Pedersen, 2008), we decided to evaluate if L. paracasei 
is able to establish this kind of alternative metabolism and, eventually, to gain technological 
advantages spendable at industrial level, as well as in the colonization of the human host. 
To assess the respiratory potential, we performed experiments in the presence of the co-factors 
responsible for respiration, i.e. heme and menaquinone, in order to measure biomass formation 
and long-term resistance. Along with these methods, we performed cytofluorimetric analyses to 
measure membrane damage and oxidative stress, gene expression analyses on the main genes 
involved in the fermentation pathways and the cytochrome oxidase, and chromatographic 
analyses to measure the production of organic acids. Moreover, we constructed a bioluminescent 
reporter system by transforming L. paracasei with the pNZ-T5-LucGR vector, which allows the 
real-time measurement of ATP production rate during bacterial growth in different cultural 
conditions. The experiments were conducted on DG and LPC-S01 strains; however, having 
obtained the same results on both strains, we decided to show only the data regarding strain LPC-
S01. 
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3.3 MATERIALS AND METHODS 
 
3.3.1. Strains and cultural conditions 
 
L. paracasei strains LPC-S01 and DG were refreshed from a glycerol stock suspension in de 
Man-Rogosa-Sharpe (MRS, Difco Laboratories Inc., Detroit, MI, USA) through an overnight 
incubation at 37°C. This pre-inoculum was then used to inoculate a chemically defined medium 
(CDM), whose composition is indicated in Tab. 2.2. L. paracasei was cultivated in anaerobiosis 
(An, allowed by the use of sealed vials) and aerobiosis (Ae, using Erlenmeyer ﬂasks ﬁlled to less 
than 1/5-volume capacity in a shaking incubator at 180 rpm) at 37 °C. Co-factors were 
differentially added to the broth culture. Heme was supplied by adding 10 µg ml
-1
 hemin porcine 
(Sigma-Aldrich), corresponding to a molarity of 15 µM. Menaquinone was added to a final 
concentration of 50 µg ml
-1
 (corresponding to 11 µM) in the form of vitamin K2 (Sigma-
Aldrich). Samples were then stored at 4°C for further analyses. 
 
 
3.3.2. Long-term resistance evaluation 
 
Concerning the viable count, an aliquot from samples stored at 4° was used to make serial 
decimal dilutions in saline solution pH 7.5, which were then plated on MRS agar medium. 
Colonies were then counted after 48-72 h of incubation at 37° C.  
Another aliquot was collected from the samples stored at 4°C and used for the cytofluorimetric 
analyses, performed with a BD ACCURY TM C6 cytometer (BD Bioscience, San José, USA). 
To prepare unstained samples (to use as control of the background of fluorescence), serial 
decimal dilutions were made by using filter sterilized saline solution. The right dilution to 
perform the analysis had to give a number of event µl
-1
 comprised between 1000 and 2000.   
The dyes we utilized were propidium iodide (PI, dissolved in dH2O) and dihydroethidium (DHE, 
dissolved in DMSO), both purchased by Sigma-Aldrich, that were added to 200 μl of broth 
culture at a final concentration of  5 μg ml-1  and incubated at 37° C for 10 min. Afterwards, 
serial dilutions were made as described above, and the analysis was performed by using a 
channel with filter of 610/20 (FL-3).     
 
 
3.3.3. Detection of heme by bathophenantroline sulfonate (BPS) assay 
 
For the BPS assay, 0.9 ml of broth culture with or without addition of heme were collected 
before the inoculum (T0). After 24 and 48 h growth, 1 ml of broth culture was collected and cells 
and medium were separated by centrifugation at 10,000 x g for 10 min. Cells were then washed 
with 1 ml of 50 mM Tris buffer pH 7.4 and centrifuged again, in order to obtain the washed 
fraction. Cells were then resuspended in 1 ml Tris buffer and added with about 200 mg 0.1 mm 
glass beads to obtain a clarified lysate fraction after treatment with a Bead Beater Precellys 24 
(Bertin Technologies, Montigny le Bretonneux, France). All the fractions were added with 100 µl 
of 6 M TCA in order to detach complexed iron. Afterwards, the sample was neutralized by 
addition of Tris-base salt until reaching pH 7.4. The colorimetric assay was performed by 
addition of 0.2 mM bathophenanthrolinedisulfonic acid (BPS) and 10 mM sodium dithionite. The 
complex Fe(II)-bathophenantroline was detected at a wavelength of 535 nm, as described 
elsewhere (Ljones and Burris, 1978; Bonomi, 1998; Miriani, 2014). The calculus of iron 
concentration was performed by considering the molar extinction coefficient for the complex 
Fe(II)-bathophenantroline, which is 25000 M
-1
 cm
-1
.  
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3.3.4. Construction of the bioluminescent reporter system L. paracasei LPC-S01-LucGR 
 
L. paracasei strains were transformed, after the induction of competence, with the expression 
vector pNZ-T5-LucGR, by following a protocol suggested by Palomino (2010).  Briefly, pre-
cultures of L. paracasei were obtained in MRS medium after incubation without aeration at 37°C 
for 18 h. Competent cultures were obtained after inoculating 1 ml of the pre-culture to 100 ml 
MRS medium containing 0.9 M NaCl, and then further incubated. When OD600nm reached 2–2.5, 
growth was stopped by cooling cultures on ice for 10 min. The cells were harvested by cool 
centrifugation and washed three times with ice-cold ultrapure water. Cells were resuspended in 1 
ml of water (100-fold concentration of cell suspension), resulting in a total count of about 10
12
 
CFU/ml and fractions of 50 μl were either used directly for electroporation or stored at −80 °C. 
Electroporation was carried out using a MicroPulser Electroporator (Biorad, Milano, Italy). 50 μl 
of competent cells were mixed 
with 5 μl plasmid DNA (50 to 100 ng/experiment) in 0.2-cm electrode gap cuvettes and subjected 
to a voltage of 2.5 KV. Following electroporation, cells were mixed with 0.95 ml MRS medium 
and incubated at 37 °C for 3 h. About 100 μl of a 1/5 dilution was plated on MRS agar medium 
with chloramphenicol (12 μg ml-1). After 48–72 h of anaerobic incubation, colonies were 
screened to find positivity by checking the level of production of light.  
The obtained recombinant strains were able to express constitutively the gene lucGR, coding for 
P. plagiophtalamus luciferase enzyme. L. paracasei LPC-S01-LucGR, grown overnight in 10 ml 
CDM added with 12 μg ml-1 chloramphenicol, was used to inoculate 20 ml CDM in aerobiosis 
and anaerobiosis at 37°C, with addition of heme and/or menaquinone to the final concentration 
indicated above. Every h one aliquot of broth culture was collected and used to monitor the light 
production: specifically, to 200 μl of bacteria were added 50 μl d-luciferin dissolved in 0.1 M 
citrate buffer pH 5.5 (Sigma-Aldrich), corresponding to 125 μM of final concentration. The 
bioluminescence emitted by the recombinant cells was measured by means of a Victor3 
luminometer (Perkin-Elmer, USA), maintaining a constant temperature of 37°C inside the 
instrument.     
 
 
3.3.5. Gene expression analysis 
 
RNA from exponential and stationary phase cells was extracted as described by Arioli (2010). 
Briefly, about 2 x 10
9 
cells were collected and centrifuged to remove the medium. The pellet was 
dissolved in PureZol
® 
 buffer (provided by the Aurum™ Total RNA Fatty and Fibrous Tissue 
Kit, Bio-rad) and about 100 mg of 0.1 mm glass beads were added, to lyse properly the cells by 
means of a Bead Beater Precellys 24 (Bertin Technologies, Montigny le Bretonneux, France). 
After the removal of the beads by mild centrifugation, we followed the instructions provided by 
the Biorad kit. Afterwards, we treated 15 μl of extracted RNA by adding 1 unit of DNAse 
(Sigma-Aldrich) and by incubating at RT for 30 min. Stop solution provided by the manufacterer 
was added to inhibit the enzyme at 70°C for 10 min. After that, we quantified and checked the 
integrity of the RNA obtained by reading the absorbance at 260/280 nm and by running 1 μl of 
sample on a 1% agarose gel. 1 μg of RNA was then used for the reverse transcriptase reaction 
(iScript™ cDNA Synthesis Kit, Bio-rad) following the kit procedure.   
In the Real Time qPCR 50 ng of cDNA were used for each reaction. Real-time Quantitative PCR 
(RT-qPCR) was carried out in order to measure the mRNA expression levels of metabolic genes 
by means of the SYBR Green technology using the SsoFast EvaGreen Supermix (Bio-Rad) on a 
Bio-Rad CFX96 system according to the manufacturer's instructions. The primers used are as 
follows (5’3’): Tuf forward: CCGTGGTTCTGCTCTGAAGG; Tuf reverse: 
TGTTTCACGAACAGGTGTTGGG; GAPDH forward: GGCTATCGGTTTGGTTATCCCA; 
GAPDH reverse: GTTGTTTTCGGTGTGCTTCTTG; Pol forward: 
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GATTCAGCAAGGGCTCGGTAAG; Pol reverse: GATTGGGCTGCTTGTTCCTCAT; Rpo 
forward: CGGGCTTTCTCGGATGGAAC; Rpo reverse: AACTCACCAAGCGGATTCGTCT;  
Cydq forward: CAGTCAAAGGCATGGAGACAGC; Cydq reverse: 
CCGAGCAGGAACAGAAGAACG; Ldh1 forward: GCGACAAGCCCCAGTGTTGATT; 
Ldh1reverse: GCAAGACGGTCAAGGGACTCCT; Ldh2 forward: 
CCTGTATGGTCCCACGCTAACA; Ldh2 reverse: CGGATAGTGGCAGAACCGCATT; Ldh3 
forward: GTTGCTGACGTGCGTGGTTAC; Ldh3 reverse: 
GACCGCCTGTGTCATTTCAGTC; Ldh4 forward: CCAGGTCAGACACGCCTACAAC; Ldh4 
reverse: AACGCAGACCGATCTCAGACCG; Pfl forward: GTATTGCTTGCTGTGTCTCGG; 
Pfl reverse:  GTTGATCGCATACAGAACCGTC; Pdh forward: 
CAGAGGGCACGTACACGGTA; Pdh reverse: CAGCAGCTTTCAACGCTTCGC; Ack1 
forward: AGCCGACTGTATCGCCATCT; Ack1 reverse: CGCATTTGTGCCAATGGTTTGC; 
Ack2 forward: GTGTTTGATACGGCGTTCCACC; Ack2 reverse: 
CCTTGGACTGCGGTAACACTG. All primers were designed previously and their specificity 
was assessed with melting curves during amplification and by 1 % agarose gels. Quantitative 
PCR was carried out according to the following cycle: initial hold at 95 °C for 30 s and then 39 
cycles at 95°C for 10 s and 60.2°C for 30 s. Gene expression was normalized to the reference 
genes gapdh, pol, rpoB, and tuf. The amount of template cDNA used for each sample was 20 ng. 
All results regarding  target mRNA expression levels are reported as the fold of induction (FOI) 
respective to the control (namely sample without co-factors), to which we attributed a FOI of 1. 
 
 
3.3.6. NAD pool and organic acids quantification 
 
NAD pool was measured by means of the Abcam
®
 NAD/NADH Colorimetric Assay Kit 
(Abcam, Cambridge, UK) following the manufacturer instructions. To quantify glucose, lactic 
acid and acetic acid, 1 ml of broth culture was centrifuged at 9,000 x g for 10 min, and the 
obtained exhausted broth was used for the chromatographic analyses. For the quantification of 
glucose, the chromatographic system consisted of an Alliance model 2695 (Waters) equipped 
with a model 2420 (Waters, Milford, MA, USA) evaporative light scattering detector (ELSD). A 
5 μm Prevail Amino column (250x4.6 mm, Alltech) was used for the separation in isocratic mode 
at a flow-rate of 1.5 ml min
-1
 and the eluent was acetonitrile:water (80:20, v/v). Acetonitrile was 
purchased from Merck (Darmstadt, Germany). The column and the sample were maintained at 35 
and 20° C, respectively. The ELSD conditions were the following: gain 100, pressure 40 psi and 
drift tube temperature 40° C. All data were acquired by Empower 2 software (Waters). 
Calibration curves were obtained from glucose stock solutions prepared by dissolving 200 mg of 
standard powder in 20 ml of water. The working solutions in water:acetonitrile (1:1, v/v) were 
prepared in the range of 0.2-1 mg ml
-1
. For the quantification of lactic and acetic acid, an UPLC-
HR-MS analysis was carried out on an Acquity UPLC separation module (Waters,) coupled with 
an Exactive Orbitrap MS through an HESI-II probe for electrospray ionization (Thermo 
Scientific, San Jose, CA, USA). The ion source and interface conditions were: spray voltage -3.0 
kV, sheath gas flow-rate 35, auxiliary gas-flow rate 10 and temperature 120° C, capillary 
temperature 320° C. A 1.8 µm HSS T3 column (150x2.1 mm, Waters) was used for separation at 
a flow-rate of 0.2 ml min
-1
. The eluents were 0.001% HCOOH in MilliQ-treated water (solvent 
A) and CH3OH:CH3CN (1:1, v/v, solvent B, Darmstadt). Five µl of the sample were separated 
by the UPLC using the following elution gradient: 0% B for 4 min, 0-15% B in 6 min, 15-20% B 
in 5 min, 20% for 13 min and then return to initial conditions in 1 min. The column and samples 
were kept at 30 and 15°C, respectively. The UPLC eluate was analyzed in full scan MS in the 
range 50-130 m/z. The resolution was set at 50 K, the AGC target was 1E6 and the maximum ion 
injection time was 100 ms. The ion with m/z 91.0038, corresponding to the formic acid dimer 
[2M-H]-, has been used as lock mass. The mass tolerance was 2 ppm. The MS data were 
processed using Xcalibur software (Thermo Scientific). Lactic and acetic standard mother 
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solutions (1 mg ml
-1
, Sigma-Aldrich) were prepared by dissolving 0.1 ml of standard in 100 ml of 
water. The working solutions in 0.001% formic acid were prepared in the range of 0.2-20 µg ml
-
1
. Six-point external calibration curves were adopted to quantify lactic and acetic acid in fecal 
samples. Acid  concentrations were expressed in mg per ml of exhausted broth. 
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3.4 RESULTS AND DISCUSSION 
 
3.4.1. Effect of heme and menaquinone on L. paracasei LPC-S01 growth 
 
The first phenotype observed in lactic acid bacterial species with demonstrated respiratory 
metabolism (i.e. L. lactis) was an increased biomass formation when the microorganism was 
inoculated in a medium containing heme. Moreover, it has been reported that higher biomass 
formation is associated with higher final pH (Gaudu, 2002; Arioli, 2012). The same observations 
have been made by other authors when studying L. plantarum metabolism, even if, in this case, 
also a source of menaquinones was added to the medium due to the inability of this species to 
synthesize them (Brooijmans, 2009a). Similarly, in our experiments on L. paracasei LPC-S01, 
we added 10 μg ml-1 hemin and 50 μg ml-1 vitamin K2 to the chemically defined medium (CDM) 
we developed (Tab. 2.2). However, after 24 h growth, when cells achieved stationary phase, we 
found that the addition of the two co-factors did not improve either L. paracasei growth or pH if 
compared to controls (Fig. 3.2). The same result was found in both aerobiosis (Ae-HM) and 
anaerobiosis (An-HM).  
 
 
Fig. 3.2. Growth rate expressed in OD600nm (A) and pH (B) of L. paracasei LPC-S01 cultures in CDM after 
24 h in anaerobiosis (An, black bar) and aerobiosis (Ae, white bar), without cofactors or with addition of 
heme (H) and/or menaquinone (M). Data have been normalized against the respective control and indicate 
average geometric means of three replicates ± standard deviation, calculated from at least three independent 
assays.  
 
 
 
 
3.4.2. Effect of heme and menaquinone on L. paracasei long-term survival 
 
The second clear phenotype observed in respiring L. lactis cells was prolonged survival, or 
robustness, when stored at 4°C for a long period (Arioli, 2012). Consequently, the effects of the 
different growth conditions on the long-term storage survival of L. paracasei were examined by 
monitoring the cell viability during a period of storage at 4°C. The viable cell population of the 
anaerobic cultures after 24 h growth reached approximately 10
9
-10
10
 CFU ml
-1
, whereas the 
viability of aerobic culture was slightly lower (between 10
8
-10
9
 CFU ml
-1
), particularly in culture 
supplemented with heme, even if not statistically significant. Interestingly, when LPC-S01 was 
cultured in presence of heme and menaquinone, it was able to survive for a much longer period if 
compared to the cultures supplemented with none or just one of the molecules. Specifically, 
concerning anaerobic cultures, we observed a drastic reduction of viability after 30 days of 
storage and the complete abatement of the survival after 90 days for all samples with the 
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exception of An-HM (Fig. 3.3A). Similarly, aerobic cultures  showed a strong decrease and 
complete loss of viability after 60 and 150 days, respectively, with the only exception of sample 
Ae-HM) (Fig. 3.3B). These data suggest that: 
 
(i) both heme and menaquinone are necessary to confer to L. paracasei peculiar robustness, 
characterized by a viability decrease of only 3 logs after 210 days of storage; 
(ii)  oxygen plays an important role during growth in the establishment of robustness. 
 
These results are in accordance with previous studies performed on L. lactis IL-1403, in which 
survivability increase  was observed during 90 days of storage (from about 10
10 
to 10
5
 CFU ml
-1
; 
Arioli, 2012). An even stronger phenotype was observed in a study on L. lactis strain MG1363, 
in which a viability of 10
8 
CFU ml
-1
  was not affected during 70 days  (Duwat, 2001).   
 
 
Fig. 3.3. Viability of bacterial cells grown for 24 h in anaerobiosis (A) and aerobiosis (B), and then stored at 
4°C. Time 0 corresponds to sampling performed after 24 h of growth. Cell survival is expressed as log CFU 
ml-1 in CDM medium. Cells were grown under four conditions at 37°C: negative control (no co-factors 
added; white diamonds), addition of heme (grey squares), addition of menaquinone (grey triangles), and 
addition of both heme and menaquinone (black squares). Data points indicate average geometric means of 
three replicates ± standard deviation, calculated from three independent biological assays for each time 
point. 
 
 
 
 
 
To gain more information about the reason of this acquired robustness, we investigated 
membrane integrity and level of radical formation by means of flow cytofluorimetric assays, 
using propidium iodide (PI) and dihydroethidium (DHE) to stain bacterial cells. Specifically PI 
has been used to estimate dead bacterial according to severe membrane damage. PI, in fact, does 
not enter cells with intact membranes, i.e. viable cells. On the contrary, cells with damaged 
membrane allow PI entrance into the cytoplasm, where it binds nucleic acids, causing the rise of 
emitted fluorescence (Watanabe, 2012). On the contrary, DHE provides a measure of the 
oxidative stress levels inside the cell. In detail, this dye can freely cross cell membrane and, once 
in the cytoplasm it can be oxidized by intracellular oxidizing molecules, thus being converted 
into ethidium. Ethidium can intercalate DNA, thus increasing fluorescence. Particularly, DHE 
oxidation is relatively specific for superoxide anion, but it can also be induced by hydrogen 
peroxide, peroxynitrate, and hypochlorous acid (Herrera, 2003). 
 
We performed the analyses on samples Ae-HM, An, and Ae immediately after growth (day 0) 
and after 30, 50, 100 and 150 days of storage. We expressed the data as ratio between 
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fluorescence emitted in An or Ae (controls) and fluorescence of sample Ae-HM (Fig. 3.4). Fig. 
3.4A summarizes the analyses performed with PI; after 24 h growth the An/AeHM and, to a 
lesser extent, the Ae/AeHM ratios indicated that membrane damage was lower in cells grown in 
presence of heme and menaquinone. This can be observed also after several days of storage, 
reflecting the higher viability of sample Ae-HM for longer periods. After 150 days, the ratio was 
equal to 1 so, at that stage, the damage was similar in all samples; however, at that time point 
exclusively sample Ae-HM still contained viable cells. This difference could be due to the fact 
that two populations of cells normally exist: viable but non cultivable (VBNC) and viable-
cultivable (VC) cells (Khan, 2010). For this reason, we can hypothesize that Ae-HM cells exhibit 
a limited membrane damage that did not compromise their survival.   
Regarding oxidative stress, we found a similar trend regarding the ratio between Ae or An, and 
Ae-HM sample, which was always above 1 (Fig. 3.4B). Interestingly, the ratio An/Ae-HM 
showed a nearly linear growth, indicating that increasing formation of reactive oxygen species 
(ROSs) was occurring in the sample cultivated in absence of oxygen. This is plausibly explained 
by the hypothesis that growing in aerobiosis triggers the activation of defensive mechanisms 
which help bacterial cells to counteract the oxidative stress due to the  presence of oxygen 
(Imlay, 2013).  
 
 
 
 
 
 
Since we just observed one of the two main phenotypes related to the respiratory metabolism, we 
wondered if the contribute of heme and menaquinone to the observed phenotype occurred during 
the bacterium growth, as stated in the “respiration theory”, or only during storage. To assess this 
hypothesis, we added none, only one or both molecules to four different aliquots of a unique 
broth culture, grown 24 h in aerobiosis or anaerobiosis, and we stored them at 4°C. We observed 
that the addition of only one or both co-factors conferred robustness to L. paracasei in an 
independent way with respect to the condition of growth (Fig. 3.5). We found a big difference 
again between anaerobiosis and aerobiosis growth conditions, since the latter allowed a higher 
gain in survival, particularly when both heme and menaquinone were added. This phenotype has 
been never described before and strongly suggests that, in our strain, the observed robustness is 
FIG 3.4. Membrane integrity (A) and 
radical formation (B) expressed as mean 
fluorescence (FL-3) ratio between samples 
Ae/Ae-HM (dark grey bar) and An/Ae-HM 
(white bar). Samples were analyzed at time 
0 (corresponding to 24 h of growth at 37° 
C) and after 30, 50 100 and 150 days of 
incubation. Data indicate average 
geometric means of three replicates ± 1 
standard deviation, calculated from three 
independent biological assays for each 
time point. 
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plausibly independent from either a respiratory metabolism or any pathway related to the growth 
phase of the bacterium. 
 
 
Fig. 3.5. Bacterial survival for cells grown for 24 h in anaerobiosis (A) and aerobiosis (B), and then stored 
at 4°C. Time 0 corresponds to sampling performed after 24 h of growth. Cell survival is expressed as log 
CFU ml-1 in CDM  medium. After growth, cells were splitted into four aliquotes: negative control (no co-
factors added; white diamond), addition of heme (grey squares), addition of menaquinone (grey triangles), 
and addition of both heme and menaquinone (black squares). Data points indicate average geometric means 
of three replicates ± standard deviation, calculated from three independent biological assays for each time 
point. 
 
 
 
 
 
3.4.3. Determination of heme absorption by bacterial cells 
 
The results indicated above instilled us the doubt that hemin and vitamin K2 added to the 
medium could act just externally, since their final effect (i.e. the increasing survival) occurred 
also when they were added after the bacterial growth was completed, i.e. while samples were 
stored at 4°C, a temperature that plausibly should not allow an efficient transport and metabolism 
of the co-factor inside the cell. To confirm this hypothesis, we quantified heme in broth and cells 
fractions after bacterial growth in presence of the heme cofactor; in specific, we used a 
colorimetric quantitative assay based on the use of bathophenantroline sulfonate (BPS), which 
specifically allows the measurement of total iron in the sample (Landers JW and Zak, 1958). 
Since chemically defined medium does not contain any source of iron apart from the one 
deriving from the hemin prosthetic group, we could detect the presence of hemin outside or 
inside the bacterial cells. We collected one aliquot of broth with and without addition of hemin at 
the beginning of the experiment (i.e., before inoculating L. paracasei LPC-S01), and then an 
aliquot at 24 and 48 h of growth. Specifically, we analyzed broth, Tris buffer used to wash once 
bacterial cells (in order to remove hemin loosely attached to the cell wall or membrane), and cell 
lysate fractions. As presented in Tab. 3.2, heme was detectable only in the broth fraction, 
indicating that it is not imported inside the cells at a significant amount. It can be also 
hypothesized that heme is internalized but rapidly excreted by efflux pumps due to its 
intracellular toxicity. In L. lactis and Streptococcus agalactiae heme-specific efflux pumps were 
identified, having the function to maintain heme homeostasis inside the cells, coded by operons 
ygfCBA and pefAB/pefRCD. This latter manages heme and iron-free protoporphyrin IX 
homeostasis at low heme concentrations (below 1 µM) (Fernandez, 2010; Stauff, 2008; 
Lechardeur, 2011).      
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Tab.3.2.  Heme quantification by means of bathophenantroline sulfonate (BPS) colorimetric assay. Data are 
average geometric means of two replicates ± standard deviation, calculated from two independent biological 
assays for each time point. nd, heme not detected. 
 
 
 time (h) 
 0 24 48 
 heme (µM) 
broth 14.11 ±1.19 16.18 ±1.38 14.76 ±1.16 
washed 
 
nd nd 
cells 
 
nd nd 
 
 
 
3.4.4. Effect of heme and menaquinone on ATP production rate 
 
We constructed a bioluminescent biosensor that can be used for a quick analysis of the metabolic 
state of cells under different conditions. To construct luminescent L. paracasei, we 
electroporated LPC-S01 with vector pNZ-T5-LucGR, which contains the luciferase gene (lucGR) 
from P. plagiophtalamus under the control of a T5 phage promoter. The insect luciferase is a 
reporter gene, which catalyzes a reaction in which ATP, D-luciferin and O2 are converted to 
AMP, CO2, inorganic pyrophosphate and oxyluciferin, together with yellowish light production 
at 560 nm. Therefore, ﬁreﬂy luciferase catalyzes a bioluminescent reaction that depends 
stoichiometrically on ATP. ATP is involved in many essential metabolic processes, and its 
intracellular level provides a measure of the metabolic state of a cell. Quantiﬁcation of light 
emission, i.e. bioluminescence, is one of the most sensitive real-time means of assessing 
metabolic state of a cell (Guglielmetti, 2008). For this reason, we used the recombinant strain 
LPC-S01-LucGR to monitor intracellular ATP in anaerobiosis and aerobiosis with the addition of 
heme and/or menaquinone (Fig. 3.6). Light emission measured as a function of growth time 
showed a similar overall trend and revealed that bioluminescence drops drastically when cells 
reach the mid-log phase (i.e., after about 12 h from the inoculum). Light emission by 
recombinant cells was highest at the early-logarithmic stage of growth; particularly, the highest 
dATP/dt value was observed for cultures growing without co-factors in both conditions and with 
menaquinone, particularly in aerobiosis. Conversely, we observed that heme alone or combined 
with menaquinone, brings to lower intracellular ATP during the entire growth curve. This 
observation is in accordance with the hypothesis of the existence of a transporter involved in an 
ATP-dependent import/export of heme (Lechardeur, 2011). 
Our results are in contrast to the experiments conducted with bioluminescent L. lactis 1403-945 
(a derivative of IL1403). In fact, Arioli (2012) demonstrated that the maximum dATP/dt value 
was measured in the early exponential phase of growth during fermentation and in the late 
exponential phase of growth during respiratory metabolism. Therefore, our results do not support 
the hypothesis of respiration, which implies a higher yield of ATP production (the number of 
units of ATP generated per unit of sugar molecule consumed) due the presence of the FoF1-
ATPase, that exploits the proton gradient force generated by the electron transport chain 
(Pfeiffer, 2001). In addition, respiration should be characterized by low growth rate and high 
biomass production, whereas fermentation  is characterized by high rate of glucose consumption 
and low biomass production.  
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Fig. 3.6. ATP production rate (dATP/dt) expressed as light emission during growth (panel above) of 
Lactobacillus paracasei LPC-S01-LucGR in CDM in anaerobiosis (A) and aerobiosis (B) in four 
conditions: negative control (no co-factors added; white rombi), addition of heme (grey squares), addition of 
menaquinone (grey triangles), and addition of both heme and menaquinone (black squares). Broken lines 
represent cell densities. Solid lines represent light emission values. 
 
 
 
 
 
 
3.4.4. Gene expression analysis, quantification of organic acids, and NAD
+
/NADH ratio 
evaluation in L. paracasei LPC-S01 grown in aerobiosis 
 
Considering the pivotal role of oxygen in the observed phenotype, we evaluated the gene 
expression levels, the production of lactic and acetic acid, and the ratio between NAD
+
 and 
NADH in L. paracasei LPC-S01 grown in aerobic condition. Specifically, we determined by 
qRT-PCR the relative expression levels of ldh (lactate dehydrogenase), cydA (cytochrome bd 
oxidase subunit I), pﬂ (pyruvate-formate lyase), pdhB (pyruvate dehydrogenase E1 component β 
subunit), and ack (acetate kinase). Gene expression and the NAD
+
/NADH analyses were 
performed at two different stages of growth: mid-exponential phase (exp) and beginning of the 
stationary phase (stat, Fig. 3.7A). In addition, we collected a sample after 24 h of growth to 
measure by UPLC/MS residual glucose, lactate and acetate. 
Regarding gene expression levels, we found only few significant differences among the four 
conditions tested. In specific, among the four ldh genes identified in L. paracasei LPC-S01 
genome, the isoform ldh-1 was constitutively expressed in all conditions, as also observed in 
previous studies (Rico et al., 2008; Fig. 3.7B). Particularly, we could detect an induction of its 
expression in stationary phase in presence of menaquinone with and without heme. Isoforms ldh-
2 and ldh-4 were constitutively expressed as well; on the contrary, ldh-3 showed a strong 
inhibition during exponential phase in the Ae-H sample. Interestingly, NAD
+
/NADH ratio in AE-
H at the exponential phase was 0.97 (Tab. 3.3), i.e. significantly lower than other conditions, 
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suggesting that the inhibition of ldh-3 by heme may imply a slower rate of pyruvate fermentation 
to lactic acid, thus reducing also glycolysis process  efficiency due to the lack of the oxidized 
form of NAD (Garrigues, 1997). However, after 24 h of incubation, lactic acid was accumulated 
in Ae-H broth (Ae; Fig. 3.7C).  
Regarding pyruvate-formate lyase (pfl) expression, an enzyme that evolves pyruvate to acetyl-
CoA towards production of acetate, the presence of menaquinone (combined or not with heme) 
led to its inhibition during exponential phase and to activation during the stationary phase (Fig 
3.7B). Although having found no significant differences in acetate kinase (ack-1 and ack-2) 
expression, we observed higher production of acetate in Ae-HM condition (Fig. 3.7C). 
Addressing pyruvate to acetate instead of lactate, can give an energetic advantage to the cell, 
since it involves the gain of one molecule of ATP for each molecule of acid produced. 
Differently inform previous observation in respiring L. lactis cells (Arioli, 2012), acetoin and 
diacetyl were not detectable in our samples. The reason why the combination of aerobiosis 
condition with the two exogenous molecules heme and menaquinone led to the increase of acetic 
acid is still under investigation, but we can speculate that relies on the NAD pool status 
(Tab.3.3): NADH generated by glycolysis can take other ways to be re-oxidized that differ from 
the lactic fermentation, possibly the electron transfer chain, as in respiration metabolism in L. 
lactis, or an extracellular electron transfer (EET) (Freguia, 2009; Yamazaki, 2002). The fact that, 
in our experiments, the terminal cytochrome oxidase subunit A (cydA) expression resulted 
inhibited in presence of heme and/or menaquinone (Fig. 3.7B), further support the hypothesis of 
the absence of an actual respiratory metabolism in the L. paracasei strains under study. On the 
contrary, data collected so far suggest that the strong robustness we observed in presence of both 
heme and menaquinone (which is boosted by the presence of oxygen) is due to an external or 
periplasmic phenomenon. At this point, it would be of interest to carry out a more comprehensive 
gene expression analysis by means of transcriptomic approaches, in order to have more detailed 
information about the metabolic scenery and the involvement of specific enzymes in the 
predicted extracellular electron transfer (Pedersen, 2008; Stevens, 2008). 
 
 
 
Tab. 3.3. NAD+/NADH  ratio measured in exponential and stationary collections as indicated in Fig. 3.7A.  
 
 
  NAD+/NADH ratio  
sample Exponential Stationary 
Ae 15.44 0 
Ae-H 0.97 0 
Ae-M 11.94 0 
Ae-HM 7.4 0.02 
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Fig. 3.7. (A) Lactobacillus paracasei LPC-S01 growth curve under four conditions: aerobiosis (Ae), 
aerobiosis with addition of heme (Ae-H), aerobiosis with addition of menaquinone (Ae-HM) and aerobiosis 
with addition of both molecules (Ae-HM). Aliquots for the extraction of mRNA and quantification of NAD 
pool were collected as indicated: during exponential (exp) and at the beginning of stationary (stat) phase. 
(B) Quantitative analysis of gene expression. Expression levels of ldh-1, ldh-2, ldh-3, ldh-4, pdh, pfl, ack-1, 
ack-2 and cydA  are shown as the Log2 of the fold change of induction (FOI) relative to the control (Ae 
sample), which was set at a value of 1. Presented data are the means of measurements for a result 
representative of three independent experiments. (C) Quantification by means of LC/MS of glucose, lactic 
acid and acetic acid in the broth of L. paracasei LPC-S01 at the beginning of the stationary phase (24 h 
growth).  
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3.5 CONCLUSIONS 
Lactic acid bacteria are widely used in food industry for the production of a diverse range of 
fermented foods with improved shelf-life, taste and nutritional properties. A growing body of 
literature demonstrates how some species belonging to this group of bacteria have a double 
metabolic life: they can switch from fermentation to a respiratory-like metabolism (Pedersen, 
2012). However, such metabolic switch is achieved only upon exogenous exposure to a source of 
heme and, in some cases, menaquinones, which together with a terminal cytochrome oxidase 
help to establish a functional electron transfer chain (Koebmann, 2008; Gaudu, 2002; 
Brooijmans, 2009b). This kind of metabolism results in two main advantages for the cell: 
increased biomass and long-term survival. Starting by these previous observations, and thanks to 
the identification of the operon cydABCD in the L. paracasei strains under investigation, we 
carried out experiments aimed to evaluate if the respiratory-like metabolism was activated also in 
the strains DG and LPC-S01. All presented data refer to strain LPC-S01 since we did not find 
any significant difference between them, apart for the better capacity of LPC-S01 to internalize 
dyes used in cytofluorimetric analyses. 
We verified that only one of the two phenotypes indicative of the respiratory metabolism 
occurred in L. paracasei. However, the addition of heme and menaquinone led to a very strong 
robustness acquisition, particularly if bacterial cells were grown in aerobiosis; particularly, LPC-
S01 cells grown in aerobiosis in presence of heme and vitamin K2 survived storage at 4°C for 
more than 200 days, along with a decreased membrane damage and a lower oxidative stress level, 
as measured by cytofluorimetric analyses. Subsequently, we tried to understand why the 
contribution of heme and menaquinone was apparent only during the storage time, and not during 
growth; to this aim, we added the co-factors only after L. paracasei had reached the stationary 
phase, i.e. just before storage. This experiment allowed us to observed that  bacterial cells stored 
in presence of heme and menaquinone acquired the robustness phenotype independently from the 
condition in which they were cultivated. This fact, along with the detection of heme exclusively 
outside the bacterial cells during growth, and the under regulation of gene cydA, suggested that 
the observed phenotype was not a consequence of a respiratory metabolism but, potentially, was 
due to an export of electrons outside cell, as proposed by other works (Khan (2012a and 2012b, 
Yamazaki 2002 and Freguia 2009). Other evidences supporting our hypothesis were obtained by 
measuring ATP production rate by means of a bioluminescent reporter system inserted in strain 
LPC-S01, which demonstrated that the presence of heme (alone or with menaquinone) led to the 
decrease of energy reservoir if compared to controls. Also this evidence is not in accordance with 
the establishment of the respiratory electron transport chain, which, contrarily, should be coupled 
to a slower growth rate but an increased ATP production by the FoF1 ATPase (Pfeiffer, 2001). 
Gene expression analysis, NAD
+
/NADH ratio assay, and organic acids quantification gave us 
some insights about the possible mechanisms at the basis of the acquired robustness. In specific, 
we could speculate that L. paracasei, converting pyruvate to acetate instead of lactate, can give 
an energetic advantage to the cell, by gaining an extra ATP one molecule. This metabolic switch 
towards acetate production can be a consequence of the decreased need of the bacterial cell to re-
oxidate NADH to NAD
+
 because of the reduction of exogenous (and potentially extracellular) 
molecules. Our speculation has still several unclear points that may be clarified by two possible 
approaches: (i) a comprehensive transcriptomic approach in order to identify the regulation of 
other genes we have not considered yet and that could be involved in establishment of the 
acquired resistance; (ii) the use of microbial fuel cells, as described in previous works (Khan, 
2012a; Freguia, 2009), in order to understand if an extracellular electron transfer (EET) occurs 
upon addition of heme and menaquinone (or other similar molecules, such as riboflavin) and if 
oxygen plays a role in the process.  
Even if we do not have conclusive data about the molecular mechanisms at the basis of L. 
paracasei acquired resistance, we consider this phenotype of particular interest  that can be 
exploited at industrial level, since it can confer to the bacterium improved viability, as observed 
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for L. lactis, and a potential higher capacity to resist to environmental stresses (Pedersen, 2005). 
Moreover, L. paracasei is used as probiotic and can be delivered to the human gut, an 
environment that is a natural source of external molecules that can be electron acceptors. This 
fact could be an advantage for the bacterium itself, because it improves its resistance to the 
complex habitat in which it resides. Furthermore, potential electron acceptors, especially ketones 
and aldehydes provided with diet (e.g. acrylamide) or produced in the colon by the digestion 
process of proteins (e.g. acetaldehyde, acrolein, diacetyl, crotonaldehyde, formaldehyde, furan, 
furfural and hydroxymethylfurfural) have been connected to several human neurodegenerative 
disorders, diabetic complications, hypertension and inflammation (Ellis, 2007; Guillén and 
Goicoechea, 2008; van Niel, 2012). For this reason, the microbiota, as well as the probiotic 
intervention, may be crucial for the in vivo biodetoxification of these detrimental molecules; in 
this context, the potential capability of L. paracasei to reduce external molecule could be an 
advantage also for the host. 
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18th Workshop on the Developments in the Italian PhD Research on Food Science 
Technology and Biotechnology, Universities of Padova and Udine, Conegliano 25-27 
September, 2013 
 
Functional genome analysis, metabolism study, and probiotic characterization of 
Lactobacillus paracasei strains.  
Balzaretti S 
 
This research project is focused on the evaluation of the probiotic potential of different strains 
of Lactobacillus paracasei. Particular attention will be spent on the characterization of three 
strains isolated from different environments. To this aim, in vitro methods conventionally 
employed for the assessment of the probiotic potential of microbial cells will be used (resistance 
to acidity and bile salts, adhesion to Caco-2 human epithelial cell line, inhibition of several 
microbial pathogens). Furthermore, we will employ functional genome analysis and some 
molecular tools to characterize the catabolic properties and the host-microbe relationship of L. 
paracasei. 
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11
th
 Symposium on Lactic Acid Bacteria, 31 August – 4 September, 2014 (Egmond aan 
Zee, The Netherlands) 
 
Respiratory  condition  induces  a  catabolic  shift  that  promotes  long-term  survival  in  
Lactobacillus paracasei   
Balzaretti S, Arioli S, Taverniti V, Mora D, Guglielmetti SD   
Lactic acid bacteria are conventionally classified as obligate anaerobic microorganisms, 
however several studies support the hypothesis that certain species, such as Lactococcus lactis 
and Lactobacillus plantarum, may shift to a  respiratory  metabolism  when  exogenous  heme  
and,  if  necessary,  menaquinone  sources  are  added  to  the cultural medium. Since this 
capacity has never been investigated in Lactobacillus paracasei, the aim of this study was to 
understand if the same metabolic change may occur in L.paracasei LPC-S01 and DG, two 
strains used industrially as probiotics. The addition of heme and vitamin K2 (source of 
menaquinone) to an aerobic culture (Ae-HM) in  MRS did not improve  L.  paracasei  growth  
compared  to  anaerobic  (An)  and  aerobic  (Ae)  cultures  without  co-factors. Nonetheless,  
Ae-HM  condition  strongly  increased  long-term  cell  survival  at  4°C  in  exhausted  MRS  
broth. Interestingly,  drastically  enhanced  cell  viability  was  also  observed  when  L.  
paracasei  Ae-HM  cultures  were prepared in an industrial culture medium. To understand the 
molecular basis of this acquired resistance capacity, we performed cytofluorimetric analyses, 
which evidenced that Ae-HM cells had reduced membrane damage and oxidative stress levels 
compared to An and Ae cultures. Moreover, we observed by HPLC the production of a higher 
amount of acetate by the Ae-HM compared  to  Ae  and  An  cells.  This  result  was  also  
supported  by  RT-qPCR  analysis,  which  showed  higher expression levels of acetate kinase, 
an enzyme that converts acetyl-phosphate to acetate with production of ATP. In conclusion, we 
propose that L. paracasei can be able to activate the electron transport chain upon exogenous 
administration  of  heme  and  menaquinone,  shifting  the  metabolism  towards  the  production  
of  acetic  acid; consequently, bacterial cells may benefit of a reduced oxidative stress and an 
enhanced energy yielding, which may preserve cell viability. The respiratory-like metabolism 
of L. paracasei can represent a method to improve the resistance performances of L. paracasei 
probiotic strains at industrial level.   
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19th Workshop on the Developments in the Italian PhD Research on Food Science 
Technology and Biotechnology, University of Bari, Bari, September 24th-26th, 2014 
 
Probiotic characterization and metabolism study of Lactobacillus paracasei  
 
Balzaretti S  
 
The first two activities of the PhD thesis project are described. Firstly, we evaluated the 
probiotic potential of several strains of Lactobacillus paracasei, according to the in vitro 
methods suggested by EFSA. Secondly, we studied the shift into the respiratory metabolism in 
L. paracasei induced by exogenous heme and menaquinone sources in the cultural medium by 
means of microbiology methods, metabolite pool and gene expression analysis. 
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International Yakult Symposium, Berlin, 23-24 Apr, 2015. 
 
Probiotics can exert profoundly different effects on the intestinal microbial ecosystem of 
healthy subjects depending on the product formulation: comparison of two randomized, 
double-blind, crossover, placebo-controlled intervention trials  
 
Taverniti V, Ferrario C, Balzaretti S, Colombo S, Mugetti S, Gargari G, Guglielmetti S 
 
Introduction. Because of a lack of consensually accepted and validated biomarkers, it is difficult 
to assess the benefits of probiotics in a healthy population. The impact of a probiotic product on 
the gut microbiota composition is thus the initial target for any evaluation of its efficacy. We 
report here the results of two intervention studies called PROBIOTA-DG and PROBIOTA-Bb, 
aimed to assess the modifications induced in the fecal microbiota of healthy adults by the 
consumption of commercial probiotic products. 
Methods. We used Ion Torrent PGM high-throughput DNA sequencing technology according to 
a randomized, double-blind, crossover, placebo-controlled study design to characterize the fecal 
microbiota composition of healthy adults after four weeks of daily consumption of one capsule 
of the probiotic supplement (per capsule: 24 billion viable cells of Lactobacillus paracasei in 
PROBIOTA-DG, 1 billion of viable cells of a Bifidobacterium bifidum strain in PROBIOTA-
Bb). In post-hoc analysis, we also evaluated the fecal concentrations of short chain fatty acids 
(SCFAs) by HPLC. 
Results and discussion. No significant effect was observed upon the consumption of capsules 
containing Bifidobacterium bifidum on the fecal bacterial-community structure and SCFAs 
levels. On the contrary, the Lactobacillus paracasei-based product significantly affected the 
relative abundance of specific members of the bacterial order Clostridiales, resulting in subject-
dependent modulation of fecal SCFAs. Specifically, the intake of L. paracasei increased the 
Blautia/Coprococcus ratio, which, according to literature, can confer a health benefit on the 
host. Moreover, the probiotic intervention showed a rebalancing effect on SCFA concentrations 
(particularly butyrate), highly dependent on the initial characteristics of the intestinal microbiota 
(J. Nutr. 2014;jn.114.197723). Interestingly, the strain L. paracasei DG employed in this trial 
was demonstrated to be beneficial in several intestinal diseases when administered in the same 
formulation used in PROBIOTA-DG (Curr. Clin. Pharmacol. 2013;8:169-72; Aliment. 
Pharmacol. Ther.2013;38:741-51). 
Conclusion. This work demonstrates that both bacterial strain and dose may be crucial for the 
efficacy of a probiotic product. In addition, this work indicates that a probiotic preparation that 
is beneficial in a pathological or dysfunctional context (such as that including L. paracasei DG) 
may also exert significant potential benefit when consumed by healthy people.    
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20th Workshop on the Developments in the Italian PhD Research on Food Science 
Technology and Biotechnology, University of Perugia, Perugia, September 23rd-25th, 
2015 
Probiotic and energetic metabolism characterization of Lactobacillus paracasei. 
 
Balzaretti S 
 
 
This research activity aimed to highlight the probiotic properties of two Lactobacillus paracasei 
strains, by means of in vitro and in vivo techniques, and by the identification of a unique genetic 
cluster for the synthesis of exopolysaccharides. The peculiar ability of this species to counteract 
oxidative stress and overcome redox imbalance by exploiting external electron acceptors, also 
naturally localized in the gut, was further investigated.   
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Pharmabiotics Conference 2015, Paris, 29-30 Oct, 2015.   
 
 
A novel hetero-exopolysaccharide mediates the recognition of Lactobacillus paracasei DG by 
the immune system 
 
 
Balzaretti S, Taverniti V, Guglielmetti S, Fiore W, Ngehnyuiy H, Humphreys P, Laws AP. 
 
 
Lactobacillus paracasei DG is a bacterial strain that has been commercialized as a probiotic for 
more than 15 years under the commercial name of Enterolactis
®
. Reportedly, L. paracasei DG 
exerts health-promoting properties including maintaining remission of symptomatic 
uncomplicated diverticulosis, reducing inﬂammation in mild ulcerative colitis, and reducing 
side effects during therapy for Helicobacter pylori eradication and after antibiotic treatment of 
small intestinal bacterial overgrowth. Furthermore, L. paracasei DG was demonstrated to 
modulate fecal Clostridiales bacteria and butyrate levels in healthy adults. The mechanisms 
underlying the probiotic properties of strain DG, however, are still largely unknown. For this 
reason, we undertook the genome sequencing of this strain. 
Comparative analysis of DG’s draft genome allowed the identification of a gene cluster 
putatively involved in exopolysaccharide (EPS) synthesis. Specifically, we found a 16 kb region 
composed of 19 ORFs, which includes several putative glycosyltransferase genes and contains a 
region of about 8 kb that was found to have no significant similarity with other DNA sequences 
deposited in GenBank. 
We isolated and purified the capsular fraction of the EPS produced by DG cells. NMR 
analyses revealed that DG’s EPS is a hetero-exopolysaccharide composed of a branched 
repeating unit with a chemical structure that has never been described before in lactobacilli and 
probiotic bacteria. 
The purified EPS was then used, in vitro, to stimulate macrophages obtained from the human 
cell line U937. Immunological experiments showed that the EPS had the ability to activate 
macrophages by triggering the expression of TNF-α and COX-2. The same ability is provided 
by EPS to whole DG cells, which, in fact, displayed an increased immunostimulatory activity 
compared to other L. paracasei strains, including the reference probiotic strain Shirota. 
This study demonstrates that L. paracasei DG expresses an exopolysaccharide with a novel 
structure conferring distinctive immunomodulatory properties to this probiotic bacterium. 
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